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Thermal therapy can be regarded as one of the promising emerging technologies for 
cancer treatment. In the current study, proof-of concept patient-specific treatment 
protocols are formulated for high frequency ultrasound thermal therapy for intramural 
and external delivery. Propagation of ultrasound waves in biological tissue is first 
determined using the finite difference method, which generates the temperature 
histories from the bioheat transfer model. Thermal coagulation contours are 
determined by thermal dose information. From an analysis of the results for a range 
of parameters, treatment protocols for prostate and breast cancers are developed for a 
broad spectrum of patients. Results indicate tumors varying in size and location can 
be targeted effectively using the designs employed. To further improve simulations, 
thermal damage data for breast cancer is determined through pilot in vitro 
experiments.  The algorithms developed can help optimize the design of delivery 
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Chapter 1: Introduction 
 Fighting cancer can be stressful and uncertain, and side effects from 
traditional treatment methods such as radiation, open surgery, and chemotherapy can 
further compound the patient’s stress. Thermal therapy provides an attractive 
alternative treatment option.  It offers advantages of being minimally invasive, less 
expensive, and posing less risk of post-procedural complications, while possessing 
the potential to be effective.  The ultimate goal of the research conducted in this 
project is to increase the efficacy and accuracy of thermal therapy by ultrasound (US) 
thermal therapy, so that it can become a common cancer treatment.   
 
Prostate and Breast Cancers 
Prostate and breast cancers are two of the most prevalent cancers among men 
and women, respectively.  One in six male Americans is diagnosed with prostate 
cancer [1], while one in eight women in the U.S. will receive a breast cancer 
diagnosis [2].  The large disparity between the number of cases of prostate and breast 
cancer when compared to other cancer types is depicted in Figure 1 (for men) and 
Figure 2 (for women), from the Cancer Statistics report (reprinted with permission).  
The plots display the number of diagnoses per 100,000 people from 1975 to 2008, 
and prove how these cancers have consistently dwarfed the prevalence of other cancer 





Figure 1 The number of men who are diagnosed with different types of cancer for every 100,000 men from 
1975 – 2008 (with permission) [3]. 
 
Figure 2 The number of women who are diagnosed with different types of cancer for every 100,000 women 






 The current cancer modalities often are associated with a great deal of 
discomfort and health damage; also, these treatments often incur long patient 
recoveries in and out of the hospital.  Prostate cancer is usually treated with surgery, 
hormone therapy, chemotherapy, or radiation treatments [4].  These treatments are 
often associated with problems such as urinary incontinence, sexual dysfunction, 
urinary tract infections, and rectal damage [5, 6].  Trans-urethral resection of the 
prostate (TURP) is considered the “gold-standard” for treating BPH and prostate 
cancer, but it is not acceptable for all patients (especially those who are older or of 
poor health) [7, 8].   
Breast cancer is also primarily treated with surgery, along with chemotherapy, 
radiation treatment, and hormone therapy [9].  A mastectomy can have a negative 
social impact and degrade the quality-of-life for females, while a lumpectomy, 
although not as severe, still leaves a scar [7].  Chemotherapy can be a problem 
because there are a finite number of chemotherapy treatments that patients can 
receive because, while becoming more focused in its targeting capabilities, it is still a 
toxin that adversely affects many different body systems. [7].  Radiation treatments 
harm the tissue surrounding tumors because the harmful rays spread throughout more 





Thermal Ablation by Ultrasound Thermal therapy  
Thermal treatment is an innovative cancer treatment option which is 
potentially superior to other methods because it destroys the malignant cells without 
the harmful side-effects of radiation or chemotherapy.  Thermal therapy involves 
heating cancerous cells to supraphysiological temperatures with the goal of inducing 
cell death.  Thermal therapy refers to heating cells in the temperature range of 41 to 
46°C; if temperatures above 46°C are used in treatments then it is considered thermal 
ablation [10, 11].   
Currently microwave, radio-frequency (RF), and laser ablation are in use for 
local thermal therapy; however, they have limitations that warrant better methods be 
examined. For example, microwave therapy lacks the ability to focus heat into the 
target zones effectively, i.e., to treat tumors without affecting the surrounding healthy 
tissue, and RF therapy tends to be more invasive compared to other methods and may 
require multiple applications in smaller bursts to avoid damage to healthy 
surrounding tissue [12]. 
In the present study, high frequency ultrasound (US) ablation is utilized as a 
treatment option because of its ability to focus heat more effectively and less 
invasively compared to the other minimally invasive methods.  Additionally, delivery 
of US can be interstitial, intraluminal, or extracorporeal [7].  High intensity 
ultrasound for medical therapy was proposed back in 1942, but it was not until 1960 
that it was sufficiently validated to attempt human treatment [13].   
Ultrasound thermal therapy has the potential to be superior to traditional 




disruption to the patient’s life.  There is little pain, no dosage limit, and it allows for a 
quick recovery with no scars [7].  Also, it has the ability to treat deep-set tumors from 
an extracorporeal transducer when the US beams are effectively located and steered 
[14].  US thermal therapy has been proven effective on cancers of the liver, prostate, 
breast, kidney, bone, bladder, and non-cancerous diseases such as benign prostatic 
thermal therapy (BPH), uterine fibroids, and acoustic hemostasis [14, 15, 16, 17]. 
Most importantly to this research, the potential and efficacy of US thermal 
therapy has been proven for prostate treatment (both for cancer and non-cancerous 
BPH) [13] and breast cancer [18].  This this study will focus on the improvement of 




There are three main objectives of this study: (1) to simulate and design a 
device for prostate cancer ablation from US thermal therapy, (2) to simulate and 
design a device for breast cancer ablation from US thermal therapy, and (3) to 
develop thermal-damage models for breast cancer cells to improve the simulations.  
The devices designed will also have an associated treatment planning protocol so the 
physicians can design patient-specific treatments. 
This thesis will first provide the necessary background information, then 
detail the numerical technique used to simulate tissue necrosis and device design for 
prostate cancer, explain the steps for simulation and design of breast cancer treatment 




Chapter 2: Background 
 
The process of tumor ablation by ultrasound thermal therapy begins with an 
ultrasonic wave created by a transducer.  This wave heats up the tissue, which will 
cause cell death after a lethal heat dose is administered.  An understanding of the 
science behind ultrasound and cellular death from thermal therapy is important for the 
choices made during this study.  The following chapter will first discuss prostate and 
breast cancer, and then it will explain the general principles behind ultrasound 
thermal therapy, the physics of ultrasound propagation and generation, the physics of 
heat transfer through biological tissue, and finally the currently-available ultrasound 
thermal therapy devices. 
 
Prostate and Breast Cancer 
 It is important to understand the anatomy of the parts of the body which are to 
be modeled to create an accurate simulation.  This section details the anatomy of the 
prostate and breast. 
 
Prostate Anatomy 
 The prostate gland is a male reproductive organ which adds a nourishing fluid 
to semen.  A healthy prostate should be about the size of a walnut, and surrounds the 
top of the urethra (passes urine from the bladder outside of the body).  During 
ejaculation, sperm flows from the testes to the prostate gland, where it becomes 




and exits the body.  The prostate gland grows continuously after puberty, and if the 
prostate becomes too large it is called Benign Prostatic Hyperplasia, which can cause 
urinary disorders [19]. 
 Benign Prostatic Hyperplasia (BPH) is a non-cancerous growth of the prostate 
gland.  The enlarged prostate will block the bladder exit and the top of the urethra, 
which greatly impacts the urine flow rate (Figure 3).  This disease is very common, 
and mostly begins when the patient is in his middle ages (Figure 4).  Almost 100% of 
the males aged 90 or older are affected by BPH [20].  BPH results from a 
combination of normal prostate growth and the formation of nodules [20].   
  
Figure 3. The enlarged prostate blocks the bladder exit and the top of the urethra [21]. 
 
Figure 4. Number of men with enlarged prostates versus age, demonstrating the increase of BPH prevalence 




 BPH is not cancer and does not cause cancer, however it can be indicative of 
prostate cancer in the future.  Prostate cancer usually occurs in patients with an 
enlarged prostate and years after the development of BPH.  About ten percent of the 




 The breast is mostly consisting of fat tissue with hollow lobules surrounding 
and connected to the nipple which bring the milk to the breast during nursing [22, 23, 
24].  The pectoralis muscle lies behind the breast on the chest [23, 24].  The 
vasculature and lymph ducts mostly propagate in the radial direction away from the 
nipple.  Figure 5 is a diagram of the anatomy of the breast. 
 






The Principles of Ultrasound Thermal therapy 
 When cells are heated, there are two mechanisms which contribute to cell 
death: thermal stress from the absorption of heat energy and mechanical stress from 
acoustic streaming and cavitation effects [7, 25].  Cavitation can occur from either 
highly negative pressures caused by the US wave which create an air pocket in the 
tissue, or the phase change of the water inside the tissue into gas at temperatures 
exceeding 100
o
C [13, 17].   
When the ultrasound wave is generated into the body, it causes a vibration of 
the tissue molecules [26].  This leads to friction in the tissue, which turns the 
ultrasonic energy into thermal energy [13].  Thermal therapy (41 to 46°C) causes cell 
death by inducing apoptosis (programmed cell death [27]), whereas thermal ablation 
(> 46°C) directly kills the cells by necrosis (lysis formation and membrane 
degradation [27]) [10].  Thermal ablation requires a much shorter heating time, 
usually on the scale of seconds to a few minutes, but thermal therapy needs anywhere 
from thirty minutes to a few hours to be successful [10].  Another difference is that 
higher temperature treatments usually require only one dose, while at moderate 
temperatures multiple treatments may be necessary: this adds to the appeal of thermal 
ablation, so recently further research has been conducted to fully understand the 
associated cell death to make it a more reliable option [28]. 
 US thermal therapy can be monitored in real-time during treatments through 
use of magnetic resonance imaging (MRI) or ultrasonic imaging [13, 26].  This 
allows for control of the procedure by observing the temperature in the treatment area 




slightly different geometry of vasculatures.  This study does not research thermal 
monitoring of treatments, but it is important to be kept in mind during device design. 
 Ultrasonic waves have a higher intensity close to the transducer than at a 
distance away [26] (see Ultrasound Physics section); this is advantageous for tumors 
close to the edge of the body because a transducer can be nearby and then the tissue 
past the tumor location will be spared the high treatment temperatures.  However, if 
the tumor is deeper set, then it may be necessary to use high-intensity focused 
ultrasound (HIFU) to move the location of highest temperature further from the US 
source.  The ultrasonic wave can be focused by using a focusing transducer 
(explained in Ultrasound Physics section), and causes a very small volume of 
necrosed tissue (roughly an ellipsoid shape, with center diameter usually around 2-3 
mm with a length of 8-10 mm [17]).  There is a very distinct boundary created 
between the dead cells and non-disrupted tissue cells, which makes this treatment 
ideal for sparing healthy tissue surrounding a tumor [7].  Adding to this advantage is 
the increased toxicity of thermal therapy to tumors as opposed to healthy tissue 
because there is a lack of perfusion inside tumors, and perfusion cools the tissue 





Figure 6 Schematic of HIFU transducer focusing on a small volume of tissue.  The photo on the upper left 
shows the geometry of this necrosed region, and the image to its right displays the distinct boundary between 
the necrosed and unharmed tissue [7]. 
 This study focuses on the use of ultrasound thermal therapy for treating 
tumors in the prostate gland or the breast.  The anatomy and geometry of these body 
parts dictate the most-effective US treatment methods.  The prostate’s proximity to 
the urethra and the rectum allow for an intraluminal transducer to get very close to its 
surface.  It is especially useful in curing the non-cancerous prostate growth (BPH) 
because a total destruction of affected area is not crucial [5].  The breast works well 
with extracorporeal devices because of its convex shape, and since there are no bones 
and small vasculature, there is little blocking the ultrasonic waves from their 
predicted propagation path [15, 29]. 
 
Ultrasound Physics 
Ultrasound refers to an acoustic wave with a frequency above audible human 




kHz and 45 MHz [30].  In order to understand how US creates a hyperthermic effect 
in the body, the physics behind US propagation must be understood. 
 
Single Wave Propagation 
 Sound is a compression wave, which has its peaks and valleys in the direction 
of propagation (longitudinally), shown in Figure 7.  This wave is created because the 
speed of the particles oscillates, so when they move slower compression of the 
particles occurs, and faster motion creates rarefaction.  The distance between two 
compression or two rarefaction locations is called the wavelength (λ). 
 
Figure 7 Sound waves travel by compression and expansion of particles [26]. 
The time it takes for one wavelength to pass a fixed location defines the wave 
period, which is the inverse of the wave frequency (f).  The wavelength and 








where c is the speed of sound propagation.  This speed is highly dependent on the 
medium through which the wave travels, and some common values for biological 
materials are given in Table 1. 
Table 1 Speed of sound through different biological materials [26]. 
Type of Biological Material Speed of Sound (c) 
Soft Tissue (except lung) 1550 m/s 
Fatty Tissue 1480 m/s 
Lung  600 m/s 
Bone 1800 – 3700 m/s 
 
 The intensity of the ultrasonic wave will be very high in close proximity to the 
source, but then rapidly decreases past the “near-field” [26].  The near-field, also 
known as the Fresnel zone, is characterized by Equation 2 [26] 
   
  
 
 Equation 2 
where dF is the distance to the edge of the Fresnel zone and a is the radius of the 
planar, circular ultrasound transducer which created the wave.  A graphical 
representation of this decay in intensity is displayed in Figure 8. 
 





 The amplitude is half of the difference in magnitude between the points of 
compression and rarefaction in the sound wave.  During its travel, the wave amplitude 
does not necessarily remain constant; dispersion, attenuation, and scattering 
contribute to the decrease of a wave’s amplitude.  Dispersion is the spreading out of 
the wave into different frequencies as it travels through a medium [31].  The US wave 
dispersion is neglected in this study because it has minimal effect on the energy losses 
[32]. 
 Also, as the wave travels energy is transferred from the sound wave to the 
medium in the form of heat absorption (as mentioned in The Principles of Ultrasound 
section).  Some of the wave energy is also scattered in directions other than the 
direction of propagation.  This absorption and scattering result in an attenuation of the 
wave’s intensity, characterized for travel through a homogenous material by Equation 
3 [13, 30, 33, 34] 
     
     Equation 3 
where I is the intensity of the wave, Io is the initial intensity, α is the attenuation 
coefficient, and x is the propagation distance.  The attenuation coefficient is a 





Table 2 Acoustic attenuation coefficient of different biological materials [35]. 
Biological Material 
Acoustic Attenuation 








Skull Bone 1.3 
 
These values are both frequency and temperature dependent.  The frequency 
dependence of the attenuation coefficient is approximately characterized by Equation 
4 [13, 36, 33] 
     
  Equation 4 
where αo is the temperature-dependent factor, f is the frequency, and n is between 1 
and 2 for biological tissues.  In biological tissues, there is a large increase in acoustic 
attenuation as the tissue temperature increases [14].  For the purpose of this paper, the 
attenuation coefficient is defined by Equation 5 [32] 
                         
                            ((            )   ) 
Equation 5 
where the thermal dose is a value defining the time and temperature exposure of the 
tissue, which will be discussed in the Thermal Damage to Cells section.  No 







US Focal Point – Multiple Wave Interference 
 Wave diffraction is the diversion of the wave particles from their linear 
propagation direction [20].  This phenomenon was first reported by Francesco 
Grimaldi, and was claimed by Christiaan Huygens [20].  Huygens’ principle states 
that a wave-front is the result of the combination of many spherical wave point 
sources (shown in Figure 9), which can be proven experimentally by the diffraction 
pattern created from a light source shining through a thin slit. 
 
Figure 9 (a) Flat and (b) curved wavefronts resulting from multiple point sources, according to Huygens’ 
principle [37]. 
Each spherical wave creates its own pressure along its propagation path, and the 
summation of each pressure determines the pressure profile within the tissue volume.   
 Each wave reaches a local maximum pressure every wavelength.   
If two waves of the same frequency are in phase (their peaks coincide), then 
constructive interference is created and the amplitude of the wave is the sum of each 
wave’s amplitude.  If two waves are out of phase (the peak from one wave coincides 
with the valley from the second), then it is completely destructive interference, and 
the amplitudes are subtracted from one another (Figure 10).  If constructive 
interference occurs in one location from multiple waves, then a focal point with a 





Figure 10 Two in-phase waves combine to create (a) constructive interference; two out-of-phase waves 
combine to create (b) destructive interference [38]. 
 This focal point can be created mechanically or electronically.  If it is 
mechanical, either a curved transducer is used or multiple wave sources are placed in 
locations where their peaks will all intersect at a specified point (Figure 11).  
Electronic focal points are created by timing the US emission of multiple sources so 
that the delays cause the peaks to coincide (Figure 12).   
 
Figure 11 An ultrasound transducer with a curved lens to focus the wave [26]. 
 




The phase difference between any two point sources with the same frequency 
waves for complete constructive interference will occur according to Equation 6 [39] 
   
     
 
    Equation 6 
where Δφ is the phase difference, and d1 is the distance from the first source to the 
specified point, and d2 is the distance from the second source to the specified point (d1 
and d2 are depicted in Figure 13), and λ is the wavelength of the waves.  This 
calculation is performed for every transducer to determine the phase difference to 
create this peak.  However, it must also be considered that there will be secondary 
peaks where other wavelengths intersect with each other. 
 
Figure 13 Array of transducer elements (blue squares) and a focal point (red circle) are shown, where the 
distance between the focal point and two representative elements is shown with the distances d1 and d2. 
 
Ultrasound Transducers 
 This ultrasonic wave is created from the vibration of a piezoelectric crystal.  A 
piezoelectric material is one which generates an electric charge upon deformation, or 
inversely it deforms from an electrical stimulation [30, 33].  Therefore, the 




crystal to vibrate: if oscillated at the appropriate frequency, the vibration will be in 
the ultrasonic range.  If this crystal is placed against a backing material which has the 
same acoustic impedance as itself, then the wave generated by the vibration will 
propagate away from that backing [30].  The crystal is protected by a lens, and 
maximum energy transferal is ensured by minimizing air resistance with a coupling 
medium at the interface of the lens and the material into which the US will propagate 
[30]. 
 The shape and configuration of the transducer will change the manner of US 
propagation, so its choice depends on the application.  If the highest ultrasonic energy 
needs to be close to the transducer, then a single flat transducer can create the 
necessary field; it generates a wave perpendicular to the surface, so the attenuation 
will cause the highest heat at the transducer interface [30].  However, for situations 
where the highest US intensity must be far from the transducer, a single flat 
transducer will no longer suffice [30].  As was described in the US Focal Point 
section, a focus far from the US source can be created by a curved transducer, an 
array of flat transducers arranged in a curved configuration, or an array in a flat 
configuration which is subjected to electronic focusing.  Also, a curved lens in front 
of a planar transducer can create the same effect.  When ultrasonic energy is focused 
to create thermal ablation, it is considered high-intensity focused ultrasound (HIFU).   
 
Heat Generation 
 Ultrasonic heat is generated within the tissue from the heat absorption.  Heat 




         Equation 7 
where q’’’ is the heat generation and I is the wave intensity.  For the planar 
transducers, Equation 3 accurately describes the intensity propagation through the 
tissue, so in one dimension the final heat generation is calculated by Equation 8 
          
     Equation 8 
However, for HIFU the changes in intensity are not solely a factor of acoustic 
attenuation (as they are in Equation 3) – since the transducer is not flat, the 
interference between waves also contributes greatly.  To determine the intensity from 
created by HIFU, the heat generation is calculated from the pressure profile created 
by the ultrasound in the tissue. The pressure created at each point in the tissue by an 
individual element in a transducer array can be calculated with Equation 9 [8] 
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 Equation 9 
 where pi is the pressure profile in the volume, x, y, and z are the spatial coordinates 
of that point, W is the power of the ultrasound source, ρ is the density of the medium, 
c is the speed of sound, A is the total surface area of the ultrasound source, f is the 
frequency, S is the area of the individual element, d is the distance from the source to 
the current point, and φ is the phase of the wave.  The final pressure at each point is 
the sum of the pressure from each element at that point, as shown in Equation 10 [8] 
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 Equation 11 
The heat generation determines the temperature distribution throughout the tissue. 
 
Heat Transfer in Biological Tissues 
 Once the heat generation in the tissue is known, the temperature at those 
locations can be determined.  Biological tissues are a porous medium consisting of a 
matrix of collagen fibers, cells, and proteins, with an interstitial fluid running through 
its cavities (containing blood and plasma) (Figure 14) [40].  This results in a 
combination of conduction and convection which transfer the generated heat 
throughout the volume. 
 
Figure 14 Biological tissues consist of a solid matrix through which interstitial fluid flows [40]. 
 
Energy Balance 
 Each finite volume of tissue has the same amount of heat which exits it as the 
summation of the heat which enters, is generated, and is stored within the volume 





Figure 15 Depiction of energy balance through a finite tissue volume [41]. 
 Conduction is governed by Fourier’s Law [42], which states that the heat flux 
is proportional to the thermal gradient, shown by Equation 12 for one dimension 
      
  
  
 Equation 12 
where     is the heat flux, k is the heat transfer coefficient, and x is the propagation 
distance.  The heat flux at the entrance of the control volume is equal to the heat flux 
at the exit minus the change in flux along the length Δx (Equation 13) [42]. 
             
     
  
   Equation 13 
where      is the heat flux at the entrance and         is the heat flux at the exit.  
Rearranging this equation results in Equation 14 
             
     
  
   Equation 14 
In three dimensions, the resulting energy gain by conduction is shown in Equation 15 
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Equation 16 
The second equation, with the conduction coefficient outside of the derivative, is 
obtained only with the assumption that heat conduction coefficient is constant 
through space.  The validity of assumption will be discussed in more detail in the 
Bioheat Model Assumptions section. 
 To account for the heat transferred by the interstitial fluid, the heat flux from a 
fluid moving through a body must be considered.  The equation defining this is 
shown in Equation 17 [41] 
        ̇     Equation 17 
where ̇  is the mass flow rate of the fluid, cp is the fluid’s specific heat capacity, and 
ΔT is the temperature difference between the fluid and the body.  For bioheat transfer, 
the fluid is blood, so the specific heat and temperature of the fluid are represented by 
cpb and Tb, respectively. 
 Also, any heat generated within the control volume affects the final 
temperature of that volume.  In the case of biological tissue, without the presence of 
any external forces this is considered the metabolic heat generation per unit volume, 
     .  To express this in terms of a heat flux, it must be multiplied by the volume 
element (            ).   
 Heat storage within a volume is the product of the mass (density times 
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 Equation 18 
 Summing the terms in Equation 16 – Equation 18 and dividing by the control 
volume results in Equation 19 
   
  
  
          (    )        Equation 19 
where    ̇ (      )⁄  is the blood perfusion rate.  This equation is known as the 
Pennes Bioheat Transfer Equation (BHTE), and is widely used an accepted as an 
accurate model for energy transport through biological tissue [41, 42].  
 
Bioheat Model Assumptions 
 It is important to note the assumptions which are taken into consideration for 
heat transfer through these tissues.  The BHTE assumes the tissue vascularization has 
a negligible influence on the heat transfer, and that the effect of the interstitial fluid 
flow can be simplified to the isotropic blood perfusion term (the second term on the 
right side of Equation 19).  However, it was found that there can be a significant 
difference in the heat transfer around very small, counter current blood vessels (two 
parallel vessels with blood flow in opposite directions) [43].  Also, it assumes that the 
fluid temperature, Tb, is a constant value through space and time (the value of Tb is 
given in Table 3).  Khaled [43] describes various forms of porous media heat transfer 
equations which have been developed to more accurately describe this relationship; 
however, most models for thermal ablation have utilized Pennes and found their 
results matching well with in vivo and ex vivo experimentation (see Previous Studies 




 Another set of assumptions for the values of the tissue and blood properties (ρ, 
cp, k, cpb, w, and Tb), which are given in Table 3.  The tissue density and specific heat 
are determined by the relationship displayed in Equation 20 [44]. 
    
 
      
 Equation 20 
where thdiff is the thermal diffusivity, given by 1.80 x 10
-7
 [44].  Thermal 
conductivity, k, has been found to increase as temperature increases, but it is widely 
accepted to use a constant value [14].  Blood specific heat is a known constant, given 
in Table 3.  Blood perfusion has also been shown to change with changing 
temperature, where it rises with increasing temperature before it decreases to about 
zero at very high heats [14].  Liang [45] observed a change in blood perfusion with 
different heating powers; this experimentally-determined relationship was used for 



















for Q range Value 
0 – 7.5 W 0.0040 kg/m
3
s [48] 
7.5 – 12.5 W 0.0075 kg/m
3
s [48] 
12.5 – 17.5 W 0.0085 kg/m
3
s [48] 




For this study the metabolic heat generation term (q’’’m) is neglected.  This 
value is relatively small in comparison to the heat generated by the ultrasound input 
energy, so it has been proven that its contribution to the overall tissue temperature is 
insignificant during thermal ablation [49].  This results in a replacement of the 
metabolic generation with the ultrasonic heat generation, so the BHTE is rewritten as 
Equation 21. 
   
  
  






Thermal Damage to Cells 
 To effectively create a device to ablate tumors, knowing the temperature 
reached within the tissue is not enough; the thermal dose which results in cell death 
must be determined.  The thermal dose refers to the time and temperature 
combination of the treatment, to be discussed in this section [50].   
 
Cell Death Considerations 
 Before determining the necessary thermal dose, it is important to note a 
couple of important considerations for thermal therapy treatment.  This section will 
first explain thermotolerance because it affects the outcome of multiple hyperthermic 
treatments, and then will describe the role of thermal therapy in combined treatments 
because it may not be necessary to result in 100% cell death just from heat. 
Thermotolerance 
 After long time periods and multiple doses which are needed for lower 
temperature hyperthermic treatments (<43°C), the tissue cells start to develop a 
thermotolerance [27].  The cells adjust to the supraphysiological temperature due to 
the expression of heat-shock proteins [51, 52, 27], which reduces the efficacy of 
future rounds of treatment.  Thermotolerance is acquired more readily through 
treatments with a slower heating rate, a lower hyperthermic temperature, and a longer 
exposure time [53].  To cause the same amount of damage for treatment after 
thermotolerance is acquired, it is necessary to either increase the treatment time up to 
twice as long or to increase the temperature by as much as one to two degrees Celsius 




treatment time when compared with conventional thermal therapy; however, the 
difficulty of sustaining such high temperatures and ensuring that only cancerous cells 
are adversely affected create complications that are not present with the lower thermal 
therapy treatments [27].  Another solution to combat thermotolerance is to combine a 
low temperature thermal therapy with another cancer treatment. 
Thermal Therapy in Combination with Chemotherapy 
 Thermal therapy can also be used with other treatments such as chemotherapy 
and radiation for cancer therapy [51, 27, 55, 56, 57, 58].  In combination with other 
treatments, a lower thermal dose of thermal therapy can be used (<43°C [55]).  This is 
because it is not the goal to kill the cancer cells directly from heat exposure, but to 
enhance the effects of the other treatment methods [51].  Specifically for 
chemotherapy, a reduced dose of these drugs has been proven to provide the same 
results as a normal dosage when administered with a hyperthermic treatment [51, 27, 
55, 57, 59].  The most affective temperature range for adding to the cytotoxic effects 
of chemotherapy was found to be between 40.5 and 43°C; above that any enhanced 
effect of chemotherapy may also be due to thermal therapy-induced cell death [56].   
The effect of heat treatment combined with chemotherapeutic treatment is 
highly dependent on the type of drug.  There is a linearly increasing effect of the 
medication with increasing temperature for alkylating agents and platinum 
compounds, while antimetabolites are not at all affected by the increased temperature 
[51, 60, 61].  There are some drugs, such as doxorubicin, which have a more 
complicated combined effect – their efficacy is not improved before the temperature 




A problem encountered during chemotherapy is the drug resistance acquired 
by the cancer cells.  After the start of drug treatments, cancer cells lose sensitivity to 
not only the particular chemotherapy drug used, but other drugs as well (multidrug 
resistance) [27].  Adding thermal therapy to chemotherapy can help prevent this 
resistance [27, 60].  However, if the temperature treatments are not hot enough 
(>42°C), then they may add to the drug resistance because of the introduction of 
thermotolerance [27, 60].   
 
Thermal Damage Models 
 Mathematical models have been derived from experimental data to 
theoretically determine the cell death that occurs at each time-temperature 
combination.  The one-step Arrhenius equation is the most-widely accepted model (it 
is a two-state model, where the cells are assumed either viable or dead [52]); 
however, there has been recent research to describe hyperthermic cell death using a 
different process.  Feng [62] fit thermal therapy test data on prostate cancer cells to a 
different two-state model, which also describes the cells as either alive or dead.  This 
model was designed to fix the major problems of the Arrhenius model, specifically its 
difficulty with fitting the full range of temperature data and its large fluctuations from 
small changes in kinetic parameters.  Feng’s model was able to better describe the 
data at the lower temperatures.  O’Neill [63] developed a three-state model which 
contained a middle state where the cells were not yet dead but vulnerable.  These 
vulnerable cells could either reverse back to the alive state or continue on to 




This model fit the data well and was also able to describe not only the fast cell death 
rate during thermal therapy treatment, but also the continuing slow cell death in the 
time following treatment, where the cells are at normal physiological temperatures. 
Although there is ongoing work to find a better-fitting model, the Arrhenius is 
used for the majority of cell studies because it works well for most experiments.  
Also, if it has trouble accurately fitting the whole temperature range, then the tests 
can be split into different regions (at break points), where each region has its own set 
of kinetic parameters [52].  The kinetic parameters (A and Ea in Equation 22) define 
the Arrhenius equation, which relates the rate of cell death, k, to the prescribed 
temperature (T) by Equation 22 [64], 
 ( )         ⁄  Equation 22 
 
where A is the frequency factor, Ea is the activation energy, and R is the universal gas 
constant.  Finding a combination of the frequency factor (A) and activation energy 
(Ea) for a certain cell type allows for optimal thermal doses to be determined.  The 
reaction rate k is related to cell survival by Equation 23 [52], 
    ∫    
 
  Equation 23  
where S is the survival fraction.   
An equation introduced by He [52] to correlate Ea and A (Equation 24) works 
well for many recent studies [10, 11, 65, 66, 67].  However, this relationship cannot 
solely determine the kinetic parameters: both still need to be found experimentally to 
be accurate [28]. 




Thermal Isoeffective Dose 
 Another method of predicting cell damage at specified time-temperature 
combinations is called the “Thermal Isoeffective Dose” (TID), which is a 
simplification of the Arrhenius equation [28].  With this method, once the injury at 
one reference isothermal temperature is known, the injury for any range of times and 
temperatures can be determined.  The TID is based on an equation determined by 
Dewey [68], where from the graph of the Arrhenius relationship of cell death rate, the 
inverse of the slope is defined as  ̃ .  For any given cell survival, the time of the 
thermal treatment is proportional to  ̃ , so it can be written as shown in Equation 25 
 ̃ ( )     ( ) Equation 25 
Dewey [68] defined R as the relative decrease in the rate of cell death for a 1°C 
increase in temperature, which becomes 
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Sapareto and Dewey [69] rearranged Equation 26 to create a conversion of treatment 
times for any two isothermal temperatures (Equation 27). 
      
(     ) Equation 27 
Sapareto and Dewey [69] then proposed the TID conversion to be specific to 
43°C, where the time it takes to inflict a certain amount of damage at any temperature 
can be converted into the time it takes to cause that same amount of damage at 43°C, 
using Equation 28     
              Equation 28 
where CEM43°C is the cumulative number of equivalent minutes at 43°C, t is time 




number of minutes that are needed to compensate for a 1°C temperature difference 
[28, 53].  R is assumed to be 0.5 for temperatures above 43°C, and 0.25 for 
temperatures below 43°C [69] (however these are just assumptions, the values are 
actually different for every type of cell/tissue [53]).   
It can be difficult to have a single constant temperature throughout the entire 
treatment time, so the TID can be used for non-isothermal temperature profiles as 
well.  Transient profiles can be converted into one CEM43°C value by summing 
together sufficiently small intervals of time, shown by Equation 29 [70, 53, 69]. 
       ∑      ̅   
      
   
 
Equation 29 
where tfinal is the last time interval,  ̅ is the average temperature at the specified time 
interval, and Δt is the time interval.  The TID and Arrhenius approaches give very 
similar results until the hold temperature exceeds 50°C, where the TID predicts a 
longer time needed to incur cell death [28].  An important distinction between these 
two models is that the TID is the same for all cell and tissue types, while the 
Arrhenius equation is specific to the type of cell in question. 
 
Previous Studies with Ultrasound Thermal therapy 
 Ultrasound thermal therapy has been considered for many years as a viable 
option for cancer treatment; however it is not yet implemented in a wide-spread 
manner because more research is needed to better predict treatment outcomes.  There 
are two main types of devices studied for this thesis: intraluminal cylindrical 




transducers for breast cancer.  Intraluminal devices are designed to be inserted either 
through the urethra or rectum of the patient for close access of the prostate gland.  
There is more flexibility with the external focused transducer for breast cancer 
because there are less geometric limitations than with an intraluminal device.   
Performing numerical simulations on the ultrasonic and heat propagation 
through the biological tissues is important for device design and treatment planning 
[71].  This section will discuss the current simulation studies and devices designed for 
ultrasound thermal therapy, including devices which are being currently-tested for use 
on patients.   
 
Simulations 
 Many numerical simulations using a finite difference method [6, 29, 49, 71, 
72, 73, 74, 75, 76] have been performed which determine the resulting tissue necrosis 
for ultrasound thermal therapy.  Ensuring the accuracy of the simulation model is 
important because the results will be invalid if the setup is incorrect or simplified too 
much.  However, a model which is too complex will increase the computational 
expense, so a tradeoff between accuracy and computation time is created.  The setup 
geometry, boundary and initial conditions, and governing equations are all involved 
in creating an accurate model of heat transfer through the breast and prostate.  
Setup geometry 
 The geometry of the volume to be ablated is usually a simplified version of 
the actual anatomical shape.  However in some cases, prostate volumes were derived 
from CT or MRI images taken from actual patients [5, 71].  Cubical shapes have been 




propagation within the tissue [34, 73].  The prostate was often modeled as a hollow 
cylinder of outer radius 3 cm with the transducers in its center [75].  Tyréus did not 
use a 3D model but instead split the problem into two 2D models in cylindrical 
coordinates, r-θ and r-z planes, as shown in Figure 16 [75]. 
 
Figure 16 Model setup of intraluminal transducer inside of cylindrical prostate, used by [75].  Two 2D 
simulations were used in the r-θ (left) and r-z (right) planes. 
The breast was modeled as a 6 cm radius hemisphere by Ho [15], Huang [77], 
Cheng [72], and Ju [29].  Lin [78] modeled the breast as a bell-shape, shown in 
Figure 17.  Most studies used water as a coupling medium between the transducer and 
breast since it has similar acoustical properties to tissue, so interface attenuation was 
not included in the model [15, 29, 72].  Malinen included different thermal properties 





Figure 17 Lin modeled the breast as a bell shape, with the cylindrical transducer coaxially surrounding it [78]. 
Simulation Parameters and Boundary/Initial Conditions  
 Most simulations set the boundary and initial conditions to normal body 
temperature, 37
o
C [6, 8, 14, 15, 29, 71, 72, 73, 76, 79].  Wan [49] used a Neumann 
boundary condition instead of the Dirichlet condition because his computation 
volume was small.  For intraluminal simulations where cooling water was involved, a 
convective boundary condition was used in the center of the cavity, where the water 






C [14], or 30
o
C [71], or 
different temperatures were compared in the study ranging from 5 – 42
o
C [76].  Ho 
[15] also tested the use of cooling water external to the breast at 20
o
C. 
 The cylindrical transducers will produce heat generation by the gradient of 
intensity as was shown in Equation 7, but instead of the one-dimension result in 
Equation 8, the heat generation is described by cylindrical coordinates, resulting in 
Equation 30 [74] [80] [75] [76] [48] [14] 
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 The studies which tested phased array transducers modeled them as individual 
point sources.  Huygen’s Principle determined the summation of the individual 
sources, and Saleh [6] and Hutchinson [8] used Equation 9 – Equation 11 (in 
Ultrasound Physics section) to calculate the final pressure field.  The Rayleigh-
Sommerfeld integral was used in many studies to combine the pressure created by 
each individual element [15] [77] [72] [73] [79] [18] [5], written as 
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where p(x,y,z) is the acoustic pressure, ρ is the medium’s density, c is the speed of 
sound, k is the wave number, u is the surface velocity, α is the attenuation coefficient, 
r is the location of the point where the pressure is being calculated, and r’ is location 
of the transducer element.  The heat generation produced from this pressure is 
calculated using Equation 11 [15] [6] [29] [79] [18] [8] [49] [5].   
For most studies, the acoustic absorption was considered to be solely a 
function of the attenuation of the wave [15] [72] [29] [48].  A constant attenuation 
was considered by most studies, at 5.3 Np/mMHz for Chen [71], 8.3 Np/mMHz for 
Prakash [80], 0.5 dB/cmMHz for Chopra [5], 5.01/mMHz for Diederich [76], and 
different values from 2.5 – 30 Np/m were tested by Lin [81].  Instead of using either a 
constant value for attenuation, or varying it with frequency, Liu [79] and Tyréus [74] 
[75] varied the ultrasonic absorption with respect to the thermal dose by 
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where α1 = 4.1 Np/mMHz, α2 = 9 Np/mMHz, and TD is the thermal dose at the (x,y,z) 
coordinate.   
 The blood perfusion in the tissue was also mostly held constant through time 
and space, where Lin [81] and Liang [48] used 6 kg/m
3
s, Chopra [5] simulated 5.3 
kg/m
3
s until the temperature reach 55
o
C when it became 0, Prakash [80] used a value 
of 2.5 kg/m
3
s at temperatures less than 60
o
C and 0 kg/m
3
s at higher temperatures, 
Diederich [76] tested values of constant perfusion from 0.5 – 10.0 kg/m
3
s, and Chen 
[71] tested different constant values of attenuation at 0.5, 2.5, 3.5, and 5.0 kg/m
3
s.  
However, a more accurate model was created when it was varied.  Tyréus [74] [75] 
modeled it with a constant value (2 kg/m
3
s for prostate tissue) until the thermal dose 
reached CEM43
o
C = 300 minutes, when the perfusion dropped to 0.  In a recent 
study, Prakash [14] compared different combinations of functions which described 
the blood perfusion and acoustic absorption as a function of an Arrhenius equation 
defined by Schutt and Haemmerich [82], thermal damage thresholds, or temperature, 
in order to determine an accurate combination of parameters. 
All simulations used Pennes’ BHTE (Equation 19) to describe the heat 
transfer through the tissue [15] [77] [72] [73] [6] [29] [79] [18] [8] [49] [71] [74] [80] 
[75] [5] [76] [48] [14].  Also, to find the tissue necrosis from the thermal doses, 
Sapareto and Dewey’s thermal isoeffective dose (Equation 28) was used.  For 
necrosis to occur, the studies set CEM43
o
C to equal 120 minutes [49], 240 minutes 
[15] [73] [79] [8] [80] [14], 300 minutes [72] [18], or a conservative 600 minutes [74] 







Transducer Configurations  
 Intraluminal devices often consist of multiple cylindrical transducers axially 
arranged, which are segmented angularly so different segments can be tuned to 
different power levels (schematic displayed in Figure 18) [71] [74] [80] [81] [75] [76] 
[14].  Chopra [5] placed 4 mm x 20 mm planar transducers end-to-end inside of a 
6mm diameter catheter.  Chen’s [71] intraluminal design consisted of a 3 mm radius 
catheter, 1.75 radius transducer, and individual transducer length of 10 mm (R, Re, 
and Le in Figure 18, respectively).  Tyréus tested interstitial cylindrical transducers 
with outer diameter 2.2 mm and length 10 mm in one study [75], and outer diameters 
ranging from 1.5 – 4.0 mm with lengths 5 – 10 mm [74].  Diederich [76] had five 
axially-aligned cylindrical transducers with an outer diameter of 10 mm and length 10 
mm.  Prakash [14] simulated an intraluminal device with two cylindrical transducers 
with an outer diameter of 3.5 mm, length of 10 mm, and 2 mm of space between 
each.  To keep the transducer and cavity wall cool, chilled water can be circulated 
either inside the cylindrical transducers, or exterior to it within the catheter walls [71] 






Figure 18 Intraluminal transducer schematic displaying four independently-controlled cylindrical transducers 
with angular segments that can be blocked so power is only emitted in desired angular direction [71]. 
 
Figure 19 Schematic of Diederich’s transducer used in simulations and in vivo experiments on dogs.  It also 
demonstrates the configuration of cooling water in between catheter wall and cylindrical transducer outer 
diameter [76]. 
Individual focused transducers of radius 8 and 15 cm, and phased arrays with 
16 and 32 elements of the same radii were tested and compared by Fan [73].  A flat 
phased array was tested by Saleh [6] (64 elements creating a 2 cm x 2 cm square) and 
Hutchinson [8] (a linear array of 1.5 cm x 9.0 cm x 0.2 cm with an element width that 
varies depending on the current simulation frequency to be half the wavelength).  Liu 
[79] tested a curved phased array with 400 elements arranged in a 20 x 20 
configuration with a radius of curvature of 12 cm.  Wan [49] simulated a phased array 
shaped as a square section of a 10 cm diameter sphere, with 3 mm x 3 mm square 
elements arranged 35 x 35 (Figure 20).  A cylindrical phased array of transducers 




had a diameter of 20 cm, height of 2 cm, and included 200 elements.  Lin used 384 
elements, creating a cylinder of diameter 25 cm.  Malinen simulated and optimized 
necrosis for a hemispherical shell transducer of 530 elements (Figure 21) [18].  Cheng 
[72] split a part of a 10 cm radius square section of a spherical transducer into four 
equal transducers, each with a 45
o
 angle between their face and the central axis of the 
breast.  Huang [77] tested two phased array transducers, which were curved towards 
the breast and 24 cm apart on opposite ends of the breast.  The dimensions of the 
transducers were 15 cm x 16 cm x 1.5 cm, and they could be translated around the 
breast and rotated on their own axes parallel to each other and the base of the breast.   
 
Figure 20 A phased array transducer which is a square section of a 10 cm diameter sphere of 35 elements by 





Figure 21 The hemispherical shell phased array transducer with 530 elements, simulated by Malinen [18]. 
Frequencies of 0.5 MHz [72] [8], 1 MHz [15] [77] [79] [18] [8], 1.5 MHz [8], 
2.0 MHz [8], 2.5 MHz [78], and 4.0 – 4.5 MHz [78] were tested.  Ho [15], Cheng 
[72], and Lin [78] tested a physical scanning of the ultrasound transducer, where the 
focal points did not change location with respect to the transducer, but the transducer 
translated around the breast to ablate the entire tumor region. 
 For phased arrays, different focal patterns were tested.  The effect of one 
transducer was tested for both phased arrays and spherical transducers [72].  Ju [29] 
and Hutchinson [8] scanned a single focal point continuously throughout the ablation 
region.  Some studies tested multiple transducers concurrently ablating the tissue with 
a common focal point [77] [72] [18].  Other studies used a multifocal pattern which 
had the transducer split its focus on points in different locations around the volume to 
widen the necrosed volume tissue per ultrasound dose [15] [6] [79].  Cheng [72] 
tested the use of multiple transducers around the breast, each with a focal point in a 





Figure 22 A simulation study where there were four transducers surrounding the breast, each with a different 
focal point within the current volume to be ablated [72]. 
Conclusions of Previous Simulation Studies 
 Cylindrical intraluminal ultrasound transducers were found to be able to 
effectively heat targeted sections of the prostate with the correct set of transducer 
parameters [71] [75].  Tyréus [74] compared his data with previous ex vivo and in 
vivo experiments and found an agreement between the results, and Diederich [76] 
proved matching results with his own in vivo experiments: these verified that this 
model for cylindrical transducers is accurate.  Another finding was that the chilled 
water cooling the transducers not only lowered the temperature at the catheter wall, 
but also moved the point of highest heat away from the axis of the cavity and 
transducer [74] [75] [76].  Tyréus [74] and Diederich [76] found that larger diameter 
devices created larger necrosed tissue lesions, which was also useful because the 
devices that had cooling external to the transducers needed to be larger and were 
found to cool the cavity wall more effectively [74].  They also determined that the 
tissue perfusion was a larger factor in affecting the lesion size than the attenuation, 
where more perfusion decreased the temperature and lesion size, so it is important to 




a constant value of acoustic attenuation and blood perfusion is less computationally 
expensive, there are large differences in the results obtained between these constant 
conditions and those which vary with thermal dose so the results will be less accurate.   
 For the breast cancer focused simulations, it was found that using one curved 
transducer with a single focal point allows the heating around the focal point to be 
easily controlled [72].  The cylindrical design coaxial to the breast was found to 
effectively reach the desired target locations, and avoids excessive heat at the ribcage 
because the ultrasound propagates parallel to the ribs [15].  It was proven that using a 
phased array instead of a single curved array reduces the treatment time [73].  
Furthermore, the multifocus design allows for less cooling time between each 
sonication because the intensity is spread throughout the volume, and therefore led to 
reduced treatment times [15] [72].  Huang [77] found that with tilted transducers, rib 
heating could be avoided if the angle between the vertical and the transducer axis was 
greater than 56.6
o
.  When phased transducers are electrically steered away from the 
central transducer axis, they must be designed to avoid grating lobes because they 
produce unwanted heating in the areas around the focal point [6]; this means that the 
near-field temperature is higher for larger scan widths [8].  Including more 
transducers in phased array systems decreases the number of grating lobes, and 
therefore there is less unwanted heating in the space between the focal point and the 
transducers [18].  Another conclusion was that electrical scanning is quicker than 
physically scanning the focal point [6].  Also, since the focal point can be shifted very 
quickly to different locations that were not experiencing high heats before, then 




discovered that non-scanned multifocal patterns decreased treatment time when 
compared to multiple focus scanning. 
It was found that the driving frequency needed to be set low for deep tumors, 
and high frequencies were appropriate for superficial tumors since their power is 
absorbed in a shorter space [29] [78].  Therefore, to obtain an even heating of the 
entire breast, a combination of low and high frequencies can be used [29].   
 
Previously-Developed Device Concepts 
 Ultrasound thermal therapy has gained interest and popularity throughout the 
years, so there have already been devices created which are currently being tested, 
including some which are in use at treatment clinics outside of the United States.  
Currently, transurethral US probes inside a catheter are still in the developmental 
stage [16], and concepts which have not yet come to market have been proposed in 
patents and are being tested.  A patent from 1995 describes a transurethral US device 
for BPH and prostate cancer treatments [83].  It includes cooling external to the 
transducer, and individually-controlled segments oriented axially from one another, 
with the transducers segmented angularly for control of angular US propagation 
(Figure 23).  Prakash [80] designed an interstitial device to be used for clinical pilot 
studies where the transducer slides into a catheter, has segmented transducers, and 
water flowing between the transducer and the catheter wall (Figure 24, upper and 
lower left).  He has also designed a concept for a flexible transurethral applicator with 
includes angularly segmented transducers and an inflatable balloon at the top to arrest 





Figure 23 Intraluminal patent idea with multiple cylindrical transducers arranged axially, and the right view 
shows two possible angular segmentation configurations [83]. 
 
Figure 24 Interstitial device for clinical pilot trials (upper and lower left), and intraluminal concept for 
simulation purposes (upper and lower right). 
Zhou [7] has compared different devices which are currently in-use in Europe 
or being clinically tested for HIFU ablation, and his table comparing these devices is 
reproduced (with permission) in Table 4.  The transrectal devices with a concave 
transducer for prostate cancer treatment include the Ablatherm (6-month post-
treatment efficacy demonstrated by Thuroff [84]) and the Sonablate-500 (5-year post-
treatment efficacy demonstrated by Uchida [85]) [7].  Extracorporeal devices with 
phased arrays arranged in a spherical bowl include the Exablate 2000 and the FEP-




Table 4 Comparison of different HIFU devices currently in-use, reproduced with permission from [7]. 
 
 
Figure 25 Images of (A) the FEP-BY02 extracorporeal phased array transducer and (B) the Ablatherm 





Chapter 3: Summary of Cell Thermal Therapy Studies 
 To determine the mathematical model to represent thermal damage, thermal 
therapy studies must be conducted in a controlled experimental setting.  In vitro 
experiments are performed to isolate the cancer cells during testing, although the 
inaccuracies which are associated with this segregation must be kept in mind while 
reviewing the results of such experiments. 
 Previous review papers have compared the required thermal doses for 
hyperthermia in many human and animal cells in vitro.  In 1979, Bhuyan [86] 
reviewed the heat sensitivities for different cell types, finding the time to result in 
90% cell destruction for temperatures between 41 – 45
o
C.  He [52] and Wright [64] 
compiled the Arrhenius parameters needed for the mathematical model which 
describes their cell death (explain later in this paper) for different types of cells.  




Table 5. Compilation of most results from previous reviewon cell death for different human and animal cell 





These three authors demonstrate the difference in cell survivability between 
the different cell types, especially between human and animal cell lines.  This is 
further shown in a review by Dewhirst [53].  He compared results from Chinese 
hamster ovary cells against hyperthermia tests on human melanoma cells of the same 
temperature range.  It was found that both exhibited a similar shape, but the same 
temperature tests took longer to result in the same cell death for the human cells than 
it did for the animal cells.  Graphs from the mathematical models (Arrhenius) were 
also compared for different human and rodent cell lines, and the shallower slopes for 
the human cells also support the claim that human cells are more resistant.  Therefore, 
to have the appropriate thermal dose, it is important to be experimentally determined 
for each cancer cell type. 
 The following chapter will review recent in vitro cell studies that have been 
performed on human cells, and summarize the mathematical models determined by 
these experiments which describe the cell death rate with respect to the thermal dose.  
The type of cell, cell survival assay, and heating method are important experimental 
parameters because they greatly impact the testing results [28, 87], so the different 
cell types and testing methods of these studies are discussed.   
 
Cell Types and Preparation Protocols 
 The thermal therapy experiments discussed below have been conducted on 
cancer cells of the prostate [62, 88], liver [11, 63, 65], bladder [10], kidney [66, 67, 
89], and lung [90] (although the lung data is not analyzed further than its 




a 5% CO2 environment at 37°C [66, 89], while the other authors used 10% FBS and 
1% penicillin/streptomycin and incubated in 95% humidity and either 10% CO2 [65, 
67] or 5% CO2 [10, 11, 62, 63, 88].   
Some studies tested only attached cells, while other performed experiments on 
both attached and suspended cells for comparison.  Jen [10] and Huang [11, 67] 
prepared only attached cells by first washing away the dead cells with phosphate-
buffered saline (PBS) and removing the live cells from the flask on which they were 
cultured with Trypsin.  These cells were placed on a 35mm Petri dish and allowed to 
attach for 24 hours.  It was washed twice more with PBS and mixed with 0.6mL of its 
media.  Feng [62] placed the flasks on which the cells were cultured directly into the 
water bath after removing the medium and replacing it with PBS.  Bhowmick [88] 
trypsinized prostate cancer cells off of the flasks, and plated them on either 12 mm x 
12 mm glass coverslips, single-well microslides, or in a 25 cm
2
 flask (for the survival 
assay calcein leakage, propidium iodide, and clonogenic survival assays, respectively, 
to be discussed in the Assay section) and left them overnight to attach.  Afterwards, 
the cells on the cover glasses were washed with PBS, and the cells on the slides were 
washed with salt solution and covered with a coverslip and silicone grease.  O’Neill 
[63] seeded the cultured cells into a 96-well plate and allowed them to attach 
overnight – this was the receptacle used during the heating experiments.  Finally, 
Walsh [89] also only tested attached cells, and prepared the renal carcinoma cells by 
plating them in either well chamber slides or a 35 mm petri dish, and allowed them to 




Shah [65] and He [66] tested both attached and suspended cancer cells.  Shah 
tested suspended liver cancer cells, which were resuspended after trypsinizing them 
for 5-10 minutes to remove them from the flask on which they were grown, 
centrifuging for 5 minutes at 1200 rpm, and resuspending the cells in their media.  3 
µL of the cell suspension was placed between two 12 mm diameter cover glasses.  To 
test attached cells, Shah left some cover glasses to sit overnight with the cells on top.  
He used the same procedures, except he only trypsinized the renal cancer cells for 3-5 
minutes and specified the centrifuge speed in acceleration, 400g.   
 
Heating Methods 
 The cell heating method has a noticeable effect on the experimental results.  
One common method to heat the cells is using a heated water bath.  However, water 
baths heat cells at a slow rate.  This is a problem because if an isothermal experiment 
has a high target temperature (>50°C), then a slow heating rate will cause cell damage 
during the non-isothermal ramping before the peak temperature has been reached 
[88].  This is detrimental to the determination of a mathematical model to correlate 
thermal dose and cell death. 
Placing the cells on a heated plate or stage is another heating method used in 
the reviewed studies.  The heat is quickly transferred to the slide or petri dish 
containing the cells, so there is a significantly shorter time to reach high peak 
temperatures than with a water bath.  However, even with a heating stage the high 
temperature of thermal ablation still causes some cell death to occur while the 




determining the isothermal damage.  Also, it is more difficult to ensure an even 
temperature at all of the cells than with a water bath because a thicker layer of cells is 
tested, so the temperature of the solution in which they are suspended heats more 
uniformly. 
Some cell viability assays need to be used with a particular method of heating 
cells.  For example, although clonogenic survival is a trusted indicator of cell death, it 
requires the use of a heated water bath (restricting its use to low temperature studies) 
[88].   
 
Cell Survival Assay and Heating Protocols 
 In order to define the success of thermal therapy treatments, there must be a 
measurable assay to determine the that cell death that has occurred.  As previously 
mentioned, clonogenic survival is one such assay.  It counts the number of cells 
which can still reproduce; when this ability is destroyed, cancer cells can no longer 
proliferate.  This makes it the most reliable indicator for cancer treatment studies [28, 
88].  However, for in vitro experiments it takes at least a week for this assay to 
manifest after the treatment dose delivery [28]. 
All studies which used the clonogenic survival assay heated the cells with a 
water bath.  Bhowmick [88] used an immersion heater and a stirrer in the water bath 
to maintain the temperature.  After heating, the flasks of cells were then set in an 
incubator at normal body temperature (37°C) for seven days [88].  After Walsh [89] 
heated cells in the water bath, they were trypsinized and re-plated to be incubated for 




For Bhowmick, the time it took for the temperature to reach its peak (ramping time) 
was about 3 minutes for temperatures of 50°C or less and 4 minutes for 55°C, and 
about 1 minute of ramp down time back to 37°C.  The ramping time for Walsh was 
between 80 and 130 seconds for his hold temperatures that ranged from 55°C to 
70°C. 
Vital dyes have become a popular method for determining cell viability.  The 
dye is added to the cells and infiltrates the ruptured membrane of dead cells, resulting 
in a color change.  A second dye may also be added which will fluorescently stain the 
live cells as well.  Four common vital dyes are trypan blue dye (used by [10, 11, 67]), 
propidium iodide (PI) (used by [62, 66, 88]), EthD-1 (used by [65, 89]), and an MTT 
assay (used by [55, 90]).  For the same study, a vital dye assay will result in higher 
measurement of cell vitality than the clonogenic survival assay [28, 88, 91].  
Incubation time needs to be included post-heating because it can also take up to a few 
hours for the injury to the cell membranes to occur [28]. 
Most studies that used a vital dye assay heated their cells through use of a 
heating stage, but a few used a water bath.  Jiang [90] heated the cells in a water bath 
at the hold temperature for 2 hours, and then placed them in a 37°C incubator for the 
next 24 hours.  The cells were then plated and incubated for 2 days, at which point the 
MTT solution was introduced to them.  The solution was incubated at body 
temperature for another 4 hours.  Walsh [89] also used a heated bath with the EthD-1 
dye assay.  As was done for his clonogenic survival studies, the cells were placed in 
the heated water bath for the appropriate period of time (with ramping times of 80 to 




However, for the dye it was only incubated for 24 hours post-heating, at which time 
the cells were washed with phosphate-buffered saline (PBS) and the dye was added.  
Finally, Feng [62] used a water bath with the vital dye PI uptake assay.  The cells 
were placed in a 25 cm
2
 flask with PBS.  The flask was placed in the appropriately 
heated water bath (ranging from 44-60°C, ramp time of about 4 seconds) for the 
different treatment times (1-30 minutes).  The cells were then incubated for 72 hours 
at 37°C. 
The following are the methods used for the cell studies utilizing a heating 
stage and a vital dye assay.  Bhowmick [88] used a copper heating stage for studies 
using PI uptake.  The cells were plated overnight before they were washed and mixed 
with PI dye.  Then they were incubated for 15 minutes, covered with a cover slip, and 
then heated to the appropriate temperature on the stage (with about 10 seconds of 
ramping time).  Afterwards the cells were incubated for three hours at 37°C.  He [66] 
used PI uptake and Shah [65] used EthD-1 dye, but they had similar procedures (and 
both tested attached and suspended cells).  Their 12 mm cover glasses with the cells 
were placed on the heating stage (He used a quartz crucible between the cells and the 
stage).  There was only one heating rate for He, 130°C/min (and cooling rate of 
65°C/min), but Shah tested the effect of multiple heating rates: 100, 200, and 
300°C/min, and performed “isothermal” testing with a heating rate of 525°C/min (the 
cooling rate for all studies was 100°C/min).  Then the cells were placed in their dye 
solution, which included both the previously-mentioned vital dye and Hoechst dye so 
that both the live and dead cells could be monitored.  Next, they were incubated for 3 




for the cells, which were heated on a customized copper heating block.  The cells 
were heated on the stage (ramp time <50 seconds).  Afterwards they were stained 
with trypan blue to determine the viability.  Huang used the same method as Jen for 
experiments on liver [11] and kidney cells [67], except the liver cells were also 
stained with calcein AM prior to heating to stain the live cells green, and EthD-1 dye 
post-heating to stain the dead cells red.  Both dyes stained the cells for 30 minutes.   
Other methods which are commonly used in cell studies include calcein 
leakage assay [88], lysis assay [92], flow cytometry [90], and fluorescence [63].  As 
previously mentioned, the assay choice was also influenced by the desired heating 
method. 
 
Summary of Experimental Results 
Determining the correct thermal dose is an important part of hyperthermic 
studies.  Temperatures below about 43°C are incapable of inducing apoptosis, 
regardless of treatment times, so there is a large difference between the cell toxicity 
below this “breakpoint” and above it [27, 55, 60, 70, 86].  The required thermal doses 
for bladder, prostate, liver, and kidney cells have been compiled from recent studies 
(Figure 26 – Figure 28).  Each data point represents a different isothermal test, and 
the lines connect experiments of the same cell line.  The graphs all have a steep 
negative slope at the shortest testing times, demonstrating the minor difference in 
treatment time at very high temperatures.  Then the graphs flatten out because there 




The time necessary for 10% of the tested cells to die is displayed in Figure 
26(a-d), where each graph is a different cell type, and is sub-separated by cell line.  
Most of the cell lines were able to reach 10% death within 10 minutes at temperatures 
above 40°C. 
 
Figure 26. Times needed to achieve 10% cell death when subjected to isothermal heating at temperatures 
specified for (a) bladder cells [10], (b) prostate cells [62, 88], (c) liver cells [11, 65], and (d) kidney [66, 67]. 
Figure 27(a-d) displays the time it took for 50% cell destruction to occur in 
the different types of cancer cells.  At 50°C
1
, kidney cells required the most time to 
reduce by half: 7-8 minutes.  The bladder cells had the fastest response at this 
temperature, taking 2-4 minutes.   
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Figure 27. Times needed to achieve 50% cell death when subjected to isothermal heating at temperatures 
specified for (a) bladder cells [10], (b) prostate cells [62, 88], (c) liver cells [11, 65], and (d) kidney [66, 67]. 
Figure 28 shows the necessary thermal dose for 90% cell death.  There are 
fewer data points for these graphs than the previous figures because most of the lower 
temperature experiments were not run until 90% of the cells died (with the exception 
of Feng’s [62] prostate cell experiments, which were run for 30 minutes).  The kidney 
cells required the most time at 55°C
2
  to reach 90% cell death: 10 minutes.  The other 
three cell types only needed about 5 or 6 minutes at that same temperature. 
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Figure 28. Times needed to achieve 90% cell death when subjected to isothermal heating at temperatures 
specified for (a) bladder cells [10], (b) prostate cells [62, 88], (c) liver cells [11, 65], and (d) kidney [66, 67]. 
 
Discussion of Results 
The data displayed in Figure 26 – Figure 28 was derived from the survival 
curves provided by each source (survival curves display the percentage of cell 
survival versus time for different hold temperatures).  For hyperthermic temperatures, 
these curves typically have two distinct regions: a shallow slope at the beginning of 
the heating time (shoulder region), and then a steeper slope develops, showing a fast 
rate of cell death when a damage threshold is surpassed [53, 60].  In contrast, at high 
thermal therapy temperatures the cell death rate is very high initially, and then it 
slows.  This occurs because at high temperatures the “damage threshold” is surpassed 
at the outset of the test.  Figure 29 shows the survival curves of PC3 prostate cancer 
cells from Feng [62] (with permission), and it depicts this phenomenon because 





Figure 29. Reproduction of survival curves for PC3 prostate cancer cells (with permission) [62]. 
The graphs displayed in the results summary section are condensed into 
Figure 30 for 10% (a), 50% (b), and 90% (c) cell destruction, separated by cell type.  
A logarithmic trend line has been fitted to the compilation of the data from each 
general cell type
3
.  The graph for kidney cells flattens out the fastest for 50% and 
90% cell death, and in all three graphs the bladder trend lines have the steepest slope 
at the later times and lower temperatures.  This means that at lower temperatures, a 
small decrease in hold temperature had a much larger effect on the treatment time for 
kidney cells than bladder cells.  
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 graphs exclude the prostate data from the clonogenic survival assay, prostate cells counted after only 






Figure 30. Times needed to achieve (a) 10%, (b) 50%, and (c) 90% cell death for bladder, prostate, liver, and 
kidney cells, when subjected to isothermal heating at temperatures specified. 
Figure 31(a-d) displays those same trend lines
4
, but each graph contains one 
type of cell which has lines for the different survival rates.  Bladder cells required a 
lot of time to go from 10% - 50% and 50% - 90% cell destruction at any given 
temperature.  For example, at 50°C, 10% of the bladder cells died after 30 seconds, 
half died after about 3 minutes, and it took 10 minutes for 90% of the cells to die.  
Similarly, kidney cells required very little time to reach 10% cell destruction, but up 
to 40 minutes for 90% cell death at 50°C.  This is in contrast to prostate cells, which 
have very similar curves for all three cell death percentages, and it is not until below 
50°C that there are distinct differences in the treatment times needed to achieve each. 
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Figure 31. Times needed to achieve 10%, 50%, and 90% cell death for (a) bladder cells, (b) prostate cells, (c) 
liver cells, and (d) kidney cells when subjected to isothermal heating at temperatures specified. 
Decreasing heating time is often a goal of hyperthermic treatment, so to 
decrease it to less than an hour, following the curves in the figures above, it is 
necessary to raise the peak temperature above normal hyperthermic conditions.  
Temperatures below 46°C require a much longer hold time, and possibly multiple 
treatments, to be used as the sole method for cell death. 
Since eradicating cancer cells is the goal of treatment, the 90% curves are of 
the most interest to analyze.  However, most of the cell studies were not performed 
for sufficiently long time periods to reach 90% cell destruction at moderate 
hyperthermic temperatures, so the thermal doses can only be determined for thermal 
ablative temperatures.  According to the trend line for bladder cells, it takes 10 
minutes at 50°C, 3 minutes at 60°C, and 1 minute at 70°C to cause 90% cell death.  




level, they require 30 minutes at 44°C, 7 minutes at 50°C, and less than a minute at 
60°C.  Liver cells needed 7, 2.5, and 0.25 minutes at 55, 60, and 70°C, respectively.  
The trend line for kidney cells will not cross 50°C until after 40 minutes, but will 
reach 90% cell death around 2 minutes at 60°C and almost immediately at 70°C.   
To estimate the necessary thermal dose at any temperature, this data was fit to 
an Arrhenius model.  The parameters from these recent cell studies are listed in Table 
6.  The heating method and survival assay are also presented in the table because they 
have a significant impact on the resulting parameters. 
Table 6. Compilation of Arrhenius parameters for different cell studies.5 
 
 
These cells types all have an activation energy in the range of 100 – 360 






.  He [52] 
performed a similar review of both human and animal cells, and found that activation 
energy tended to be much higher for the clonogenic survival assay than with vital 
                                                 
5
 HR = heating rate 
Ea (kJ/mol) A (s
-1
)
HR = 100°C/min 272.4 7.757x10
40
HR = 200°C/min 262.02 1.502x10
39
HR = 300°C/min 257.38 2.576x10
38
HR = 525°C/min (attached) 248.64 5.396x10
36
HR = 525°C/min (suspended) 229.46 3.495x10
31
Liver (HepG2) heating stage trypan blue dye 170.17 4.11x10
24
Huang 2010
Liver (Hep3B) heating stage trypan blue dye 152.44 1.07x10
22
Huang 2010
heating stage calcein leakage 0.7 threshold 81.33 5.069x10
10
Bhowmick 2000
heating stage PI uptake 0.7 threshold 244.8 2.99x10
37
Bhowmick 2000
water bath clonogenic survival 0.7 threshold 526.39 1.04x10
84
Bhowmick 2000
Bladder (TSGH-8301, grade 2) heating stage trypan blue dye 164.65 7.04x10
23
Jen 2009
Bladder (J82, grade 3) heating stage trypan blue dye 145.48 8.15x10
20
Jen 2009
Bladder (TCC-SUP, grade 4) heating stage trypan blue dye 114.4 1.35x10
16
Jen 2009
Suspended w/all T(t) 287.49 4.362x10
43
Suspended w/T(t) @ 0 hold 338.54 6.375x10
51
Attached w/all T(t) 314.89 3.153x10
47
Attached w/T(t) @ 0 hold 358.51 2.291x10
54
Kidney (A498) water bath EthD-1 99% destruction 202.80 1.29x10
29
Walsh 2007
Kidney - embryonic (293T) heating stage trypan blue dye 211.79 5.95x10
30
Huang 2008
Kidney (SN12) heating stage PI uptake He 2005
Reference
Liver (HepG2) heating stage EthD-1 Shah 2006






dyes, which can be seen in Table 6 from the AT-1 cell studies performed by 
Bhowmick. 
 
Conclusion of Cell Studies 
The graphs of the cell data from this literature review display the significant 
difference in thermal dose results for different types of cells.  It is important to note 
that none of the studies in this review included breast cancer cells.  Literature for in 
vitro experiments was not available for breast cancer cells, so to have an accurate 
model for cell death of breast cancer, experiments on those cell lines will have to be 






Chapter 4: Numerical Modeling and Device Design for 
Ultrasound Thermal Therapy of Prostate Cancer  
As was proven in Chapter 2, numerical modeling of ultrasound propagation 
and heat transfer in biological tissues can accurately predict the outcome of a 
hyperthermic treatment.  It is a useful tool for both designing new devices to perform 
ultrasound thermal therapy and for treatment-planning purposes because it can 
individualize patient treatments [14].  Therefore, it is important to continually 
improve the numerical models so that the results will be closer to experimental 
values. 
The following prostate cancer simulations include a few novelties which 
distinguish them from the previous studies.  First, the tissue and blood properties vary 
throughout the duration of the simulation.  The acoustic attenuation and blood 
perfusion are dependent on the thermal dose and US power, respectively, where most 
studies just used constant values.  Without considering a variable attenuation and 
perfusion, the results could have a significantly different result from the realistic 
value [14]. 
Another important aspect of the prostate cancer simulations is the use of the 
Arrhenius equation to determine cell death, with parameters specific to prostate 
cancer cells.  Most simulations use an equivalent number of minutes at 43
o
C 
according to Sapareto and Dewey’s thermal effective dose, which is common to all 
soft tissue.  As was proven in Figure 30 in Chapter 3, there is a significant difference 
between the rate of cell death by thermal therapy for different cell types, so it is 




This chapter will discuss the methods used to develop this numerical 
simulation, the results of these studies, and concepts designs of the US delivery 
device and treatment planning protocols.  The results will provide a relationship 
between ultrasound parameters and the final necrosed volume, which is important for 
treatment planning for physicians.   
 
Methods 
 MATLAB software was used to compute the final temperature throughout the 
volume and the resulting necrosed tissue locations.  The first step to achieving this is 
to define the geometry of the computational domain, which is the prostate gland in 
this case.  Next, the tissue, blood, and ultrasound properties are defined.  Then, the 
code runs through the total heating time.  At each time step, the acoustic attenuation 
and heat generation are calculated for every node in the domain.  Then the 
temperature distribution is calculated based on the heat generation value.  The 
necrosed cells are determined by the nodes (and therefore their associated volume 
elements) which have surpassed the thermal dose for cell death outlined by the 
Arrhenius relationship for prostate cancer.  The methods used to develop this 
simulation are described in this section, which include the discretization of the 
governing equation, the geometry used for the simulation, and the constants and 




Finite Difference Method 
 Using the numerical technique of finite difference (FD) is a common method 
for solving differential equations, and was used in many numerical studies of 
ultrasound thermal therapy (see Previous Studies with Ultrasound section).  It is only 
an approximation of the solution the results are discretized into finite volumes and 
time steps, so its accuracy is directly dependent on the size of those intervals.  This 
simulation uses an explicit scheme, so at each time step the results are calculated 
once, instead of an implicit scheme where the solution is determined by iterations at 
each time step until there is a sufficiently small error between the results in that step.  
The implicit scheme was not needed because the solution converged for this model. 
 Each differential equation is split into a finite central difference by the Taylor 
Series approximation, Equation 33. 
 (    )   ( )    (    )       Equation 33 
where x is the current location, Δx is the length step in the x-direction, and HOT are 
higher order terms, which can be neglected because they are negligibly small 
compared to the preceding terms.  Rearranging this equation results in an 
approximation of a first-order derivative, shown in Equation 34. 
  (    )  
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 Equation 34 
Equation 34 is an example of a forward difference, to compute a central difference 
the derivative at x spans two nodes, and is calculated by Equation 35. 
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 A second derivative is derived by plugging the forward (and backwards) 
difference of the derivative shown in Equation 34 in for f’(x), resulting in Equation 
36 
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 Equation 36 
 
Discretizing the Bioheat Transfer Equation 
Equation 35 and Equation 36 will be used to discretize the bioheat transfer 
equation (BHTE), defined in Chapter 2 and rewritten below. 
   
  
  
          (    )       Equation 21 
The ultrasound propagation does not have to be modeled with a central differencing 
scheme because the heat generation at each point is solely a function of its location 
and the temperature distribution at the previous time step. 
 The first term on the left and right sides of Equation 21 will be discretized 
with the Taylor series approximation because they include differential equations; they 
describe the storage of heat and conduction of heat, respectively.  The derivative of 
temperature with respect to time is written with the backwards difference method, and 
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 Equation 37 
 The spatial derivatives are all determined based on the temperatures calculated 
at the previous time step at each point.  The Laplacian of temperature only includes 
second derivatives in a Cartesian coordinate system, but changes when the 
coordinates are no longer expressed in terms of (x,y,z).  For geometric simplicity, a 
cylindrical coordinate system (Figure 32) is used for prostate studies.   
 
Figure 32 3D cylindrical coordinate system used for prostate simulations (adapted from [93]). 
 The cylindrical system transforms the perpendicular linear (x,y,z) coordinates 
into the orthogonal radial, angular, and linear coordinates (r,θ,z), depicted by Figure 
32.  The Laplacian in cylindrical coordinates is described by Equation 38. 
    
   









   
   
 
   
   
 Equation 38 
 The discretization of each of these terms is determined by either Equation 35 
or Equation 36, and is displayed in Equation 39 – Equation 42.  All coordinates not 
specified in the equation are held constant. 
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 Equation 39 
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Equation 41 
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 Equation 42 
 
Geometry of Domains/ Testing Parameters for Prostate Studies 
 The geometry of the prostate is simplified to a cylindrical shape commonly-
used in the former simulation studies detailed in Chapter 2.  The prostate is modeled 
as a hollow cylinder with thick walls, whose dimensions are displayed in Figure 33. 
 
Figure 33 Dimensions of cylindrical prostate geometry. 
 The US device simulated includes three cylindrical transducers which are 





.  Chilled water runs between the transducers and the prostate wall, providing 
a convective boundary condition at the inner wall of the prostate.  This setup is 
depicted in Figure 34, where the coordinate system is also displayed.   
Ø 60 mm 






Figure 34 Schematic of prostate simulation model, showing the prostate, transducers, chilled water, and r-θ-z 
coordinate system in the a) top view, and b) front cross-sectional view.   
 Each transducer is 8 mm tall with a radius of 1.1 mm.  There is a 4 mm gap 
between each transducer in the z-direction.  The prostate tissue is initially set to body 
temperature, 37
o




 Table 7 displays the values of the parameters tested for the independent 
variables for the prostate simulations.  Throughout the results and discussion, the 
transducer powers will be written as Q = [Q1 Q2 Q3], where Q1 is the power for the 




transducer power.  The dependent variables for the prostate simulations were the 
maximum temperature and the final volume of necrosed tissue. 
Table 7 Prostate simulation testing parameters and their values used in simulations. 
Independent Variables Tested Values 
Transducer Powers, Qi (W) 0, 30, 45, 60 
Heating Time, th (sec) 30-300 
Transducer Angle, Θ (degrees) 90, 120, 150, 180, 210, 270 
 
 The temperature in the tissue should not get too high because a patient’s pain 
threshold is generally exceeded after about 45
o
C, so minimizing temperatures above 
this value is important [94] [36].  For that reason and because cavitation effects were 
not taken into account for this simulation, a constraint on these studies was that the 
maximum temperature could not exceed 100
o
C anywhere in the computational 
domain.  The prostate code was run until either a set heating time was reached, or the 
necrosis reached a prescribed radial location.   
 
Determination of Cell Necrosis 
To determine cell necrosis, as was explained in the Background section, it is 
important to first determine the heat generation at each point in the volume.  For the 
prostate study a cylindrical transducer is used, so it is governed by previously-defined 
Equation 30, re-written below. 
             
   
    





Therefore, it is only a function of the transducer efficiency η, acoustic attenuation α, 
the initial intensity Io, the outer radius of the transducer ro, and the radial location of 
the current cell.  A transducer efficiency of 50% (η = 0.5) was used for all studies.  
The acoustic attenuation was defined in Chapter 2 (Equation 5), rewritten below 
                         
                            ((            )   ) 
Equation 5 
The intensity is calculated from the input transducer powers by Equation 43 [34] 
   
  
 
 Equation 43 
where the values for Q are defined in Table 7 and S is the surface area of the 
transducer.  The radius of the transducer is the same as the inner radius of the 
prostate, defined in Figure 33. 
 After the heat generation is known, the temperature at each point is calculated 
using the discretized bioheat transfer equation.  The blood properties used in the 
bioheat equation can be referenced in Table 3 of Chapter 2. 
 The final step is to determine if the thermal dose administered to each node in 
the volume is sufficient to conclude if the cells have been killed.  In this study, the 
Arrhenius relationship is defined in Equation 22 of Chapter 2, rewritten below 





The Arrhenius parameters used in this study were found through a literature study for 
prostate cancer cell death [88].  A two-step equation was used
6
, where there are 
different parameters for temperatures below 50
o
C than above it.  Their values are 
listed in Table 8, and their accuracy was validated with canine prostate studies [47]. 
Table 8 Arrhenius parameters for prostate cancer studies. 
 
Ea (kJ) A (s-1) 
Below 50oC 526.39 1.04 x 1084 




To ensure that the grid of nodes within the volume was sufficiently dense to 
account for the thermal gradients, a grid refinement study was performed.  The 
number of nodes in the three dimensions started with nominal values and were evenly 
multiplied by higher factors for different levels of grid fineness, and the maximum 
temperature and necrosed volume for two different sets of ultrasound parameters 
(parameters listed in Table 9) were recorded at each level.   
Table 9 Transducer parameters of two different cases tested for grid refinement study. 
Case # 
Center 





1 45 W 90
o
 55 sec 
2 60 W 90
o
 30 sec 
 
                                                 
6
 The Arrhenius parameters for the prostate were derived from Bhowmick’s study comparing different 
survival assays for prostate cancer cell death [67].  He recommended using the PI uptake numbers for 
temperatures above 50
o
C and the clonogenic survival parameters for temperatures below 50oC, which 




The multiplication factor was increased until the two most-fine grids have a 
negligible error between their values of maximum temperature and necrosed volume.  
Table 10 also includes the multiplication factor for the final node and its percent 
error, and Figure 35 displays the temperature and necrosed volume of each grid.  The 
final differential elements were Δr = 0.6750 mm, Δθ = 11.25
o
, and Δz = 1.000 mm.  
Separately, an accurate time step was calculated to be Δt = 0.3052 sec. 
 
Figure 35 Temperature and necrosed volume for the different grids for Θ = 90
o
 for case 1 (Q = [0 45 0] W and th 
= 55 s) and case 2 (Q = [0 60 0] W and th = 30 s). 
Table 10 The percent errors of the temperature and necrosed volume of each case when compared with the 
finest grid. 
  
Case 1 Case 2 
# of nodes Terror Verror Terror Verror 
nominal 11500 14.79 % 98.00 % 7.60 % 84.21 % 
1.5x 34600 3.00 % 10.00 % 3.83 % 10.53 % 
2x 92200 6.25 % 34.00 % 3.64 % 26.32 % 
3x 553000 1.30 % 8.00 % 0.70 % 7.89 % 










Results from Prostate Studies  
 Multiple combinations of the parameters displayed in Table 7 were tested in 
multiple combinations, and the results were studied if the thermal dose was sufficient 
to result in necrosed tissue and the maximum temperature was less than 100
o
C.  The 
complete results are listed in Table 30 – Table 39 in Appendix A.  Each test produced 
different temperature fields, and therefore different tissue necrosis contours.  The 
results will first display the effect of different parameters on the temperature fields, 
and then will demonstrate the resulting necrosed volumes.  
 
Temperature Fields 
 An example of a temperature distribution created by the cylindrical transducer 
is displayed in the 2D cross-sections at θ = 0
o
 (Figure 36a) and at z = 0 mm (Figure 
36b), created by 3 transducers at Q = [45 45 45] W, propagating at Θ = 90
o
 for th = 
100 s.  The white region between r = 0 and 3 mm in Figure 36a (rectangular region) 






Figure 36 Temperature contours for Q = [45 45 45] W, Θ = 90o, and th = 100 s at (a) θ = 0
o
 and (b) z = 0 mm. 
 Another example is shown in Figure 37 for Q = [0 60 0] W, propagating at Θ 
= 270
o
 for th = 600 s.   
 
Figure 37 Temperature contours for Q = [0 60 0] W, Θ = 270o, and th = 600 s at (a) θ = 0
o
 and (b) z = 0 mm. 
 The effect of one transducer on the maximum temperature versus the 
treatment time are displayed in Figure 38 and Figure 39, where Figure 38 compares 
graphs of different transducer powers Q for each transducer angle Θ, and Figure 39 





Figure 38 For single transducer simulation, the maximum temperature versus the heating time for 30 W (blue 
diamonds), 45 W (red squares), and 60 W (green triangles).  Graphed for (a) Θ = 90o, (b) Θ = 120o, (c) Θ = 150o, 





Figure 39 For single transducer simulation, the maximum temperature versus the heating time for Θ = 90o 
(blue diamonds), Θ = 120o (red squares), Θ = 150o (green triangles), Θ = 180o (purple x’s), and Θ = 210o (teal 
stars).  Graphed for (a) 30 W, (b) 45 W, (c) 60 W. 
 Next, the effect of varying the powers of two transducers was studied.  An 
example of the temperature contours created by transducers at two different powers is 
displayed in Figure 40 for Q = [45 60 0] W, propagating at Θ = 180
o
 for th = 200 s. 
 
Figure 40 Temperature contours for Q = [45 60 0] W, Θ = 180o, and th = 200 s at (a) θ = 0
o
 and (b) z = 0 mm.  
 A sample of the data for selected angles is graphed to compare the effect of 
the power from a second transducer for a constant value of the middle transducer.  




constraints of Tmax ≤ 100
o
C and Vnecr > 0 mm
3
.  Figure 41a displays the resulting Tmax 
versus heating time for Θ = 90
o
 the middle transducer set to 30 W, the top transducer 
varying from 0 – 60 W, and the bottom transducer is set to 0 W.  Figure 41b and 





the middle transducer power set equal to 45 W and 60 W, respectively.  
 
Figure 41 Maximum temperature versus heating time for a constant heating power for the center transducer 
compared to different transducer power on the third transducer for (a) Q2 = 30 W at Θ = 90o, (b) Q2 = 45 W at 
Θ = 150o, and (c) Q2 = 60 W at Θ = 210o. 
 Similar graphs were produced to compare the effect of activating multiple 
transducers at the same power level.  Figure 42a displays Tmax versus time for either 
one, two, or three transducers on at 30 W for Θ = 90
o
, Figure 42b is for 45 W and Θ = 
150
o







Figure 42 Maximum temperature versus heating time for a specific heating power for different numbers of 
active transducers for (a) Q = 30 W at Θ = 90o, (b) Q = 45 W at Θ = 150o, and (c) Q = 60 W at Θ = 210o. 
 
Necrosed Tissue Contours 
 When the thermal dose for prostate cancer cell death has been surpassed in a 
volume element of the computational domain, that element will be marked as dead 
cells.  To pictorially present the necrosed tissue from the simulations, two different 
types of graphs are employed and shown in Figure 43: the first is similar to Figure 
36a except instead of the temperature contour it is the necrosis contour displayed; and 
the second is a three-dimensional isometric view of both the urethra and necrosed 
tissue.  The frontal cross-section (Figure 43a) is split into areas where the highest 
temperature which caused the coagulation is displayed, and non-necrosed tissue is 
uncolored.  In the isometric view (Figure 43b), the blue cylinder represents the 
urethra, within which the transducer is located, and the red volumes are the areas of 




a thick-walled cylinder surrounding the urethra.  The graphs are of the same set of US 
parameters as in Figure 36 (Q = [45 45 45] W, Θ = 90
o
, th = 100 s). 
            
Figure 43 Necrosis contours for Q = [0 60 0] W, Θ = 90o, and th = 100 s at (a) θ = 0
o
 and (b) 3D view. 
 Another example of these graphs is shown in Figure 44 for the same 
transducer parameters as Figure 37 (Q = [0 60 0] W, Θ = 270
o
, th = 600 s). 
  
Figure 44 Necrosis contours for Q = [0 60 0] W, Θ = 270o, and th = 600 s at (a) θ = 0
o
 and (b) 3D view. 
 The results for the effect of one transducer on the necrosed volume versus the 
treatment time are displayed in Figure 45 and Figure 46, where Figure 45 compares 
graphs of different transducer powers Q for each transducer angle Θ, and Figure 46 





Figure 45 For single transducer simulation, the necrosed volume versus the heating time for 30 W (blue 
diamonds), 45 W (red squares), and 60 W (green triangles).  Graphed for (a) Θ = 90o, (b) Θ = 120o, (c) Θ = 150o, 





Figure 46 For single transducer simulation, the necrosed volume versus the heating time for Θ = 90o (blue 
diamonds), Θ = 120o (red squares), Θ = 150o (green triangles), Θ = 180o (purple x’s), and Θ = 210o (teal stars).  
Graphed for (a) 30 W, (b) 45 W, (c) 60 W. 
 Another important result of these studies is the location of the necrosis.  
Predicting the location of necrosed tissue in the angular and axial directions is 
relatively accurate when considering the bounds defined by the transducer heights 
and angles of propagation.  However, the resulting radial distance that the cell 
necrosis reaches is important to measure because it takes longer heating times and 
higher powers to reach further towards the edge of the prostate gland with a 
cylindrical transducer.  Therefore, the depth of radial necrosis is limited by the 
necessity to remain under 100
o
C. 
 Figure 47 – Figure 51 have graphs showing the maximum radial distance 
reached by the necrosis (open markers) and the radial centroid of the necrosed 
volume (filled markers).  They are compared for one transducer at (a) 30 W, (b) 45 
W, and (c) 60 W, at Θ = 90
o
 (Figure 47), Θ = 120
o
 (Figure 48), Θ = 150
o
 (Figure 49), 
Θ = 180
o
 (Figure 50), and Θ = 210
o





Figure 47 The centroidal and maximum radial coordinates for the necrosed lesion at Θ = 90
o
 for one transducer 
set to (a) 30 W, (b) 45 W, and (c) 60 W. 
 
Figure 48 The centroidal and maximum radial coordinates for the necrosed lesion at Θ = 120
o
 for one 





Figure 49 The centroidal and maximum radial coordinates for the necrosed lesion at Θ = 150
o
 for one 
transducer set to (a) 30 W, (b) 45 W, and (c) 60 W. 
 
Figure 50 The centroidal and maximum radial coordinates for the necrosed lesion at Θ = 180
o
 for one 
transducer set to (a) 45 W and (b) 60 W. 
 
Figure 51 The centroidal and maximum radial coordinates for the necrosed lesion at Θ = 210
o
 for one 
transducer set to 60 W. 
 Figure 52 graphs the maximum radial necrosed point versus the heating time 




radius location necrosed for 30 W at different angles of propagation, Figure 52b 
displays this for 45 W, and Figure 52c is for 60 W. 
 
Figure 52 The maximum radial location of the necrosed legion for Θ = 90
o
 (blue diamonds), Θ = 120
o
 (red 
squares), Θ = 150
o
 (green triangles), Θ = 180
o
 (purple x’s), and Θ = 210
o
 (teal stars).  Graphed for (a) 30 W, (b) 
45 W, (c) 60 W. 
 For multiple transducers, in Figure 53 graphs similar to Figure 41 show the 
necrosed volume with two active transducers: the top transducer set to varying 
powers and the middle transducer at a constant power (30 W at Θ = 90
o
 for Figure 
53a, 45 W at Θ = 150
o
 for Figure 53b, and 60 W at Θ = 210
o





Figure 53 Necrosed volume versus heating time for a constant heating power for the center transducer 
compared to different transducer power on the third transducer for (a) Q2 = 30 W at Θ = 90o, (b) Q2 = 45 W at 
Θ = 150o, and (c) Q2 = 60 W at Θ = 210o. 
 The necrosed volume versus heating time graphs for multiple transducers at 
the same power level are displayed in Figure 54.  Transducers emitting 30 W at Θ = 
90
o
 are compared in Figure 54a, 45 W at Θ = 150
o
 in Figure 54b, and 60 W at Θ = 
210
o





Figure 54 Necrosed volume versus heating time for a specific heating power for different numbers of active 
transducers for (a) Q = 30 W at Θ = 90o, (b) Q = 45 W at Θ = 150o, and (c) Q = 60 W at Θ = 210o. 
 
Discussion 
 The r-θ temperature contours (such as those seen in Figure 36b and Figure 37) 
show a clear distinction between the temperatures within and outside of the angle of 
US propagation (Θ).  This is important for treatment-planning because the healthy 
tissue outside of the chosen propagation angle will not experience high treatment 
temperatures (only reaches around 30
o
C).   
These figures also display the highest temperatures occurring closest to the 
transducers.  However, the location of the maximum temperature is slightly shifted 
away from the surface of the transducer, which is a result of the cooling water 
flowing between the transducer and the catheter wall.  To investigate this further, 
different coolant properties were tested.  The temperature contours are shown for Q = 
[45 60 0] W, Θ = 180
o
, and th = 200 s at Tc = 10
o




(reproduction of Figure 40a), and Tc = 5
o
C and tc = 150 s in Figure 55b.  There is a 
drastic difference in their maximum temperatures, and the areas of highest heat have 
moved away from the urethra with the cooler water temperature and precooling time.  
Also, the temperature of the tissue is colder at the urethral wall. 
 
Figure 55 Temperature contours for Q = [45 60 0] W, Θ = 180o, and th = 200 s at θ = 0
o
 for (a) Tc = 10
o
C and tc = 
0 s and (b) Tc = 5
o
C and tc = 150 s. 
 As would be expected, the maximum temperature increases more quickly with 
for the higher power settings.  In Figure 38a, for 30 W to reach about 95
o
C it took 
almost seven times as long as with the transducer set to 60 W.  This difference 
becomes more exaggerated as the propagation angle increases.   
Figure 39 shows the importance of the angle of propagation of the transducer 
to the final maximum temperature.  At 30 W there are no graphs for Θ > 150
o
 (and 
only two data points at 150
o
) because the temperature never reached a value sufficient 
to cause tissue necrosis.  Therefore, if a tumor stretches around a large angle, then a 
higher power setting will be necessary.  Conversely, at 60 W there is only one data 
point for Θ = 90
o
 because after a short time the maximum temperature will exceed 
100
o




with tumors that only require tight propagation angles, it may be necessary to use a 
lower power setting to have more control over the necrosed region.   
 When a second transducer was activated, the maximum temperature was only 
dependent on the power of the transducer with the highest setting.  Figure 41a has a 
slight difference between one and two transducers activated to 30 W, and then the 
temperature increases quicker for the increasing power of that first transducer.  In 
Figure 41b, the data almost exactly overlaps if the top transducer is powered less than 
or equal to the center 45 W transducer.  The fourth data series in that graph is much 
steeper because the top transducer is set to a higher power (60 W).  All of the data 
overlaps in Figure 41c because the center transducer is set to the maximum power of 
60 W, so the top transducer is always less than or equal to this setting.  This is further 
proven in Figure 42, where the effect of increasing the number of transducers with the 
same power on the maximum temperature yields little difference in any of the graphs. 
 When Figure 43a and Figure 44a are compared with Figure 36a and Figure 
37a, respectively, it becomes apparent that the shape of the necrosis contour closely 
follows the temperature contours with the highest magnitudes.  This is a reasonable 
result because higher heats take less time to cause tissue ablation, so they would 
necrose first.  Also, the isometric views of the dead cells (Figure 43b and Figure 44b) 
display the wide variety of necrosis shapes which can be created by different sets of 
treatment parameters.  When three transducers are activated at a low angle of 
propagation, the dead tissue is in a long, thin rectangular shape spanning most of the 
height of the prostate (Figure 43b).  Conversely, one transducer activated at a large 




(Figure 44b).  This depicts the extremes of the wide variety of tumor shapes which 
can be accommodated with the cylindrical US transducers. 
 The graphs of the necrosed volume versus heating time shown in Figure 45 
were always steeper for the higher powers regardless of the propagation angle, 
showing the expected conclusion that higher powers cause tissue death more quickly.  
However, it is interesting to note that for Θ = 90
o
 (Figure 45a), when one transducer 
is set to 30 W it is able to achieve a higher volume of necrosed tissue than 45 W and 
60 W because it is able to propagate the necrosis further before 100
o
C was reached.  
Similarly, 45 W reaches a higher volume of necrosed tissue than 60 W at the same 
angle.  However, at the highest angle, 210
o
, 60 W is the only one that was able to 
cause tissue necrosis. 
 For 45 W and 60 W, almost the same volume of necrosis is able to be attained 
for differing angles of propagation (as seen in Figure 46b and c), it just takes longer 
with the larger angles.  This is helpful because different tumor shapes, whether 
oriented longer in the radial or angular direction, can be targeted with the correct 
combination of transducer properties.  For 30 W (Figure 46a), angles above Θ = 90
o
 
do not create a sufficient region of ablated tissue. 
 Based on the volume of tissue necrosed, the resulting radial necrosis locations 
are predictable: the maximum and centroid location of the necrosis are greater for 
lower transducer powers at Θ = 90
o
 (Figure 47).  At that angle with a power of 30 W, 
the necrosis reaches its furthest distance of all single transducer trials, about 20 mm 




tumors fall much past that location, a different transducer design may be necessary, 
such as a transrectal, interstitial, or external device.   
At the higher angles of propagation, a higher power is necessary to reach 
further radially through the prostate.  For example, at Θ = 180
o
 (Figure 50d), in 100 
less seconds 60 W is able to ablate tissue about 3.5 mm further than 45 W.  This 
shows that tumors which are large in both the radial and angular directions will need 
a high power setting, as would be expected. 
As shown in Figure 52, as the angle of propagation increases, the maximum 
radial location of necrosis decreases.  This occurs because the acoustic energy is 
spread around the larger angle instead of focusing on one section as it does at the 
higher angle. 
Figure 53 shows the greatest necrosed volume occurring for two transducers 
set to the same power setting.  However, this is misleading because propagation 
angles were chosen where the middle transducer was able to have the most data 
points within the constraints of temperatures under 100
o
C and non-zero necrosis 
volumes.  Therefore, it is not the fact that the powers are the same which causes the 
greatest tissue ablation, but that they are both values which were optimized at the 
specified angle.  So it is most important to realize that there is a specific power which 
needs to be chosen for large tumors which are situated at each angle. 
As would be predicted, the necrosed volume increases with increasing number 
of transducers activated, as seen in Figure 54.  This is attributed to the increase of 
ultrasound energy distributed in the axial direction.  Since the maximum temperature 




large distance in the axial direction can be necrosed by using the power and angle 
setting appropriate for the r-θ area of the tumor in those directions, and then the 
transducers at the appropriate axial distance along the transducer can be activated.   
To succinctly examine the results, an energy parameter was created which 
combines each of the transducer settings based on their influence on the final 
necrosed volume, where the goal is to result in a linearly positive relationship 
between this parameter and the necrosed volume.  This energy parameter, ξ, is 
displayed in Equation 44 
  
  
 (   
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 Equation 44 
where k is an exponential constant less than one.  The heating time and transducer 
powers are both on the top of the fraction because an increase in either causes an 
increase in the necrosed volume, and the propagation angle is in the denominator 
because an increase in the angle causes a decrease in volume with other parameters 
held constant.  th has an exponent between zero and one because it is less influential 
than the power.  The power is not simply a summation of all three powers because as 
was shown previously, the highest power transducer has the greatest effect on the 
resulting temperature and necrosis curves.  Q2, the center transducer, is assumed to be 
the highest power.  One third of the average of the top and bottom transducers is 
therefore the importance of their contribution to the total input power for ξ.   
 For all of the data, k is determined to create the best fit when equal to 0.5.  
The resulting plot of Vnecr v. ξ is shown for all data collected in Figure 56, along with 
its line of best fit (including the equation and R
2
 value).  The resulting volume of 




This can be a helpful initial resource for physicians to find a good combination of 
transducer parameters for a tumor of a certain volume.  However, with only an R
2
 
value of 0.72, further analysis is needed. 
 
Figure 56 Graph of the necrosed volume Vnecr versus the energy parameter ξ.  The line of best fit, its 
equation, and its corresponding R2 value are also shown. 
 This energy parameter is considered for single transducer trials, and separated 
by power level.  The value of k is altered for each power level, and its resulting value 
which achieved the best linear fit of each data series is displayed in Table 11.  The 
graph showing the individual fits of each transducer power is shown in Figure 57, and 
they all have a very accurate linear fit, with R
2
 values ranging from 0.88 to 0.98. 
Table 11 The exponential constant of the heating time for different individual transducer powers. 














Device Design and Protocol Development for Prostate Cancer 
 The prostate cancer studies are focused on finding the appropriate set of 
transducer parameters for different size and location tumors.  This section will outline 
a concept of the device which can be used for this treatment, along with important 
considerations for determining the treatment planning for physicians. 
 
Device Concept 
 For designing the US transducer for prostate cancer ablation, it was important 
to first determine the important functional requirements and design parameters of the 
device.  The functional requirements are the requirements which satisfy the customer 




requirements [95].  The functional requirements for the transducer are listed in Table 
12.   
Table 12 Functional requirements for US device to ablate prostate cancer. 
Functional Requirements 
1) Necrosed tissue must reach tumor area. 
2) Minimal ablation of healthy tissue (only a margin should remain). 
3) Easy to use correctly. 
 
 The design parameters which satisfy these functional requirements are shown 
in Table 13.  The second column of this table also provides the functional 
requirements (FRs) which are satisfied by each design parameter. 
Table 13 Design parameters for US device to ablate prostate cancer, including the functional requirements 
they each satisfy. 
Design Parameters FR satisfied 
Situated near prostate gland. (1) 
Targets tumorous tissue. (2) 
Harmful rays blocked from healthy prostate. (2) 
Easily arrests in correct location. (3) 
 
 Designs which fulfilled many of the parameters were presented in Figure 18 
and Figure 19 in Chapter 2 and are reprinted below.  Figure 18 shows a schematic of 
the intraluminal transducer which was simulated for an optimization study [71].  This 
device has multiple transducers inserted into a catheter, arranged axially, and 
independently controlled.  Its angle of propagation can be partially blocked to allow 
for a control of the ultrasound intensity distribution.  Figure 19 shows a drawing of 




This also has multiple axially-arranged transducers inside of a catheter, and includes 
an integrated coolant external to the transducers.  The coolant was input through the 
base of the device, flowed through tubes to the tip of the catheter, and then flowed 
across the transducer surface back towards the base of the catheter.  The coolant 
exited the device through tubes at the base. 
 
Figure 18 reprinted, displaying the intraluminal transducer schematic displaying four independently-controlled 
cylindrical transducers with angular segments that can be blocked so power is only emitted in desired angular 
direction [71]. 
 
Figure 19 reprinted, which is a schematic of Diederich’s transducer used in simulations and in vivo experiments 
on dogs [76]. 
 These ideas were integrated into the concept sketch of the transducer, which 
was designed to fulfill all design parameters.  This concept is shown in a CAD three-
dimensional view in Figure 58.  The diameter of the catheter was designed to be 




prostate, so a large range of tumor locations can be treated.  Three cylindrical 
transducers are inserted into the catheter and arranged axially, with inert material 
separating the transducers.  The multiple transducers will allow the device to easily 
target tumors which are in any axial location without having to perfectly position the 
device and tumors which are longer in the axial direction.   
Physicians will have multiple of these devices, each with a different set angle 
of propagation because the transducer will only be a fraction of a circular cylinder, 
with the remainder of the circle completed with non-transmitting backing material.  
The location and size of the tumor will dictate which of those catheters will be used 
for the duration of the treatment.  Also, coolant fluid flows past the transducer surface 
to prevent the urethral tissue from burning (and to move the necrosed region further 
into the prostate if desired, as discussed in the previous section).  The fluid enters and 
exits the device through tubes at the base of the catheter, and channels are built to 
create different paths for the inlet and outlet flows.  There is a locating balloon 
situated at the tip of the catheter, which will inflate in the patient’s bladder to arrest 
the device in the correct location. 
 






 An important aspect of creating patient-specific treatment planning protocols 
is to design an easy method for physicians to determine the best treatment option for 
each case.  The studies performed in this chapter resulted in a database of input US 
parameters and output temperatures and necrosed volumes.  This information can be 
used to create a guide for physicians, where the physician would input the tumor 
positioning, and the output will be the ultrasound parameters.  An example of this is 
shown in the flowchart in Figure 59.  In the Treatment Outcome section of the chart, a 
necrosed tissue margin is mentioned.  Not only does the tumor need to be completely 
engulfed by the necrosed region, but there should be at least a margin of 1 mm which 
is ablated around all sides to ensure that all cancerous cells are destroyed, so this 
needs to be taken into consideration for treatment planning.   
 
Figure 59 Flowchart showing the patient-specific protocol for physicians to use for prostate cancer treatment 
planning. 
 To show an example of this, a separate code was written which determines the 




parameters for one active transducer.  An example result is shown in Figure 60 for 
transducer settings Q = [0 45 0] W, Θ = 120
o
, and th = 60 s, showing the frontal cross-
section at θ = 0
o
.  The largest spherical tumor which this set of parameters could 
ablate had a diameter of Ø6 mm (depicted as a black circle).  An orange target zone 
surrounds this tumor with the appropriate margin of healthy tissue ablation, and as 
can be seen the necrosed tissue (red area) mostly fills this area.  This will kill the 
tumor with a minimal amount of healthy tissue destroyed, although a slightly larger 
region of necrosis may be chosen to fully ablate the margin as well.  The complete 
results of this study are shown in Table 40 – Table 42 in Appendix B. 
 
Figure 60 Tumor (black circle) of diameter Ø6 mm is the largest spherical tumor which can be fully ablated 
(necrosed tissue is red volume) with the appropriate 1 mm margin from US parameters Q = [0 45 0] W, Θ = 
120
o
, and th = 60 s.  The target zone (orange open circle) displays the 1 mm margin which needs to be ablated 
outside of the tumor. 
The physician should have an easy-to-use configuration for both the device 
and the treatment planning tools.  Figure 61 displays an example of a possible user 
interface, where the physician just has to provide the patient’s tumor specifics into a 
“black box” (left column of the interface), and after clicking the “Calculate” button 




device will be created to connect to this software and automatically input these 
parameters. 
 
Figure 61 Physician user interface to easily receive device parameters.  They input the tumor information on 





Chapter 5:  Numerical Modeling and Device Design for 
Ultrasound Thermal Therapy of Breast Cancer  
Simulating breast cancer ablation has a lot of similarities as the prostate 
studies, but the different geometry and the use of HIFU instead of planar ultrasound 
creates important differences.  As in the prostate studies, these simulations use 
variable properties for the acoustic attenuation and tissue perfusion to obtain realistic 
results.  However, a thermal damage model specifically for breast cancer cells is not 
used because the Arrhenius parameters for these cells are not available.  Instead, the 
general tissue model with the thermal isoeffective dose is used, which decreases the 
accuracy of these simulations. 
A phased array with electrical focusing for HIFU is simulated for tissue 
ablation.  The following study tests different transducer geometries, including the 
overall shape of the transducer and the height of the individual elements of the 
transducer.  The results determine the shape and volume of the necrosed tissue 
created by each combination of the transducer geometry and parameters.  The 
concepts of the device design and physician protocols which can be used with the 
results of these simulations will be presented.   
Ideally, one sonication would be sufficient to completely ablate the breast 
tumor with little cell death of the healthy tissue.  However, this is generally not 
possible with the small necrosed volumes typically created by HIFU, so finding a set 
of parameters which results in the maximum necrosed volume is important, while still 
resulting in a predictable shape of that volume.  These considerations are accounted 
for during the testing and reviewing the results of the breast cancer thermal therapy 




treatments, and then present the results from these simulations, discuss their 




MATLAB software is again used for the breast cancer simulations.  The order 
of the computation is the same for the breast cancer studies as it was for the prostate 
simulations: define the computational domain and tissue and ultrasound properties, 
calculate the heat generation and temperature at every node in the domain at every 
time step, and finally determine the nodes which represent dead breast cells from the 
temperature history. 
As was done before, the FD method discretizes the bioheat transfer equation 
(BHTE).  However, this time a spherical coordinate system is used for geometric 
simplicity (so the spatial derivatives in the BHTE are defined differently).  This 
system is defined by a radial coordinate and two angular coordinates (r,θ,φ), depicted 
in Figure 62.  Note that the angle φ is not defined in the traditional manner of 






Figure 62 3D spherical coordinate system used for breast simulations [96]. 
 The Laplacian in spherical coordinates is defined by Equation 45 
    
   








      (     )
   




   
   
 
   (     )





The partial derivatives of T with respect to r and θ are the same as were derived in 
Equation 39 – Equation 41, and the derivatives with respect to φ are similarly 
derived, and displayed in Equation 46 and Equation 47, where the r and θ coordinates 
are held constant. 
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Equation 46 
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Equation 47 
 The preceding discretized differential functions are inserted into the BHTE, 
which is rearranged to be solved in terms of T(t,r) (where r is the spatial vector), and 





Geometry of Domains/ Testing Parameters for Breast Studies 
 A simple hemispherical geometry is used to represent the breast in the 
simulations, which was also often used in the previous studies which simulated HIFU 
to the breast (described in Chapter 2).  The radial dimension of this hemisphere is 
displayed in Figure 63. 
 
Figure 63 Dimensions of the hemispherical breast geometry. 
 The coordinate system is displayed in Figure 64, and the bounds of the region 
are r = [0, 60] mm, θ = [0, 360]
o
, and φ = [0, 90]
o
.  Figure 64 also depicts the coupling 
water which is used for a smooth transmission of the US waves to the breast, and 
cools the surface of the breast to prevent burning.  There are two main transducer 
configurations: flat and curved.  With each configuration, the transducers are 
arranged around the breast in four segments, and elements span perpendicular to the 
chest from the base of the breast to the top (60 mm height).  The transducer variables 
are the number of transducers in each row parallel to the base of the chest, the number 
of rows of these elements from the bottom to the top of the breast (which in turn 
determines the transducer height since the total height is fixed at 60 mm), the number 




activated, where the middle row of active elements is centered on the tumorous 
region.  The transducer configurations are shown in Figure 64 (curved transducer) 
and Figure 65 (flat transducer) with a sample number of elements (5 elements per 
angular segment (ne) and 5 rows of elements in the height (nr)).   
 
Figure 64 Schematic of breast simulation model for a curved transducer, showing the breast, chest (not part of 
simulation domain), transducer elements, coupling water, and r-θ-φ coordinate system in the a) top view, and 
b) front cross-sectional view.  This is showing a sample where there are 5 elements per transducer segment, 
and 5 rows of segments tall.  The US beams are focused on a point in the upper half of the breast and off-
center in the plane perpendicular to the chest, the bottom two rows of elements and the segment across from 





Figure 65 Schematic of breast simulation for flat transducer. 
Each element width (le) is 1.5 mm (which determines the resulting US 
frequency to be f = 0.5 MHz because   
 
   
 where c is the speed of sound, 1500 m/s 
[8]).  There is no gap between the elements within each segment or between the rows 
up the height of the breast; it is displayed this way in the schematics for clarity.  The 
breast tissue is initially set to body temperature, 37
o
C, the interface between the base 
of the breast and the chest is held to a constant 37
o
C, and the exterior of the breast is 





 Studies are run to first test the affect the transducer parameters have on the 
location and magnitude of the heat generation (q’’’).  Then, separate studies are 
performed which examine the temperature gradients and necrosis contours resulting 
from the transducer settings. 
Parameters for Heat Generation Studies 
 Before simulating the heat transfer through the tissue, different transducer 
configurations were tested to determine optimal parameters to achieve a focal point of 




of segments activated (ns), the number of elements per segment (ne), and the number 
of rows (nr) were varied.  The values tested are shown in Table 14.  If ns = 1, then the 
first transducer is activated, and if ns = 3, then the two transducers which are on either 
side of the first transducer (the second and fourth transducer segments) are activated 
as well.  The shape and number of rows of elements are fixed values for a given 
device, but the number of transducers activated and the number of elements per 
transducer can be adjusted on a patient-specific basis (as long as the total number on 
the device are initially at the maximum). 
Table 14 Values tested for the different transducer configurations.  If this value needs to be fixed before 






shape curved, flat yes 
ns 1, 2, 3 no 
ne 41, 51, 61 no 
nr 20, 30, 40 yes 
 
Also, there were 9 different focal locations tested, each in the plane in front of 
the first transducer (θ = 0
o
).  The foci are in three evenly-spaced heights (the total 
height is the breast radius, R, so the distance between heights is R/4), and three 
evenly-spaced locations from the center of the breast to its side at that height (the line 
segment length from the center to side of the breast is called ls), which changes at 
each height, so the distance between the points tested on this line were ls/4.  These 





Figure 66 Locations of tested focal point in the plane of θ = 0
o
 (in front of 1st transducer). 
 The location of the maximum q’’’ is determined for each set of 
transducer parameters for a set transducer power of Q = 100W.  This location is 
compared to the location of the desired focal point, so the studies which minimize the 
difference in their distances are the optimal settings.  The desired focal point locations 
which were defined in Figure 66 are labeled in Figure 67, where each point is given 
the ordered pair (xn, zn) to represent its location in the x and z directions (not the 
actual value of the x-z coordinates).  This is the notation which will be used for the 
remainder of this report. 
 
Figure 67 Labels of the desired focal points, where the ordered pair (xn, zn) defines the point as the x-location 




Parameters for Necrosis Studies 
 Table 15 displays the testing parameters for the breast cancer studies which 
examined the tissue ablation caused by different sets of transducer parameters.  The 
majority of the tests were performed with just one transducer to determine the effect 
of the other transducer parameters.  If multiple transducers are used, the transducer 
powers will be listed as [Q1 Q2 Q3 Q4], where Q1 is the power for the transducer 
centered on the desired focal point, and moving clockwise around breast for 
transducers Q2 – Q4.  Each study heated the tissue until 100
o
C was reached anywhere 
in the volume.  The dependent variables for the breast cancer thermal therapy 
simulations were the heating time and the final necrosed volume. 
Table 15 Breast simulation testing parameters and their values used in simulations. 
Independent Variables Tested Values 
Transducer Powers, Qi (W) 0, 50, 75, 100 
Transducer Fixed Geometry: 
 
Shape flat, curved 
Number of Heights 20, 30, 40 
Number of Horizontal Active 
Elements 
41, 51, 61 
Number of Active Transducers 1, 2, 3, 4 
Location of Necrosis  
 
xn-value 1, 2, 3 
zn-value 1, 2, 3 
 
 As with the prostate studies, the breast cancer studies did not surpass 100
o
C 
because the temperature in the surrounding healthy tissue needs to be kept below the 
pain threshold, and because the effects of water at its boiling point temperature are 
not accounted for in this study.  These simulations were stopped when the maximum 







Determination of Cell Necrosis 
 A similar procedure is followed as with the prostate studies, where first the 
heat generation is determined, then the temperature fields within the computation 
volume, and finally the resulting cell necrosis is found.  However, the heat generation 
in the breast cancer studies first needs the pressure at each point defined because it 
uses a phased array transducer.  This was defined in Equation 9 in Chapter 2, and is 
rewritten below 
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 Equation 9 
Then the heat generation at each point was determined in Chapter 2 to be defined 
according to Equation 11, rewritten here 
    (     )  
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 Equation 11 
where α is the same as that for the prostate studies (Equation 5), P is the sum of all 
individual element pressures, tissue density ρ is defined in Table 3, and c is the speed 
of sound, which is 1500 m/s in tissue [8]. 
 As would be expected, the same blood properties (Table 3) are used for the 
BHTE for the breast studies as was used for the prostate simulations.  That equation 





 To determine the thermal dose for the cell necrosis, a general tissue model 
using the thermal isoeffective dose (TID) of CEM43
o
C = 240 minutes was used (as 
was shown to be used by multiple studies in Chapter 2 [15] [73] [79] [8] [80] [14]).  
The equation of this model was given in Equation 28 in Chapter 2, and is rewritten 
below. 
                     Equation 28 
240 minutes was the most-common value used for simulations in the previous 
literature reviewed.  An Arrhenius model was not used here as it was for the prostate 
cancer studies because there is little information available on the Arrhenius 
parameters specific to breast cancer, and this equation changes drastically with 
different cell lines. 
 
Grid Validation 
A similar grid refinement study was performed for the breast ultrasound 
simulations as was conducted for the prostate studies.  The nodes in the r (rn) are 
tested from 41 to 81, in the theta (θn) 65 – 125 nodes are tested, and in phi the nodes 
(φn) are varied from 17 – 67.  There are fewer nodes in phi than in theta because phi 
only varies from 0 – 90
o
, while theta varies from 0 – 270
o
.  A test case with a flat 
shape, ns = 1, ne = 61, and nr = 6 was used for the study.   
 For the breast cancer grid study, the individual numbers of nodes in each 
coordinate direction must be chosen separately because the shape of the volume 
element changes a lot based on the number of nodes in each coordinate (as opposed to 




graphs holding two of the directions constant were created for every combination of 
grid.  The maximum temperature was compared for each grid, and the percent error 
compared to the finest grid was calculated.  Two sample graphs are displayed in 
Figure 68 and Figure 69.  Figure 68 shows the graphs of percent error compared to 
the maximum temperature of the finest grid size v. θn for a set value of rn = 41 and for 
different series of φn.  For this value of rn, θn = 85 gives very similar results to the 
finest size in that coordinate, θn = 125, and also minimizes the error when coupled 
with φn = 27.   
 
Figure 68 The % Error of Tmax compared to the most fine grid versus the number of nodes in the θ axis (θn) for 
rn=41 and different values of φn. 
 Figure 69 displays the graph of the percent error v. rn for a set φn = 27 for 
different values of θn.  Error for this grid size is minimized with the smallest node 
size of rn = 41.  Therefore, the final grid size chosen for the experiments to be used 
was Δr = 1.500 mm, Δθ = 4.286
o
, and Δφ = 3.462
o
.  Also, it was tested that the code 







Figure 69 The % Error of Tmax compared to the most fine grid versus the number of nodes in the r axis (rn) for 
φn=27 and different values of θn. 
 
Calculating Acoustic Attenuation 
 As explained in the introduction to this section, the acoustic attenuation is 
again varied for these simulations as a function of the thermal dose.  The thermal dose 
will change at every iteration, so to calculate the exact attenuation throughout the 
simulation it also needs to be determined at each time step.  For the prostate studies, 
the time step was sufficiently large that this could be easily performed; however with 
the breast cancer studies this is very computationally expensive since the time step is 
much smaller.  To reduce its expense, the attenuation was only calculated at certain 
time intervals instead of every time step.  The number of iterations between 
calculations was determined by testing different numbers to ensure it would retain the 
accuracy of the results.  The maximum temperature after 0.4 seconds of heating with 
one transducer activated at 100W was determined for simulations with a different 
number of iterations between calculations of the attenuation coefficient (α), and the 




temperature versus the number of iterations and the percent error between the 
maximum temperature of the current point and the case where α is calculated every 
iteration.  At 1000 iterations there is less than a 0.5% error, so this is the value which 
will be used during the simulations.  This will be greatly beneficial for computation 
time, as shown in Figure 70b, where α calculated at each iteration takes about 570 
minutes to complete the heating loop, while if it is calculated only every 1000 
iterations it takes less than 5 minutes. 
 
Figure 70 Graphs showing (a) the maximum temperature and % error, and (b) the computation time and % 
error versus the number of iterations between each α calculation.  The % error in Tmax series in each graph is 





Results from Breast Studies  
 For the breast cancer simulations, first the results of the focal point studies 
will be presented.  Next, the temperature and necrosis contours will be provided 
concurrently for comparison purposes.   
   
Focal Location Studies 
The data from all focal location studies are listed in in Table 43 – Table 54 
Appendix C.  The heat generation created by the different transducer parameters and 








.  The values are 
spread evenly through this range, as is depicted by Figure 71, which displays the 
natural log of the heat generation for each trial. 
 
Figure 71 Boxplot of the natural log of the heat generation for the focal location studies.  The red line in the 
center is the mean, the blue box spans the upper (75%) and lower (25%) quartiles, the black horizontal lines 
span the data range without outliers, and the red plus is an outlier.  
An example of the resulting contour plot of the heat generation is shown in 
Figure 72 (transducer parameters: flat, 41 elements/row, 40 rows, focused at (3,1)).  
The top image is a sliced isometric plot displaying the contours on the three x-y-z 




















(the patient’s chest is located at the z = 0 plane).  There is a very sharp difference in 
heat generation between the focal point and the rest of the breast.   
 
Figure 72 Contour plot of the heat generation (W/m
3
) in the sliced isometric view (top), x-z plane (bottom 
left), and x-y plane (bottom right).  (Transducer parameters: flat, 41 elements/row, 40 rows, focused at (3,1)). 
The shape of this focal point varies drastically depending on its location.  
When the location of the focus is shifted to the coordinate (1,1) (with all of the same 
transducer parameters), a much larger focus is created, as demonstrated by Figure 72.  
It should also be noted that this larger focal point has a maximum heat generation 






Figure 73 Contour plot of the heat generation (W/m
3
) in the sliced isometric view (top), x-z plane (bottom 
left), and x-y plane (bottom right).  (Transducer parameters: flat, 41 elements/row, 40 rows, focused at (1,1)). 
Effect of Transducer Parameters on Heat Generation 
 The goal of the focal location studies was to find the optimal transducer 
parameters, both for qualities which need to be decided before fabrication (the shape 
and number of rows of elements) and ones which should be adjusted based on the 
tumor location (the number of active elements and transducers).   The final focal 
point of the simulations was defined by the location of the maximum heat generation.  
The accuracy of each transducer configuration is shown in the pie chart in Figure 74, 
where difference between the final focal point and the desired location are examined 
for each trial performed.  The majority of the different transducer configurations 
resulted in the focal point exactly on the node which was input as the desired focal 
location.  The trials which resulted in a distance of 1 to 2 mm away from this point 




were one node away in two coordinate directions.  There were no trials which 
resulted in maximum heat generation points more than two nodes away. 
 
Figure 74 The percentage of total trails which resulted within different ranges for the distance of the location 
of the maximum heat generation from the desired focal point.  Tests between 1 and 2 mm away were one 
node off in any direction, and above 2 mm away the tests were one node away in two different coordinate 
directions. 
To determine which parameters created an accurate focal point, a bar graph 
was created which gives the number of tests that resulted in exact matches between 
the focal point and the desired location for each parameter (Figure 75).  Each color 
groups the different types of parameters together, so the blue graphs represent the 
different shapes, red is for the different number of elements in one transducer row, the 
green bars are the different numbers of possible rows, and purple represents the 
number of active transducers.  The teal color for the desired location of the focal point 
is further delineated by its shade, where the light shade represents the focal points at 
the bottom height level (zn = 1), the medium shade is for the second height level 
halfway up the breast (zn = 2), and the dark shade is for the third height level (zn = 
3).  The gray bars on top of each value represent the number of studies with each 





Figure 75 Number of trials which resulted in the focal point exactly coinciding with the desired location.  Blue 
graphs are for the transducer shape, red graphs are for the number of elements in each transducer row, green 
graphs are for the number of transducer rows, purple graphs are for the number of active transducers, and 
teal graphs are for the location of the desired focal point.  The gray bars on top of each value represent the 
number of studies with each parameter that did not result in exact focal point matches.  *(xn,zn) 
 Most of the parameters achieved similar success in resulting in an accurate 
focal point.  The transducer parameters which had the most successful trials were flat, 
51 elements per row, 30 rows, and 3 transducers.  The most accurate focal points 
were at the focal point location (1,3) which is in the top third of the breast and closest 
to the center, while (1,1) at the bottom third and closest to the center of the breast had 
the least successful trials.  From this graph it is apparent that each transducer 
parameter individually has the potential to be acceptable for HIFU treatments, so later 
the combinations of parameters need to be examined for patient-specific treatments 
 Next, the heat generations created by each combination of these parameters 
are compared.  Graphs of the maximum heat generation versus the number of active 
transducers are shown in Figure 76 – Figure 81.  In all cases, an increase in the 
number of rows of elements resulted in an increase in the maximum heat generation.  
While examining these graphs, it is important to keep in mind that the y-scales are 




 Figure 76 displays the curves for the flat transducer at the height level at the 
bottom third of the breast (zn = 1) for each of the xn-values.  At xn = 1, where the 
focal point is closest to the center of the breast, the heat generation increases as the 
number of transducers increases for all combinations of number of elements and 
rows.  However, for xn = 2, when there was 41 and 51 elements per row, three 
transducers caused a decrease in the maximum generation.  Similarly for xn = 3, with 
41 elements greater than two elements decreased the final heat generation. 
 
Figure 76 For the flat transducers focusing on the height zn = 1 (top: xn = 1; bottom left: xn = 2; bottom right: 
xn = 3).  Plots of the natural log of the maximum heat generation versus the number of active transducers, for 
different numbers of elements and rows of elements. 
 Figure 77 displays the plots for a curved transducer at zn = 1.  With the curved 
geometry, increasing the number of transducers never decreased the heat generation, 
but with xn = 2 and 3, with 61 elements per row there was only a slight increase 





Figure 77 For the curved transducers focusing on the height zn = 1 (top: xn = 1; bottom left: xn = 2; bottom 
right: xn = 3).  Plots of the natural log of the maximum heat generation versus the number of active 
transducers, for different numbers of elements and rows of elements. 
 Figure 78 shows these same graphs for the flat transducer at zn = 2.  At xn = 
2, 61 elements causes a decrease in the max q’’’ with more than two transducers 





Figure 78 For the flat transducers focusing on the height zn = 2 (top: xn = 1; bottom left: xn = 2; bottom right: 
xn = 3).  Plots of the natural log of the maximum heat generation versus the number of active transducers, for 
different numbers of elements and rows of elements. 
 Figure 79 shows the trends of maximum heat generation versus the number of 
active transducers for curved transducers focusing at zn = 2.  The maximum heat 
generated increases with increasing numbers of transducers except when the focal 






Figure 79 For the curved transducers focusing on the height zn = 2 (top: xn = 1; bottom left: xn = 2; bottom 
right: xn = 3).  Plots of the natural log of the maximum heat generation versus the number of active 
transducers, for different numbers of elements and rows of elements. 
 Figure 80 depicts the graphs for flat transducers at zn = 3, in the top third of 
the breast.  For this case, it is 51 elements which causes a decrease in the heat 





Figure 80 For the flat transducers focusing on the height zn = 3 (top: xn = 1; bottom left: xn = 2; bottom right: 
xn = 3).  Plots of the natural log of the maximum heat generation versus the number of active transducers, for 
different numbers of elements and rows of elements. 
 Figure 81 depicts the same graphs but for a curved transducer at zn = 3.  The 
heat generation decreases when the number of active transducers is increased from 2 






Figure 81 For the curved transducers focusing on the height zn = 3 (top: xn = 1; bottom left: xn = 2; bottom 
right: xn = 3).  Plots of the natural log of the maximum heat generation versus the number of active 
transducers, for different numbers of elements and rows of elements. 
 The outcome of these parameter studies shows that increasing the number of 
transducers is most beneficial for increasing the maximum heat generation when the 
desired focal point is close to the center of the breast (xn = 1).  This is reasonable 
because the tumor is further from the transducer when it is closer to the breast’s 
center, so more transducers are needed to reach the same heat generation.  For 
locations towards the edge of the breast, the number of elements in the row needs to 
be determined individually based on the exact location of the tumor.  Also, with just 
one transducer the heat generation generally increased as the focal point moved closer 
to the edge of the breast. 
 The results are very similar for all cases close to the breast’s center (xn = 1).  
Also, the magnitudes of the heats generated were usually very similar for the flat and 




decrease in heat generation with the inclusion of the third transducer.  Also, as was 
noted at the beginning of this section, the maximum heat generation always increases 
with increasing number of rows of elements.  The contour graphs of these studies 
show that the focal point has the exact same shape between graphs of two different 
numbers of rows, just with a change in magnitude.   
Effect of Change in Acoustic Attenuation 
 The preceding heat generation results were generated prior to heating the 
tissue (at the first time step).  The heat generation will change throughout the 
simulation because of the changes in the tissue’s acoustic attenuation.  To determine 
the importance of including the variability of this parameter, the heat generation 
contours are compared for two example cases.  Figure 82 shows the first example 
case (transducer parameters: curved, 51 elements, 40 rows, at (1,1)), where Figure 
82a is the heat generation contour prior to heating, and Figure 82b contains the same 
contours after the heating completes (when temperature reaches 100
o
C, in 0.53 
seconds).  There is a degeneration of the focal point, so the highest magnitude is 
moving towards the transducer and there is a larger fringe area of high heat 
generation.  In the x-y plane the elliptical shape of the focus has become a Y-shape.  





Figure 82 The maximum heat generation (W/m
3
) contours in the x-z and x-y  planes (a) prior to tissue heating, 
and (b) upon completion of heating when temperature has reached 100
o
C.  (Transducer parameters: curved, 
51 elements, 40 rows, at (1,1)). 
 In Figure 83, this same comparison is made for the same transducer 
parameter, except moving the focal point to the edge of the breast (transducer 
parameters: curved, 51 elements, 40 rows, at (3,1)).  In contrast with the first case, the 
beginning and end of the heating cycle showed little change in the heat generation 
contours.  This can be attributed to the higher initial heat generation (about one order 
of magnitude increase), so the temperature reached 100
o
C much quicker (only 0.06 
seconds), therefore the changing acoustic attenuation of the tissue was not as 
significant.  As was noted in the Focal Location Studies section, the heat generation 




closer to the transducer), so the heat generation will be more predictable throughout 
heating for those locations. 
 
Figure 83 The maximum heat generation (W/m
3
) contours in the x-z and x-y  planes (a) prior to tissue heating, 
and (b) upon completion of heating when temperature has reached 100
o
C.  (Transducer parameters: curved, 
51 elements, 40 rows, at (3,1)). 
 
Temperature and Necrosis Contours 
 This section examines how the temperature throughout the breast and the 
resulting necrosed tissue change from the different transducer parameters.  The data 
from all necrosis studies are listed in Table 55 – Table 64 in Appendix D.  The two 
representative cases used in the heat generation study (transducer parameters: flat, Q 




example of the resulting temperature and necrosis contours.  The first case, focused at 
(3,1) is shown in Figure 84 (temperature) and Figure 85 (necrosis).  As would be 
expected, the location of the highest temperature coincides with the location of the 
necrosis.  Also, both coincide with the location of the maximum heat generation (as 
seen in Figure 72 and Figure 83).  This agrees with the literature on the expected 
outcome of a HIFU treatment, where a small volume of tissue is necrosed at the focal 
point (71.3 mm
3
, which has an equivalent radius of 2.58 mm).  The temperature in the 
majority of the breast was kept to around 40
o
C, which is below the pain threshold of 
45
o
C [94] [36]. 
 
Figure 84 Contour plot of the temperature (
o
C) in the sliced isometric view (top), x-z plane (bottom left), and x-





Figure 85 Contour plot of the necrosed cells in the sliced isometric view (top), x-z plane (bottom left), and x-y 
plane (bottom right).  (Transducer parameters: flat, Q = 100 W, 41 elements/row, 40 rows, focused at (3,1)). 
 However, the second representative case in Figure 86 for temperature and 
Figure 87 for necrosis shows a less expected result of the treatment.  When the focal 
point moves towards the center of the breast at (1,1), the highest temperatures are 
spread from the focal point, creating a larger lesion with a less-predictable shape.  
When it is compared with the heat generation prior to heating (Figure 73 and Figure 
82a) the necrosed tissue falls outside of just the highest heat generation locations, but 
the heat generation contour at the end of heating (Figure 82b) matches more closely.  
This shows that the normal shapes of necrosis for HIFU treatments are less valid 





Figure 86 Contour plot of the temperature (
o
C) in the sliced isometric view (top), x-z plane (bottom left), and x-





Figure 87 Contour plot of the necrosed cells in the sliced isometric view (top), x-z plane (bottom left), and x-y 
plane (bottom right).  (Transducer parameters: flat, Q = 100 W, 41 elements/row, 40 rows, focused at (1,1)). 
This section first examines the effect of the parameters of an individual 
transducer.  Then, how the necrosed region changes by introducing more active 
transducers is shown. 
Effect of Transducer Parameters on Necrosis 
 The volume of the necrosed region is an important outcome of the HIFU 
simulations.  An equivalent radius is also used to describe the volumes in this section, 
defined by Equation 48 
    (










where req is the equivalent radius and Vnecr is the necrosed volume.  The resulting 
equivalent radius from different combinations of transducer parameters is explored.  
Figure 88 and Figure 89 display graphs of the necrosed equivalent radius versus the 
transducer power for one active transducer.  For most graphs, the radius increases 
with decreasing number of elements.  Also, for all graphs, as the focal point moves 
closer to the edge of the breast (from xn = 1 to 3), the necrosed volume decreases. 
 Figure 88 displays these plots for flat transducers at zn = 1 (a), zn = 2 (b), and 
zn = 3 (c) for different values of xn.  For xn = 1, as the power increases, the radius 
decreases.  This relationship is weaker for xn = 2, at the edge of the breast (xn = 3) 
there is no change in the equivalent necrosed radius when the power increases except 
at zn = 3.  These relationships are similarly true for curved transducers, shown with 
the same graphs in Figure 89, except the negative slopes are flatter. 
 
Figure 88 Necrosed equivalent radius versus transducer power for flat transducers focused at (a) zn=1, (b) 






Figure 89 Necrosed equivalent radius versus transducer power for curved transducers focused at (a) zn=1, (b) 
zn=2, (c) zn=3 for different values of xn (distinguished by line type) and transducer parameters (distinguished 
by color). 
As mentioned previously, the equivalent radius of the necrosed volume 
decreases towards the edge of the breast (and therefore closer to the transducer, 
towards xn = 3), which is in agreement with the example necrosed contours shown in 
Figure 85 and Figure 87.  Also, in all cases, as the focus gets closer to the edge of the 
breast, the transducer power has less of an effect on the final necrosed volume.   
Effect of the Number of Active Transduces on Necrosis 
The necrosis contours when more than one transducer was activated was also 
tested.  The same transducer parameters were tested with 1, 2, 3, and 4 active 
transducers all set to Q = 100 W.  Also, the transducers were tested when the total 
power summed to 100 W, so there may be the powers [50 50 0 0] W, [33 33 0 33] W, 




the focal point closest to the transducers (xn = 3, zn = 1) and furthest from the 
transducers (xn = 1, zn = 3).   
Figure 90 shows the case of (3,1) for increasing numbers of transducers 
activated at 100 W (transducer parameters: flat, 41 elements, 40 rows).  The shape of 
the focal point changes minimally with increasing numbers of transducers at the same 
power.  The exact volume of the necrosed region and the heating times are displayed 
in Table 16.  The necrosed volume is the most and the same for one and three active 
transducers (71.30 mm
3
), and all four cases had the same heating time, just 0.06 
seconds. 
 
Figure 90 Temperature (left, 
o
C) and necrosis (right) contours in the x-y plane for (a) one, (b) two, (c) three, and 




Table 16 The necrosed volume and heating time for different numbers of active transducers at (3,1). 
Location 
# of  
Trans 
Q (W) Vnecr (mm
3) Heat Time (s) 
(3,1) 
1 [100   0     0     0  ] 71.30 0.06 
2 [100 100   0     0  ] 55.17 0.06 
3 [100 100   0   100] 71.30 0.06 
4 [100 100 100 100] 42.72 0.06 
 
Figure 91 shows the temperature and necrosis contours for increasing numbers 
of transducers which sum to 100 W (Figure 91a is the same as Figure 90a).  There is a 
slight difference in the temperature contours between this decreased transducer power 
and having all transducers set to 100W, but the necrosis contours look the same.  The 
volume of the necrosis and the heating time are displayed in Table 17.  The necrosed 
volumes are the same for each number of active transducers as in Table 16, but as the 





Figure 91 Temperature (left, 
o
C) and necrosis (right) contours in the x-y plane for (a) one, (b) two, (c) three, and 
(d) four transducers activated, powers summing to 100 W.  (Transducer parameters: flat, 41 elements, 40 
rows, (3,1)). 
Table 17 The necrosed volume and heating time for different numbers of active transducers at (3,1). 
Location 
# of  
Trans 
Q (W) Vnecr (mm
3) Heat Time (s) 
(3,1) 
1 [100   0     0     0  ] 71.30 0.06 
2 [ 50   50    0     0  ] 55.17 0.11 
3 [ 33   33    0    33 ] 71.30 0.19 
4 [ 25   25   25   25 ] 42.72 0.22 
 
The case with the same transducer parameters, but at xn = 1 and zn = 3, there 
is a much larger initial volume.  Figure 92 shows the temperature and necrosis 




to the previous case, there is now a very big difference in the necrosis contours.  The 
necrosed volume decreases when more than one transducer is activated, but the 
necrosis is more focused towards the center of the focal point.  Table 18 displays the 
necrosed volumes and heating times of these simulations.  Three transducers takes the 
least time to heat but also results in the least volume necrosed. 
 
Figure 92 Temperature (left, 
o
C) and necrosis (right) contours in the x-y plane for (a) one, (b) two, (c) three, and 




Table 18 The necrosed volume and heating time for different numbers of active transducers at (1,3). 
Location 
# of  
Trans 
Q (W) Vnecr (mm
3) Heat Time (s) 
(1,3) 
1 [100   0     0     0  ] 1779 0.71 
2 [100 100   0     0  ] 561.8 0.29 
3 [100 100   0   100] 135.0 0.11 
4 [100 100 100 100] 652.6 0.15 
 
Figure 93 shows the temperature and necrosis contours for multiple 
transducers summing to 100 W.  The necrosed volumes are larger than when all 
transducer were activated to 100 W, but one focused region of necrosis is not created.  
Table 19 displays the necrosed volumes and heating times of these simulations.  The 
case with four transducers activated to 25 W each takes 1 second to reach 100
o
C, but 





Figure 93 Temperature (left, 
o
C) and necrosis (right) contours in the x-y plane for (a) one, (b) two, (c) three, and 
(d) four transducers activated, powers summing to 100 W.  (Transducer parameters: flat, 41 elements, 40 
rows, (1,3)). 
Table 19 The necrosed volume and heating time for different numbers of active transducers at (1,3). 
Location 
# of  
Trans 
Q (W) Vnecr (mm
3) Heat Time (s) 
(1,3) 
1 [100   0     0     0  ] 1779 0.71 
2 [ 50   50    0     0  ] 930.2 0.69 
3 [ 33   33    0    33 ] 498.5 0.53 






Discussion of Breast Studies Results 
 As was previously-established, there is a clear connection between the heat 
generation created, the resulting temperature contours, and finally the necrosed tissue 
in the breast.  Figure 85 showed a small lesion with the predictable ellipsoidal shape 
known for HIFU.  A larger lesion would be desirable to decrease the high treatment 
times of the multiple HIFU sonications which are needed for the smaller ablated 
volumes.  Figure 87 showed how having the focal location at a distance further from 
the transducer achieves this larger volume with the tested transducer parameters, but 
it must also be noted that the necrosis contour was not a predictable shape.  This is 
mainly attributed to the change in the heat generations as is dictated by the 
dependence of the acoustic attenuation on the thermal dose experienced by the tissue.   
 The first case described (at (3,1)) had a maximum heat generation which was 
almost a full order of magnitude greater than the maximum heat generation in the 
second case (at (1,1)), which resulted in a larger lesion.  The negative relationship 
between the necrosed volume and the maximum heat generation is shown in Figure 





Figure 94 Graph of the equivalent necrosed radius versus the natural log of the maximum heat generation for 
single transducer cases.  The equation of the line of best fit and its R
2
 value are given. 
 A lower heat generation will result in a greater heating time before 100
o
C is 
reached.  This is an important factor in creating the larger necrosed volumes with the 
lower heat generations, however it must also be minimized to decrease treatment 
time. 
 The difference between the heat generation before and after the heating cycle 
was proven through Figure 82, which showed degeneration of the focal point.  Figure 
87 shows the effect of this on the shape of the necrosis, where there is no longer a 
well-defined volume of dead cells.  This proves that it is very important to include the 
dynamic definition of acoustic attenuation in a HIFU simulation so that accurate 
treatment planning can occur.  Shorter heating times were shown to minimalize this 
effect, so manipulating the transducer parameters to allow for shorter heating times 
for the larger lesions will be necessary for patient treatments. 
 The effect of the individual transducer parameters on the final necrosed 
volume was also examined.  The input transducer power had a much greater effect on 




breast – for most cases it had no effect when the focus was at the points closest to the 
transducer, xn = 3.  The relationship between the necrosed volume and the x-
coordinate (in mm with the origin at the breast center, not xn) is shown in Figure 95.  
As was earlier described, the necrosed volume generally decreases as the focal point 
moves towards the edge of the breast and the transducer (breast radius x = 60 mm and 
transducer edge at x = 65mm). 
 
Figure 95 Graph of the necrosed volume versus the x-coordinate of the focal point.  The equation of the line of 
best fit and its R
2
 value are given.  The breast radius is shown at x = 65 mm, and the transducer surface is 
shown at x = 65 mm. 
The cases closer to the breast’s center had a higher necrosed volume with 50 
W when compared with an input power of 100 W.  However, this will also increase 
the treatment time.  The relationship between the transducer power and the heating 
time for different combinations of transducer parameters is shown in Figure 96.  In all 




transducer parameters decreased proportionally to each other because none of the 
lines were intersecting.
7
   
 
Figure 96 Heating time versus transducer power for different series of transducer shape, number of elements 
per row, and the number of rows.  Graphs showing individual parameters displayed in Figure 128 and Figure 
129 of Appendix E. 
 The inclusion of more active transducers shortened the long geometry in the 
x-y plane of the necrosed tissue for focal points close to the breast center (Figure 92 
and Figure 93).  The temperature contours showed a more focused area of the 
maximum temperature, especially with three active transducers, but the final necrosis 
shape was still a cross-like geometry.  This is showing that the tissue remained at the 
lower temperature for a sufficient period of time to cause cell death, so it may be 
beneficial to halt the ultrasound heating prior to the 100
o
C maximum has been 
achieved. 
 Another method which was discussed in previous literature to increase the 
necrosed volume is with multiple focal points used for each trial.  This was tested 
                                                 
7
 The legend is not provided because the focus of this graph is the overall trend.  For the effect of the 
transducer power on the equivalent necrosed radius on individual transducer parameters, see graphs in 
Figure 128 and Figure 129 of Appendix E. 

























with three or four transducers activated, each focusing on a different point.  The three 
geometries tested are shown in Figure 97, where a focal point configuration with 
three transducers (a), and two different configurations with four active transducers (b 
and c) are tested.  Transducer 1 focuses on the given (xn,zn) focal point. 
 
Figure 97 Focal point configurations for tests with multiple focal points for (a) three transducers, (b) four 
transducers spaced evenly, or (c) four transducers in t-shape.  Transducer 1 is focusing on the given (xn,zn) 
value. 
 These configurations were tested for the focal points (1,1) and (3,1) to 
determine effect for a large and small necrosed volume with one transducer, 
respectively.  The transducer power was set to either every transducer at 100 W, or all 
transducers sum to 100 W.  For a curved transducer with 51 elements and 40 rows, 
the final necrosed volumes and heating times are computed for each configuration.  
Table 20 compares these values for the different focal point configurations and each 
power.  The largest necrosed volume was created by configuration (c) for the initial 
focal point (1,1), but for the smaller focal point at (3,1) the different configurations 
made no difference in the necrosed volume other than when compared to the 
coinciding focal points.  This occurs because the only transducer which changes 




point at (3,1) to cause tissue ablation.  Mainly, the different focal point locations 
increased the necrosed volume, except for location (1,1) when all transducers were set 
to 100 W.  This decrease in necrosed volume could be attributed to the ultrasound 
waves of one transducer causing destructive interference at the focal point of another 
transducer.   
Table 20 The final necrosed volume and heating time for different configurations of multiple focal points.  
(Transducer parameters: curved, 51 elements, 40 rows). 




3) Heat Time (s) 
(1,1) 
[100 100   0   100] coinciding 244.92 0.16 
[100 100   0   100] (a) 563.45 0.23 
[ 33   33    0    33 ] coinciding 630.12 0.74 
[ 33   33    0    33 ] (a) 1203.59 1.01 
[100 100 100 100] coinciding 425.67 0.16 
[100 100 100 100] (b) 301.27 0.13 
[100 100 100 100] (c) 371.59 0.16 
[ 25   25   25   25 ] coinciding 1884.33 1.41 
[ 25   25   25   25 ] (b) 2176.23 1.46 
[ 25   25   25   25 ] (c) 2187.85 1.48 
(3,1) 
[100 100   0   100] coinciding 27.56 0.04 
[100 100   0   100] (a) 42.72 0.06 
[ 33   33    0    33 ] coinciding 27.56 0.11 
[ 33   33    0    33 ] (a) 42.72 0.18 
[100 100 100 100] coinciding 27.56 0.03 
[100 100 100 100] (b) 42.72 0.05 
[100 100 100 100] (c) 42.72 0.05 
[ 25   25   25   25 ] coinciding 27.56 0.13 
[ 25   25   25   25 ] (b) 42.72 0.21 
[ 25   25   25   25 ] (c) 42.72 0.21 
 
 Another consideration for the physician along with the necrosed volume and 
the treatment time is the input energy.  The relationship between the input energy 
(power*time) and the necrosed volume is displayed in Figure 98.  The graph is split 






 values around 0.96).  Increasing the input energy also increases the necrosed 
volume, so this creates the tradeoff for the physician. 
 
Figure 98 Graph of the necrosed volume versus the input energy, split by the number of transducer heights.  
The equation of the line of best fit for each number of rows of elements is displayed, along with its R
2
 value. 
 The quadratic relationship between the necrosed volume and energy still holds 
true for multiple active transducers.  A graph of the necrosed volume versus the input 
energy is shown in Figure 99 for the simulations for multiple transducers focusing at 
different points (results shown in Table 20).  The R
2
 value is almost 1, showing the 





Figure 99 Graph of the necrosed volume versus the input energy for multiple active transducers, with the 
parameters described in Table 20.  The equation of the line of best fit for each number of rows of elements is 




Device Design and Protocol Development for Breast Cancer 
 The final outcome of the simulations of ultrasound ablation for breast cancer 
is to determine the best device to perform this treatment, along with the 
accompanying patient-specific treatment planning protocols for the physician.  This 
section will give the concept designed for the device, and then will detail how the 
physician can use this device. 
 
Device Concept  
 The functional requirements for the breast cancer study are similar to the 
prostate study’s requirements; however the different anatomy and nature of HIFU 
instead of planar ultrasound waves does change the needs of the delivery device.  




Table 21 Functional requirements for US device to ablate breast cancer. 
Functional Requirements 
1) Necrosed tissue must reach tumor area. 
2) Predictable necrosis geometry. 
3) Can be used for most/ all patients. 
4) Easy to use correctly. 
 
 The design parameters which are needed to satisfy these functional 
requirements are shown in Table 22.  The second column specifies which FR is 
satisfied by each design parameter. 
Table 22 Design parameters for US device to ablate breast cancer, including the functional requirements they 
each satisfy. 
Design Parameters FR satisfied 
Creates distant focal point with minimal near-field heating. (1) 
Creates ellipsoidal lesion. (2) 
Creates lesion at desired focal point. (2) 
Adjustable for different patient sizes. (3) 
Can reach tumor at any point in the breast. (3) 
Includes symmetry. (4) 
 
The simulations showed that the first three and the fifth design parameters can 
be satisfied by many different combinations of transducer parameters.  The physical 
embodiment of the device needs to include the fourth and sixth design parameters, 
along with a consideration for patient-comfort.  An example of a design concept 
which includes the symmetry parameter was designed by Payne [97] and is shown in 
Figure 100.  The breast lies inside of the hole, a cylindrical phased array surrounds it, 




submerged in a tank of water, and there is a cushion not shown which sits on top of 
the platform matching the contours of the patient’s body.  Problems with this design 
are that it does not accommodate for all patient sizes and it requires the patient lie in 
an uncomfortable position for a considerable period of time. 
 
Figure 100 Device concept for breast cancer HIFU ablation [97]. 
 The cylindrical array shown in Figure 100 is integrated into one embodiment 
of the device concept determined by this study.  Segmented cylindrical transducer 
sections were tested in the simulations, but those results can similarly be used for a 
complete cylindrical array (multiple active transducers can be represented with more 
active elements in the angular direction).  A concept sketch including this feature is 
shown in Figure 101.  The transducer will be concentric to the breast axis, and there is 
a cuff between the transducer and the breast which fills with fluid to minimize the 
ultrasonic energy lost between the transducer to the tissue, cooling the breast exterior, 
and arresting the breast in place (it works similar to a blood pressure cuff).  The 
transducer is secured to the patient with a chest strap, so they are able to be situated in 
their choice of a comfortable position during treatment.  Shoulder straps may also be 
included for increased stability.  This design is symmetrical for ease of physician use.   
However, although the chest strap can be adjusted, this design is limiting because the 





Figure 101 Device design concept for cylindrical phased array HIFU transducer for breast cancer. 
 The flat transducer design that was tested gave similar results to the curved 
transducer, and increases the flexibility for use with more patients.  Figure 102 
depicts this concept, showing four planar transducers which fit into a holder, attached 
to a chest strap similar to the one in the previous design.  There are multiple chest 
straps with different-sized transducer holders, to accommodate any patient size 
without needing different transducers.  There is also a fluid-filled cuff (not pictured) 





Figure 102 Device concept for flat phased array HIFU transducers for breast cancer.  The four planar arrays are 
individually removable from the chest strap, and there are multiple transducer holder size options.  The 
separate fluid-filled cuff is not pictured. 
 
Physician Protocol 
The goal of this research was to ablate breast tumors using ultrasound thermal 
therapy without the combination of chemotherapy or radiation treatments.  At a 
minimum, the simulations need to demonstrate that these devices can ablate common 
sizes of breast cancer tumors.  Data from the National Cancer Institute [98] is graphed 
in Figure 103.  Three standard deviations away from the mean in both directions 






Figure 103 Prevalence of different tumor sizes from 1988 - 2001 [98].  Includes curve connecting data points, 
with the range of tumors which were proven to be able to be necrosed with this study filled in. 
 From the simulations performed, the equivalent radii calculated from the 
different sets of transducer parameters for one active transducer ranged between 2 – 
9.5 mm with a mean of 4.5 mm (equivalent to 4 – 19 mm diameter, with a mean of 9 
mm).  This encompasses a large portion of the tumor sizes within the six standard 
deviation range of Figure 103 with just the one sonication (filled-in under the curve 
created by history data); however, the larger tumors generally had an unpredictable 
shape.  The average ablated volume from the simulations is about 10% of the 
estimated mean tumor volume from Figure 103.  This shows that if the larger radius 
lesions could be developed in a more predictable shape, the number of ultrasound 
sonications (and therefore the total treatment time) can be reduced.  As was shown 
from the studies with multiple active transducers, the shape of this lesion can be 
manipulated to keep the focus closer to the desired point when the ultrasound is 




 The treatment planning for HIFU is simpler than it is for the prostate studies 
because if the lesion diameter is known, then the focal point can be shifted to 
sufficiently overlap the previous region ablated until the total tumor is ablated.  The 
transducers described in the previous section use electronic scanning to move the 
focal point, so after the physician secures the device onto the patient, it will not need 
to be moved until the treatment is complete.  After further studies are performed, the 
correct set of transducer parameters will be determined which create an ellipsoidal 
lesion at any location.  Once this is known, the physician only needs to input the 
tumor geometry into the device’s software.  This protocol is shown in a flowchart 
similar to the one which was given for the prostate treatment planning in Figure 104.  
The sonications’ outputs will include multiple simultaneous focal points and any 
cooling time needed between sonications to avoid healthy tissue damage. 
 
Figure 104 Flowchart showing the patient-specific protocol for physicians to use for prostate cancer treatment 
planning. 
 The change in acoustic attenuation caused high temperatures in locations 
outside of the focal point, which is hard to predict before treatments.  Using these 




implementing real-time temperature monitoring with ultrasound or MRI imaging will 
further better the clinical results. 
 
Accuracy of Results from Breast Simulations with TID 
 Studies have shown that above 50
o
C, the TID tissue model is no longer 
accurate [28] [99].  HIFU causes cell necrosis solely with temperatures above this 
value because the time of each sonication is too short for the lower temperatures to be 
effective.  The Arrhenius model can be used for these higher temperatures, but the 
parameters specific to the type of cells studied must be known because there is a 
significant difference between the parameters of different cell types [14]. 
 As previously-stated, there are few studies which have performed experiments 
on thermal therapy for breast cancer cells, and the Arrhenius parameters for these 
results were not present.  To accurately model the HIFU simulations for breast cancer 
in the future, the next step of this study was to determine the Arrhenius parameters for 
the thermal damage of breast cancer cells.  Those results can then be input back into 






Chapter 6: Developing Thermal Damage Models for Breast 
Cancer Ablation 
To determine the necrosed regions in future breast US thermal therapy 
simulation studies, the thermal damage correlations must be experimentally 
determined.  As was shown in Chapter 3, this dosage can be determined through in 
vitro experimentation with thermal therapy.   
 This study experiments with MCF-7 and T-47D breast cancer cell lines, which 
are two of the most commons cell lines used to accurately model breast cancer [100] 
[101].  They are hormone-dependent invasive ductal carcinomas, and originate from a 
metastic pleural effusion of tissue [100] [101].  Also, they are estrogen receptive cell 
lines, and estrogen can cause cancer (although the reason it does is not known) [100] 
[101]. 
These cells lines were tested to determine the Arrhenius parameters associated 
describing the thermal dose for their cell death.  To ensure an even, quick heating of 
the cells, a monolayer of cells was plated on a slide, which was placed on top of a 





C to calculate the parameters.  The methods and results of 
this study are presented in this chapter. 
 
Methods 
 The methods used to develop the thermal damage model include creating a 
custom heater setup, validating its ability to heat cells evenly and consistently, and 




heater design considerations are explained, then the thermal therapy testing 
procedures are detailed, an explanation of the tests which were performed is given, 




 The complete heater setup comprised of an original heater assembly, three 
treatment slides within the heater assembly, a temperature controller, and a data 
acquisition (DAQ) instrument which connects to a computer to record the 
temperature measurements (Figure 105).  The heater’s power cord is connected to the 
controller.  There are nine thermocouples assessing the system temperature at 
different locations: one connects to the controller and the other eight are in various 
positions on the heater assembly.  The exact location of each thermocouple is 
























Figure 105 Diagram of cell heating setup.  The green lines are thermocouples, where the ends with the 





The cell heater consisted of a wooden base, temperature-insulating foam, 
silicone heater, aluminum adapter, plastic slide holder, U-aligner, plexiglas top, and 
top aluminum piece (Figure 106, technical drawings provided in Appendix F).  The 
design choices for each component of this heater are explained in this section. 
 
Figure 106 Cell heater, silicone strip heater sits between foam and aluminum adapter (not pictured except for 
white wire). 
To heat the cells, a 120V W3”x L6” silicone strip heater was purchased 
(TEMPCO Electric Heater Corporation, Model #80408), displayed in Figure 107.  
The maximum temperature of the heater is 232
o
C, so it was an appropriate choice for 




Figure 107 TEMPCO 120V, 3" x 6" silicone strip heater [102]. 
 The aluminum adapter, shown in Figure 108, was created to have a flat 
surface on which the slides could sit, which spread the heat for an even temperature 


















everywhere except a 1.300” x 5.000” rectangle in the center of the piece.  The cell 
slides (standard W1” x L3” x t0.039” glass slides) sit flat on the raised platform with 
their length perpendicular to its length, so only the center of the slides are heated and 
the ends of the slides are exposed so they can be easily placed and removed during 
experimentation.   
 
Figure 108 Aluminum adapter sitting on the silicone heater (orange), foam (black), and wooden base, with 
1/4-20 screws securing it to the base. 
Four ¼-20 tapped holes were drilled through the thickness at the corners of 
the plate for securing it to the base.  The screws used have a rubber foot on one end 
which sits under the wooden base, so as they are screwed into the aluminum plate a 
compression force is created between the aluminum adapter and the base, which 
flattens the silicone heater and ensures an even heat distribution through the 
aluminum. 
Three blind holes Ø0.0930” x 0.6500” depth are drilled parallel to the base 
into the middle of the raised platform.  They are located at the center of the width of 
each of the three treatment slides, so a thermocouple (TC) can be inserted into each 
hole to measure the temperature directly below the center point of the slide (more 














Finally, a 1.3500” x 4.000” rounded rectangular slot was removed from the 
base of the aluminum, centered lengthwise on the adapter.  Its purpose was to allow 
for the manufacture of the three previously-mentioned holes without interference 
between the drill chuck and the aluminum base.  A second slot was added on the 
other half of the base to ensure thermal symmetry.  The final part was polished to 
create a smooth surface for heat transfer.  
The foam and wooden base provide thermal insulation for the heater and 
aluminum adapter.  This allows most of the heat to propagate upwards towards the 
slides, and provides a cool surface for user safety and work-surface preservation. 
The ABS plastic slide holder was created by an automatic prototying machine.  
Its purpose is to quickly get the slides on and off the heater, which is especially 
important during high-temperature testing.  Figure 109 shows the holder with the 
three treatment slides sitting in their designated positions.  It is open in the center to 
allow for the raised platform of the heater to touch the slides, and slightly lift them off 
of the holder to ensure full contact.   
 















The walls of the holder keep the slides in position during placement and 
removal of the holder from the heater, and there are only three walls for ease of 
getting the slides into and out of the holder.  There is a slot at the beneath each slide 
on the bottom of the holder and parallel to the length of the slides to give an opening 
for the thermocouples which are inserted in the aluminum adapter.  Without these, the 
holder and therefore the slides would not sit flatly on the adapter.   
Two Ø1/8” steel rods were inserted into blind holes perpendicular to the base 
at the closed end of the holder.  Holes in the plexiglas lid (Figure 112) will slide into 
these rods, centering and securing the lid on the plastic holder, but allowing for a 
quick removal of the lid after the experiment.  Two identical plastic heating holders 
were built so one could hold empty cells while the heater reached steady state (see 
Testing Procedure section). 
The rapid-prototyped ABS plastic U-aligner holds the coverslips, which sit on 
top of the cells on the slide, in place during heating.  Sliding of these coverslips 
creates a shear stress on the cells, which can cause cell death not related to the 
thermal dose, so it is important to keep them still.  Figure 110a shows the top view of 
the aligner, and Figure 110b is the bottom view.  Figure 111 displays the U-aligner on 
top of the treatment slides on the plastic holder.  The two long walls on the bottom sit 
flat along the two short sides of the three slides.  The slot is slightly wider than the 
width of the coverslips, so the inner walls of the slot are just outside of the sides of 






Figure 111 The U-aligner is situated on top of the slides on the plastic holder, and its sides are outside of 
where the coverslips are situated (not shown). 
 The two raised platforms on the bottom of the U-aligner sit on top of the 
plastic holder’s base, just to the side of the slides.  This takes some of the pressure off 
of the slides, so that the extra weight in the back will not tip the slides off of the 
surface of the heater.  Between them the connection of the two walls of the U has a 
very thin thickness, so it does not touch the aluminum raised platform but solely 
connects and supports the sides of the U. 
 The machined plexiglas lid and aluminum top piece are rigidly attached to 








piece is to provide a means of measuring the temperature at the top of the coverslip.  
The temperature below the slides is not sufficient to accurately determine the 
temperature of the cells, even if the temperature gradient is known, because the 
temperature read by the thermocouples in the aluminum adapter does not show the 
transient temperature of the cells when first placed upon the heater.  However, a 
thermocouple could not be attached to the top of the coverslip because it would create 
a shear stress on the coverslip and the adhesive would mar the optical clarity needed 
to look at the cells under the microscope.  
 
Figure 112 Bottom view of plexiglas lid and aluminum top piece. 
The aluminum top piece sits just above the coverslips, but does not apply 
pressure to them (which also causes cell damage) because it is supported by the lid.  It 
was manufactured from a W1.8000” x L2.7000” x t1/8” aluminum plate, and 1/8” of 
the thickness was symmetrically removed on the long sides 0.3250” into the piece.  
This ensures the aluminum top piece will not touch the U-aligner (shown in Figure 
113).  Four 4-40 tapped through holes are perpendicular to the thickness at the 


















clearance hole in the plexiglas lid, through two silicone washers, and screw into the 
designated tapped hole. 
The W3.7700” x L4.500” x t¼” plexiglas lid contained ten through holes 
drilled perpendicular to its thickness.  The two in the back are Ø0.1360” to allow 
clearance for the rods in the plastic slide holder.  The four in the middle are Ø0.1285” 
clearance holes for the screws which attach to the aluminum top piece.  And finally, 
the four holes at the corners of the lid are tapped for an 8-32 screw.  The four screws 
which are screwed through those holes are the only parts of this lid assembly which 
touch the plastic holder.  They can be adjusted so that the distance from the lid to the 
holder keeps the aluminum top piece just above the top of the coverslip (shown in 
Figure 113).  The screws provide the tight tolerance needed for this height (which is 
derived because of the thinness of the coverlip); this tolerance was smaller than the 
accuracy of the manual milling machine. 
 
Figure 113 Plastic holder with lid on top and U-aligner between them.  The screws in the lid position the 
aluminum top piece above the coverslips (not shown), and the aluminum top has rails machined out so it does 
not touch the U-aligner. 
Controller  
The controller in this system was used to maintain a constant experimental 
temperature from the heater (Digi-Sense Advanced Temperature Controller, 115V, 




(PID) controller, and its parameters could be auto-tuned before each test period to 
ensure accuracy in different ambient environments.  After tuning, the controller could 
be set to any desired temperature and maintain the set temperature ±0.2
o
C. 
The power cord from the silicone heater plugged into the controller, which 
controlled the temperature by turning the power on and off as was necessary (when 
the desired temperature was reached, there was a high frequency of the power turning 
on and off).  A thermocouple was also plugged into the controller, and its junction 
was placed between the silicone heater and the foam insulation to provide the 
controller the temperature of the heater.    
 Data Acquisition System  
The DAQ system consisted of a 31-channel port for the thermocouple input 
(National Instruments TC-2095) connected to an isolation amplifier module (National 
Instuments SCXI-1121), which connected to the computer for data collection and 
storage.  Eight thermocouples connect to the DAQ, with their junction in various 
locations on the setup: one on the front surface of the aluminum adapter’s raised 
platform, one on the back surface of the raised platform, three in the holes in the 
aluminum adapter raised platform under the slides, and three on top of the aluminum 
top piece (above the centers of the treatment slides). 





Figure 114 Full heater setup. 
Thermocouples 
K-type thermocouples were used to measure the temperature because their 
temperature boundaries are well outside of the necessary range, and their sensitivity is 
sufficient at the operating temperatures of this experiment.  Two different series of 
thermocouples were used: for measurements under the silicone heater and in the holes 
in the aluminum adapter, an insulated thermocouple with an exposed junction was 
used (Omega Engineering, Inc. Model # 5SRTC-GG-K-30-36).  Thermocouples with 
surface mount adhesives (Omega Engineering, Inc. Model # SA1-K-SRTC) were 
used for thermocouples which were attached to the aluminum top piece and the raised 
platform of the aluminum adapter.   
As mentioned at the beginning of this section, there are nine thermocouples 
total: one which provides feedback to the controller (TC under the silicone heater) 
and the remaining eight read measurements for the DAQ system.  The physical 












Figure 115 Thermocouple positions during testing. 
 
Thermocouple Calibration 
To ensure the thermocouples have the correct reference temperature values, 
they are calibrated before testing begins.  The controller only uses one temperature 
point to calibrate the thermocouples, so the temperature was set while the junction 
was submerged in boiling water (assumed to be 100
o
C).  The thermocouples inserted 
into the DAQ could use multiple temperature points, so the thermocouples were 
calibrated at three temperatures: ambient room temperature, an ice water bath 
(assumed to be 0
o
C), and the boiling water. 
 
Cell Culture 
 MCF-7 and T-47D breast cancer cell lines were grown to confluency and 




















which varied between 250 x 10
6
 cells/mL and 450 x 10
6
 cells/mL.  During the 
experimentation, the cell solution was kept in an ice bath. 
 
Testing Procedure 
 Before testing began, the temperature and humidity of the room were 
recorded.  A plastic heating holder with 3 blank slides was placed on the heater, and 
the controller was set to the first testing temperature.  The test could begin once the 
entire heating setup reached a constant temperature. 
 150µL of the current cell solution was mixed with 150µL of Trypan Blue 
viability staining dye.  Five slides were set out on a slide-centering mat, each within 
one of five the rectangles (Figure 116).  They were labeled with the cell line, heating 
temperature, and heating time of the current test, and each one was given a slide 
identification of C-37, C-var, 1, 2, or 3.  A coverslip with side rails (W0.868” x 
L1.182” x t0.010”, Thermo Scientific Lifterslip P# 22x301-2-4734) was placed on top 
of each slide within the smaller rectangle drawn on the centering mat, with its rail-
side on the slide with the rails parallel to the long sides of the slide.  The rails created 
a short gap between the top of the slide and the bottom of the coverslip so that there 
was no compression force on the cells from the coverslip, and an even distribution of 
solution was ensured.  50µL of the cell solution/ Trypan Blue mixture was pipetted 
slowly at one non-railed end each coverslip; capillary action drew the mixture 





Figure 116 Slide centering mat.  Each slide is placed within a large rectangle and the coverslip is put on top of it 
within the smaller rectangle. 
 
Figure 117 Labeled slide with cell solution/ Trypan Blue inserted under the coverslip. 
 Each slide was placed under an upright microscope fitted with a camera 
(OPELCO), and 3 photographs were taken at 100x magnification in varying locations 
across the coverslip area.  This recorded the initial viability of the cells.   
 The slide identified as “C-37” was placed in an incubator set to 37
o
C at 5% 
CO2.  The “C-var” slide was placed on the counter next to the heater setup.  These are 
the two controls for the experiment: the former is to compare the treatment slides to 
cells that remain at body temperature for the duration of testing (compared with 
respect to body cells), and the latter compares the treatment slides to cells which 
experience the testing environments without heating (compared with respect to 




pushed all of the way to the back.  Next, slide “2” was placed in the holder, so its side 
was touching the side of slide “3”.  Finally, slide “1” was inserted into the plastic 
slide holder in the same manner, touching slide “2” (Figure 118).  The U-aligner was 
placed on top of the slides, with the closed end of the “U” facing the open end of the 
slide holder.  The lid was slid on top of the plastic slide holder. 
 
Figure 118 Slides with cells inserted into plastic slide holder; slide "3" was placed first, then slide "2", and slide 
"1" was at the front of the holder. 
 The DAQ began recording and the slide holder with the treatment slides and 
the lid replaced the empty slide holder on the heater.  After the desired heating time 
passed, the slide heating holder assembly was removed from the heater, the lid and U-
aligner were removed, and the C-var slide and the holder with the treatment slides 
were placed in a fridge at 4
o
C for five minutes to prevent the cells from heating 
further. 
 The five slides were again placed under the upright microscope and 
photographed in three locations for each slide (an example of one of these photos is 





Figure 119 A photo taken at 100x of T-47D cells after heating for 4.5 mins at 50
o
C.  The white dots are the live 
cells and the blue dots are the dead cells. 
 
Tests Performed 
 To obtain an accurate mathematical model to describe the thermal damage 
correlations of these breast cancer cell lines, a sufficient number of time and 




Table 23 The time and temperature combinations of the trials performed for each cell line. 


































































Setup Validation and Thermal Gradient Determination 
 The holes which were drilled into the aluminum adapter’s raised platform for 
the temperature measurements beneath the slides could possibly create an uneven 
temperature distribution under the slides.  Thermal uniformity cannot be 
compromised at the expense of the temperature measurement, so it was important to 
validate that no cool spots were created from these drilled holes.   
 First, the heater was tested prior to the drilling of these holes.  Using a 
thermally-conductive compound (Arctic Silver, Céramique) and thermally-insulating 
tape, thermocouples were secured to the top of the aluminum adapter where the 
centers of the slides would.  Two more thermocouples were attached to the front and 
back of this raised platform, in the locations the thermocouples would sit during 
testing (Figure 120).  The adhesive thermocouples were not used for these tests to 
avoid any residual adhesive remaining on the aluminum adapter after they were 





Figure 120 Setup to test of the temperatures at the top of the aluminum adapter prior to drilling holes for TCs. 





outside of the testing extremes.  Then, the holes were drilled in the aluminum adapter, 
and the test was repeated, but now with measurements being taken within the 
aluminum as well (setup shown in Figure 121). 
 
Figure 121 Setup to test of the temperatures at the top of the aluminum adapter after drilling holes for TCs, 
also measuring the temperature in the drilled holes. 
 The results of this testing are summarized in Table 24.  There is only about a 
3% change in the temperatures measured before and after the holes are drilled, which 
is sufficiently small to give valid testing results. 
Table 24 The average of the temperatures measured on the top of the aluminum adapter before and after 
drilling the holes for the thermocouples in the side of its raised platform. 
 
Without holes With holes Percent Error 
Silicone Heater Temp (oC) 48 65 48 65 48 65 
Average Temp Over Slide 
Locations (oC) 





 Next, it was important to determine the thermal gradient between the 
temperature read by the thermocouples beneath the slides and the actual temperature 
of the cells.  The temperature observed by the cells cannot be obtained during testing, 
so it was estimated according to this pre-determined gradient.  Since the exact thermal 
contact resistances are not known, this thermal gradient is determined experimentally. 
To experimentally determine the thermal gradient, three thermocouples were 
attached to the top and center of three blank slides.  The slides were placed in the 
plastic holder and onto the heater.  Thermocouples were also inserted into the holes 
under the slides, so the temperature was being measured both below the slides (as 
would occur during testing) and in the location where the cells would be located.  





C.  The average temperatures resulting from these 
experiments are displayed in Table 25, and the differences between the temperature at 
the cells and below them are calculated in the last row of the table. 
Table 25 Temperature at cell location and directly below the slides in the aluminum adapter at the 
temperature extremes of the silicone heater.  The resulting thermal gradients are calculated for each silicone 
heater temperature. 
Silicone Heater Temp (oC) 45 65 
Average Temp at cells (oC) 45.02 64.02 
Average Temp under cells (oC) 47.90 69.03 
Gradient (oC) 2.88 5.01 
 
This discrepancy between thermal gradients at the two silicone temperatures 
can be attributed to the contact resistance increasing between the aluminum and the 




gradient and the temperature measured within the aluminum adapter, so the slope of 
that relationship is 
         
    
 
         
           
      
where TTC is the temperature under the slide as measured by the thermocouple inside 
of the aluminum adapter.  Therefore, the equation for the thermal gradient is 
             (         )       Equation 49 
which leads to the equation for the cell temperature based on the temperature under 
the thermocouple as 
                                Equation 50 
To validate this experimental calculation of the gradient, a theoretical 
determination of the cell temperature was performed.  A schematic of the thermal 
resistances for the final test setup is shown in Figure 122.  The purple dots labeled TAl 
and Ttop represent the temperatures measured by the thermocouples in the aluminum 
base and on top of the top aluminum plate, respectively.  The heat flows up through 
the aluminum base into the slide (losing some energy to the contact resistance 
between them), then through the cell solution (labeled in blue since it is the desired 
measurement) and cover slip.  At this point there is a thin layer of air between the top 
of the coverslip and the bottom of the aluminum top piece, so there are both 
conduction and convection effects (combination represented by dashed resistor).  
Finally, the heat flows through the aluminum top plate to reach the thermocouples at 





Figure 122 Schematic of thermal resistances in final test setup.  The blue cell temperature is the value sought 
from this calculation. 
Through the above process, the heat flux is constant, so if this flux is 
determined then the temperature at any point can be calculated.  As heat flows 
through a medium, its energy is transferred through convection calculated using 
Equation 51 [103] 
     
  
  
 Equation 51 
where q” is the heat flux, k is the thermal conductivity of the material and x is the 
direction of interest.  Through a medium the temperature at the second wall (T2) can 
be calculated if the temperature at the first wall (T1) is known by discretizing the 
above equation, shown in Equation 52. 
      
     
 
 Equation 52 
 The heat flux due to thermal contact resistance between two surfaces is 
calculated by Equation 53 [103] 
   
     
     
 Equation 53 
where R”t,c is the thermal contact resistance, which is different for each type of 
interface.  This formula can be similarly discretized as Equation 51 to solve for the 




 Finally, the layer of air has both conductive and convective effects, which 
occur because the air is not stagnant during testing so its flow against the surfaces 
removes heat.  The heat flux due to convection is described by Equation 54 [103] 
    (     ) Equation 54 
where h is the convection heat transfer coefficient of the fluid, TS is the surface 
temperature, and T∞ is the ambient air temperature.   
Combining the thermal gradients for each resistance layer results in Equation 
55.  




      



















   
 
 





      
] 
Equation 55 
This equation can be solved for q”, which is assumed to be constant during all 
tests.  The values for the material thicknesses (Δxi) are shown in Table 26, and Table 
27 displays the material constants k, R”, and h used in this calculation. 
Table 26 Thicknesses of different material layers. 





Air (estimated) 0.001 





Table 27 Material constants for theoretical thermal gradient calculation [103]. 


















 A sample test was performed with a layer of water under the coverslip 
(instead of cell solution) to determine the heat flux.  The heater was set to 50
o
C, and 
when steady state was reached the temperatures in the aluminum base and above the 
aluminum top were collected and averaged.  Plugging these values into Equation 55 
resulted in a heat flux of q” = 0.531 W/m
2
. 
 Finally, to relate the theoretical calculation back to the experimentally 
determined thermal gradient, the cell temperature was calculated for both the 
experimental and theoretical method with the test case presented in the previous 
paragraph.  With an average aluminum temperature of 53.0
o
C, the theoretical 
calculation yielded a cell temperature of 50.5
o
C, and the experimental gradient 
calculation (Equation 50) resulted in an average of 49.6
o
C.  This is less than a 2% 




the theoretical calulation was estimated and does not include the increase in thermal 
losses at higher temperatures.  Also, the thickness of the airgap was an estimate as 
well.  Therefore, the experimentally-determined thermal gradient calculation is 
acceptable to use to determine the cell temperatures during testing. 
 
Final Consideration: Temperature Ramping 
 The goal of this testing is to find the cellular responses to isothermal heating 
because the Arrhenius equation is most-accurate when determined for constant 
temperatures.  However, there is an inherent ramping time where the temperature of 
the cells is changing rapidly when the treatment slides are first placed on the heater 
because there cannot be an instantaneous temperature increase.  For long testing 
times, the ramping period will be a negligibly small percentage of the total treatment 
time.  Ramping has the greatest impact on high temperature tests because cell death 
occurs quickly, therefore many cells will die before the steady state temperature is 
reached.  This is an error that must be considered while reviewing results from this or 
any thermal therapy cell study. 
 Equation 50 is used to determine the temperature of the cells from the 
experiments conducted.  The temperatures read from the thermocouples on the 
aluminum top piece are used to determine when a steady state temperature has been 
reached during testing.  The temperatures measured in the aluminum adapter will not 
change much when the slides are placed on the heater, so the calculation from 
Equation 50 (where that temperature is labeled TTC) will not reflect the true 




temperatures were only calculated after the aluminum top piece reached about 90% of 
its final temperature. 
 
Data Analysis Methods 
 To analyze the data, first any obvious outliers were removed and the viability 
of each slide before testing began was calculated by Equation 56   
    
  
  
 Equation 56 
where %di is the initial percent of dead cells, Nd is the number of dead cells, and NT is 
the total number of cells on the slide. 
Then, the results from each slide post-heating were normalized by their initial 
viability, so the number of dead cells becomes the value it would have been if 100 
live cells were initially present.  This calculation is shown in Equation 57 
      
         
   
 Equation 57 
where %dn,j is the percent of dead cells normalized to the initial viability (and j 
represents the slide being considered, which can be C37 for the controls at 37
o
C 
labeled C-37 , CV for the controls at the variable ambient temperatures labeled C-
Var, or t for the test slides), %dp-h is the percent dead post-heating, and %Vi is the 
percentage of viable cells before heating. 
 The normalized viabilities of the control slides post-heating are then averaged 
for each control (an average of three photos for the C-37 and separately three photos 




post-heating for three slides) was normalized a second time to account for the control 
cells which have died, separately for each type of control cell, according to Equation 
58 for C-37 cells, 
         
     
       
 Equation 58 
where %dnC,C37 is the percent dead normalized to the C-37 control cells, and Equation 
59 for C-Var cells, 
        
     
      
 Equation 59 
where %dnC,CV is the percent dead normalized to the C-Var control cells.  The percent 
viable cells were then determined by Equation 60 – Equation 62  
              Equation 60 
                    Equation 61 
                  Equation 62 
where %Vn,t is the viability percentage post-heating without normalizing to the 
controls, %VnC,C37 is the viability percentage normalized to the C-37 slide, and 
%VnC,CV is the viability percentage dead normalized to the C-Var slide.  The 
following calculations are performed three times, once for %Vn,t, %VnC,C37, and 
%VnC,CV. 
Each of those viability percentages are comprised of nine points, and the final 
viability was determined by averaging each point.  Since less than 30 samples were 
tested, a t-test statistic was performed to determine the 95% confidence intervals of 





 ̅   
 √ ⁄
 Equation 63 
where  ̅ is the sample mean, µ is the population mean, S is the standard deviation, 
and n is the number of samples (9 in this case).  The calculation to determine the 
standard deviation is shown in Equation 64 
  ∑
(    ̅)
 
   
 
   
 Equation 64 
Therefore, the confidence interval for the population mean is shown in Equation 65 
[104] 
 ̅     ⁄        ̅     ⁄     Equation 65 
where α is the probability that the mean falls outside of this interval, ν is the number 
of degrees of freedom (ν = n-1), and t is a value determined by the t-Distribution 
table. 
  
Results and Data Analysis for Cell Studies 
First, an example of the resulting temperature curves obtained by the 
thermocouples during testing is shown.  Then, the resulting cell viabilities are 
presented in in graphical form.  The raw data of the cell viabilities can be found in 
Appendix G.     
 
Temperature Curves 
An example of the temperature curves (temperature versus time) measured by 
the thermocouples during a trial is shown in Figure 123 for T-47D cells at 50
o




minutes.  The three thermocouples on the top aluminum piece (red squares, green 
triangles, and purple X’s) clearly delineate the phases of testing: first, there is a short 
constant temperature portion at the beginning of testing where the DAQ was 
collecting data but the slides had not yet been placed on the heater.  Then, there is a 
ramping portion of the graph, indicating the time when the cells are heating up but not 
yet at their steady-state temperature.  When the graph flattens indicates the steady-
state portion of the test (the start of this period was the time when the temperature 
reached about 90% of its final value).  Finally, the end of the graph shows a steep 
decrease in temperature, which indicates the end of the test because the slides (and 
therefore the thermocouples on the top) were removed from the heater. 
 
Figure 123 Graph of the thermocouple temperature readings during the trial for T-47D cells at 50
o
C for 20 
minutes. 
The data collected during the pre-testing and post-testing time periods were 
discarded.  The temperatures on the tops were used for the purpose of determining the 
previously-mentioned time periods, but were also not used in any of the data analysis.  
The graph of the thermocouple attached to the aluminum base’s top surface (pink 




the aluminum surface instead of the two described in the procedures because early on 
in testing this thermocouple stopped giving reliable data, so its results are not shown).  
The thermocouples in the aluminum base under the slides (blue stars, orange circles, 
and purple plusses) initially decreased in temperature when the slides were placed on 
the heater, but then quickly returned to their stead-state value.  Only the data taken 




 The resulting survival curves for the MCF-7 cell lines are displayed in Figure 
124.  The x-axis shows the heating time, the y-axis is the cell viability, and each data 
series is for a different temperature.  The results are shown for the treatment slides 
without normalization, and then separate graphs are displayed to show it normalized 
with respect to the C-37 and C-Var results.  The vertical lines represent the 





Figure 124 Survival curves of the MCF-7 cell line at different temperatures for (a) the treatment slides, (b) the 
treatment slides normalized to C-37, and (c) the treatment slides normalized to C-Var. 
These graphs show that the higher the heating temperature, the less time 
required for a decrease in cell viability.  With the exception of certain data points, an 
increase in heating time at a set temperature results in a decrease in cell viability.  The 
means and confidence intervals for each data point are displayed in Appendix H. 
 
T-47D Results 
The resulting survival curves for the MCF-7 cell lines are displayed in Figure 





Figure 125 Survival curves of the T47-D cell line at different temperatures for (a) the treatment slides, (b) the 
treatment slides normalized to C-37, and (c) the treatment slides normalized to C-Var. 
The T-47D cell line requires more time for cell death to occur than the MCF-7 
cells.  For example, at 49
o
C it took 27 min for the T-47D cells to decline to 50% 
viability, whereas it was only 19 min for MCF-7 cells to reach that same viability. 
 
Discussion 
 During testing, there was a problem where the cell viability declined before 
testing began.  After the cells were trypsinized, there was anywhere from 4 – 7 hours 
that tests were conducted.  Even though the cell solutions are kept in an ice bath, the 
cell viability would decrease.  After enough time had passed, the lower viability had 




 All of the graphs of the results shown in the previous section do not give the 
same shape of the survival curve that was seen in Figure 29 because some trials were 
performed with cells that were already dying.  For example, for the MCF-7 cells at 
52.8
o
C, the trials heated for 8 and 11 minutes were the last tests performed one day, 
while the tests heated for 14, 16.5, and 18 minutes were conducted at the beginning of 
a different day.  This has caused the mismatch in viabilities between these two sets of 
data points.   
 
Determination of Arrhenius Parameters 
 As was discussed in Chapter 2, one method to determine the mathematical 
model of the cell death is using the Arrhenius Equation (Equation 22), reproduced 
below,   
 ( )  
  
  
        ⁄  
Equation 22 
where Ω is the percentage of dead cells.  Equation 22 can be rearranged into the 
integral in Equation 66 
∫  
    
 
 ∫        ⁄   




where τ50 is the time where 50% of the cells have died.  50% viability was chosen for 
determination of the parameters because this is the half-life of the cells.  Since the 
tests were assumed to be isothermal, the integral can be evaluated as Equation 67 




The parameters which need to be determined are the frequency factor A and the 
activation energy Ea, so evaluating the natural log of Equation 67 will separate these 
factors, shown in Equation 68 
  (    )    ( )  
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Equation 68 
This becomes a linear equation of ln(τ50) v. (1/T) when rearranged as shown in 
Equation 69 
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Equation 69 
The ln(0.50) can be neglected because it is negligible compared to ln(A).  
 The graphs shown in Figure 124b and Figure 125b are used to determine the 
mathematical model of each cell line because it is most accurate to normalize the cells 
to the control which represents non-treated cells in the body (since it is at 37
o
C).  The 
point where the cell viability is 50% is estimated for each temperature, whose values 
are listed in Table 28.  The natural logarithms of these values are calculated, and they 
are plotted against the inverse of the temperature in Kelvin in Figure 126. 





















Figure 126 Graph of the natural log of the time when the viability declines to 50% versus the inverse of the 
temperature for MCF-7 cells (blue) and T-47D cells (red).  The equations and R
2
 values are included for the line 
of best fit of each line, and the Arrhenius parameters are determined by these functions. 
The slope of the line indicated Ea/R (R = 8.314J/molK), and the y-intercept 
represents ln(A) [62].  Therefore, the final Arrhenius parameters are shown in Table 
29 for each cell line.   
Table 29 Arrhenius parameters determined by the cell experiments. 
 Ea (J) A (1/s) 
MCF-7 201.2 x 10
3
 3.445 x 10
29
 
T-47D 210.2 x 10
3





Recommendations for Future Testing 
 For future testing, the cell viability prior to heating should be ensured to be 
close to 100% for accurate results.  To do this, the time spent testing cells in a 
particular vial should be shortened.  To avoid wasting cells, smaller flasks of cells 
should be grown; after trypsinization no more than three hours should pass until the 




 There were also some inaccuracies with the heating setup.  The error bars on 
the graphs are very large because there was a lot of variability in the results between 
the different photographs taken of each trial.  Although an even heating was ensured 
down the length of the heater before experimentation began, the thermal gradient 
along with width of the heater was not tested – one side of the slides usually had a 
higher viability than the other side, indicating that this was a problem.  This 
variability could also be a function of the low concentration in some of the studies, so 
not enough cells were present to get an accurate measurement.  The controller system 
also had times of temperature fluctuations, so a more accurate controller is necessary. 
 The calculations of the Arrhenius parameters were assuming a constant 
temperature, but as was discussed in the Temperature Ramping section, this causes 
inaccuracies in the mathematical model.  In Figure 123 there is a distinct non-
isothermal ramping portion of the trial.  In this case, with 20 total minutes of heating, 
the nonisothermal portion was only a small percentage of the total testing time, but 
for shorter tests at higher temperatures this ramping period makes up a large portion 
of the trial.  An example of this is shown in Figure 127 for T-47D cells at 57
o
C for 2 
minutes – the thermocouples on the top aluminum piece do not reach their steady-
state temperature before the test was completed.  For consistency, the temperatures 
used for determining the Arrhenius parameters are calculated the same for these tests 
as with the previous tests (once 90% of the final temperature is reached), but it 
obviously introduces inaccuracies.  Future calculations of the mathematical models 





Figure 127 Graph of the thermocouple temperature readings during the trial for T-47D cells at 57
o
C for 2 
minutes. 
 A different viability assay may also increase the accuracy of these 
experiments.  It was suggested that since Trypan Blue is harmful to the cells, it would 
be more accurate to re-plate the cells after heating and put them back in a 37
o
C 
incubator for about two days.  If more cells are present after incubation than before, 
then it is proven that that thermal dose was not sufficient to cause complete cell death.  
Also, a higher volume of cell solution on each slide should improve the temperature 
consistency along the slide.  However, it must be kept in mind that this will increase 
the temperature ramping error of these “isothermal” tests. 
 Finally, it has been proven that cell viability continues to decrease after the 
heating trial has completed; Shah [65] tested different incubation times and found that 
cell death ceased after three hours at 37
o
C.  This study mainly focused on the 
immediate impact of the hyperthermic treatment (so there will be more certainty of 
tumor destruction using this data), but a sample of trials with the three-hour post-
heating incubation period were also attempted.  However, there was an appreciable 




solution remained and all cells were always dead (including controls).  To prevent 
this evaporation in future testing, silicone grease should be applied at the exposed 





Chapter 7:  Conclusion 
 This study was split into three main sections: the simulations of and device 
design for prostate cancer US ablation, the simulations of and device design for breast 
cancer HIFU ablation, and the determination of the thermal damage model for breast 
cancer cell.  The results of these studies are important for the future of treating cancer 
with ultrasound thermal therapy, which are summarized in this chapter.  Then, future 
work will be detailed. 
 
Summary of Prostate Simulation Results 
 The goal of the prostate studies was to determine sets of ultrasound 
parameters that are needed to necrose different size tumors within the prostate.  As 
would be expected, the necrosed region coincided with the regions which experienced 
the highest temperatures in the prostate.  The necrosed volume was a function of the 
heating time, transducer power, and transducer angle used for the treatment, so an 
appropriate combination of those parameters needs to be used depending on the 
patient.  The graphs of necrosed volume versus the energy parameter (Figure 56 and 
Figure 57) can be used as a preliminary resource to determine the appropriate 
transducer parameters, but more thorough treatment-planning is needed than just 
knowing the necrosed volume.  To account for the location and shape of the necrosed 
region, a sample code was written to demonstrate how the US parameters can be 
linked to the specific size and location of the tumors which they can ablate. 
 The practical use of these results was shown by the device design and 




parameters and can transmit the same US that was simulated in the studies.  However, 
the device will not be useful if the physician cannot operate it correctly.  Creating a 
database with the code mentioned in the previous paragraph will allow the physician 
to solely need to determine the tumor location and geometry, and then the device 
parameters will be provided to him/her and automatically input into the device.  
 
Summary of Breast Simulation Results 
 HIFU treatments are usually not designed to fully ablate the tumorous tissue 
with one sonication because the necrosed regions are so small.  However, it was the 
attempt of this study to increase that necrosis volume so the number of sonications 
can be minimized, therefore minimizing the treatment time.  Larger volumes were 
able to be created in the simulations (up to 3340 mm
3
), but studies will need to be run 
to develop an ellipsoidal shape with the larger necrosed volumes as is created with the 
smaller volumes. 
 There was a good agreement between the location of the maximum heat 
generation, maximum temperature, and the necrosed tissue in the breast.  The variable 
acoustic attenuation was incorporated into this model, which affected the heat 
generation during the simulation and caused a degeneration of the focal point.  This 
will need to be taken into account for treatment-planning, and it showed that shorter 
sonication times were important for avoiding this variable having a significant effect. 
 Flat and curved transducers were tested, and it was found that both work well 
with certain combinations of their number of elements and the number of rows of 




which will increase patient comfort, while still being easy-to-use for physicians and 
working for multiple patients.  The simulations from this section will need to be 
updated because a general tissue model was used to model the thermal damage since 
breast cancer data was not available, which decreased the accuracy of the results. 
 
Summary of in vitro Cell Experimentation Results 
 These studies have established the procedures which will be used for finding 
the breast cancer thermal dose model.  The results from the in vitro cell experiments 
are similar to those shown in the literature review of previous experiments, and the 
activation energy and frequency factor which were calculated from these studies fall 
well within the range of values from the past studies (seen in Table 6).  However, 
there was a lot of variability in the results, so more studies will need to be performed 
to validate the means determined for each trial.  These results will be very useful in 
receiving better results from the breast cancer simulations.   
 
Future Work 
 The next step is to improve all three of the studies performed during this 
research.  The prostate and breast cancer simulations do not account for porous media 
or cavitational effects.  More in vitro experiments need to be performed to validate 
the results from those studies.  After improving the experiments (as was 




the new Arrhenius parameters should be input into the breast simulations and those 
results will be recalculated.   
 
 Ultrasound thermal therapy has the potential to be very effective for the 
treating tumors, and since the entirety of the treatment involves a vibration of the 
body’s tissue, it is much better for patient health.  Both the intraluminal and external 
devices were proven to be effective in targeting tumors in the prostate and breast, 
respectively.  Improving the devices available and the treatment planning protocols 
associated with those devices will allow this treatment to be more-quickly 
implemented in cancer treatment programs in the U.S, and will result in an increase in 




Appendix A: Prostate Simulations Results 
 Results from the simulations of US thermal therapy ablation for prostate 
cancer are displayed in Table 30 – Table 39. 








































1 0 30 0 90 60.77 62.01 0.36 9.69 8.60 0.00 5.70 12.45 -4.00 4.00 -30.00 30.00
2 0 30 0 90 120.46 78.37 1.27 20.96 10.60 0.00 4.35 16.50 -4.00 4.00 -30.00 30.00
3 0 30 0 90 200.76 96.17 1.92 30.52 11.71 0.00 3.00 19.20 -6.00 6.00 -45.00 45.00
4 0 30 0 120 120.25 56.60 0.20 9.39 8.24 0.00 5.03 11.10 -3.00 3.00 -33.75 33.75
5 0 30 0 120 150.16 58.45 0.33 13.36 8.63 0.00 5.03 11.78 -3.00 3.00 -33.75 33.75
6 0 30 0 120 180.38 60.00 0.45 16.93 8.85 0.00 5.03 12.45 -3.00 3.00 -33.75 33.75
7 0 30 0 120 210.29 61.30 0.53 18.63 9.19 0.00 4.35 13.13 -3.00 3.00 -33.75 33.75
8 0 30 0 120 240.20 62.42 0.58 20.54 9.18 0.00 4.35 13.80 -4.00 4.00 -33.75 33.75
9 0 30 0 150 300.33 52.90 0.03 2.65 7.88 0.00 6.38 9.08 -1.00 1.00 -11.25 11.25
10 0 45 0 90 30.39 67.38 0.49 10.08 8.01 0.00 4.35 11.10 -4.00 4.00 -30.00 30.00
11 0 45 0 90 45.58 85.90 1.04 17.56 9.62 0.00 4.35 15.15 -4.00 4.00 -30.00 30.00
12 0 45 0 90 55.35 99.84 1.44 23.04 10.82 0.00 3.00 16.50 -4.00 4.00 -30.00 30.00
13 0 45 0 120 30.22 54.62 0.04 3.27 6.50 0.00 5.03 7.73 -2.00 2.00 -22.50 22.50
14 0 45 0 120 60.43 67.89 0.63 21.94 8.52 0.00 3.68 12.45 -4.00 4.00 -45.00 45.00
15 0 45 0 120 120.25 93.97 1.74 48.90 10.53 0.00 3.00 17.18 -5.00 5.00 -56.25 56.25
16 0 45 0 150 120.25 66.11 0.83 27.50 8.98 0.00 4.35 13.13 -4.00 4.00 -45.00 45.00
17 0 45 0 150 150.16 70.30 1.15 35.12 9.47 0.00 3.68 14.48 -4.00 4.00 -56.25 56.25
18 0 45 0 150 210.29 77.40 1.58 45.61 10.05 0.00 3.68 15.83 -5.00 5.00 -56.25 56.25
19 0 45 0 180 120.25 55.91 0.24 11.85 7.84 0.00 5.03 10.43 -2.00 2.00 -45.00 45.00
20 0 45 0 180 150.16 57.85 0.41 17.53 8.29 0.00 5.03 11.10 -3.00 3.00 -45.00 45.00
21 0 45 0 180 180.38 59.48 0.56 21.94 8.54 0.00 5.03 11.78 -3.00 3.00 -56.25 56.25
22 0 45 0 180 210.29 60.85 0.69 24.96 8.77 0.00 4.35 12.45 -3.00 3.00 -56.25 56.25
23 0 45 0 180 240.20 62.04 0.80 27.86 8.90 0.00 4.35 13.13 -4.00 4.00 -56.25 56.25
24 0 45 0 180 270.42 63.09 0.90 31.02 9.00 0.00 4.35 13.13 -4.00 4.00 -56.25 56.25
25 0 45 0 180 300.33 64.00 0.98 32.47 9.13 0.00 4.35 13.80 -4.00 4.00 -56.25 56.25
26 0 60 0 90 30.39 97.29 1.08 18.14 9.50 0.00 3.00 15.15 -4.00 4.00 -30.00 30.00
27 0 60 0 120 30.22 66.52 0.40 14.66 7.50 0.00 3.68 10.43 -3.00 3.00 -45.00 45.00
28 0 60 0 120 45.17 83.55 1.01 29.58 8.92 0.00 3.00 13.80 -4.00 4.00 -45.00 45.00
29 0 60 0 120 55.24 96.76 1.39 40.70 9.69 0.00 3.00 15.83 -5.00 5.00 -45.00 45.00
30 0 60 0 120 60.43 104.17 1.60 46.15 10.02 0.00 3.00 16.50 -5.00 5.00 -56.25 56.25
31 0 60 0 150 60.43 71.73 0.95 30.25 8.67 0.00 3.68 13.13 -4.00 4.00 -56.25 56.25
32 0 60 0 150 105.30 98.35 2.09 58.21 10.36 0.00 3.00 16.50 -5.00 5.00 -56.25 56.25
33 0 60 0 180 60.43 59.64 0.44 17.84 7.68 0.00 4.35 10.43 -3.00 3.00 -56.25 56.25
34 0 60 0 180 120.25 75.26 1.52 44.17 9.46 0.00 3.68 14.48 -4.00 4.00 -67.50 67.50
35 0 60 0 180 150.16 82.46 1.97 55.83 9.95 0.00 3.00 15.83 -5.00 5.00 -67.50 67.50
36 0 60 0 180 180.38 89.36 2.32 63.95 10.30 0.00 3.00 16.50 -5.00 5.00 -67.50 67.50
37 0 60 0 180 210.29 95.54 2.64 71.92 10.61 0.00 3.00 17.18 -5.00 5.00 -67.50 67.50
38 0 60 0 210 120.25 62.55 0.99 34.01 8.50 0.00 4.35 12.45 -3.00 3.00 -78.75 78.75
39 0 60 0 210 150.16 66.30 1.38 43.88 8.94 0.00 4.35 13.13 -4.00 4.00 -78.75 78.75
40 0 60 0 210 180.38 69.70 1.71 50.76 9.26 0.00 3.68 13.80 -4.00 4.00 -78.75 78.75
41 0 60 0 210 210.29 72.71 1.97 57.17 9.52 0.00 3.68 14.48 -4.00 4.00 -90.00 90.00
42 0 60 0 210 240.20 75.39 2.16 61.72 9.71 0.00 3.68 15.15 -4.00 4.00 -90.00 90.00
43 0 30 30 90 45.17 54.66 0.09 5.71 7.39 6.00 5.70 9.08 -2.00 14.00 -11.25 11.25
44 0 30 30 90 60.43 57.95 0.31 13.54 8.43 6.00 5.03 11.78 -3.00 15.00 -11.25 11.25
45 0 30 30 90 120.25 68.44 1.46 46.98 10.30 6.02 4.35 15.83 -4.00 16.00 -22.50 22.50
46 0 30 30 90 150.16 72.77 1.87 54.80 10.89 6.01 3.68 17.18 -4.00 16.00 -22.50 22.50
47 0 30 30 90 180.38 76.66 2.25 64.25 11.32 6.01 3.68 18.53 -4.00 16.00 -22.50 22.50
48 0 30 30 90 210.29 80.08 2.60 73.50 11.62 6.01 3.68 19.20 -5.00 17.00 -33.75 33.75
49 0 30 30 90 240.20 83.11 2.88 80.09 11.77 6.02 3.68 19.20 -5.00 17.00 -33.75 33.75













































51 0 30 30 90 300.33 88.17 3.27 87.49 12.01 6.02 3.68 19.88 -5.00 17.00 -33.75 33.75
52 0 30 30 90 360.46 92.13 3.64 97.23 12.38 6.01 3.00 21.23 -5.00 17.00 -33.75 33.75
53 0 30 30 120 120.25 57.61 0.61 27.07 8.48 6.00 5.03 11.78 -3.00 15.00 -33.75 33.75
54 0 30 30 120 150.16 59.87 1.01 38.47 8.90 6.00 5.03 12.45 -3.00 15.00 -33.75 33.75
55 0 30 30 120 180.38 61.85 1.30 44.54 9.34 6.01 4.35 13.80 -3.00 15.00 -33.75 33.75
56 0 30 30 120 210.29 63.55 1.57 52.20 9.55 6.02 4.35 14.48 -4.00 16.00 -33.75 33.75
57 0 30 30 120 240.20 65.04 1.87 62.08 9.69 6.05 4.35 14.48 -4.00 16.00 -45.00 45.00
58 0 30 30 150 180.38 52.22 0.00 1.02 7.73 6.00 7.73 7.73 0.00 12.00 -45.00 45.00
59 0 30 30 150 210.29 52.95 0.07 6.10 8.06 6.17 6.38 9.08 -1.00 13.00 -11.25 11.25
60 0 30 30 150 240.20 53.57 0.17 11.32 8.15 6.00 6.38 9.75 -1.00 13.00 -22.50 22.50
61 0 30 45 90 30.22 63.77 0.22 8.95 7.70 11.93 4.35 11.10 9.00 15.00 -22.50 22.50
62 0 30 45 90 45.17 76.05 0.63 21.27 9.13 11.05 3.68 14.48 -2.00 16.00 -22.50 22.50
63 0 30 45 90 60.43 89.63 1.14 35.93 10.14 10.09 3.00 17.18 -3.00 17.00 -33.75 33.75
64 0 30 45 120 30.22 54.65 0.04 3.64 6.53 11.89 5.03 7.73 10.00 14.00 -22.50 22.50
65 0 30 45 120 45.17 61.43 0.34 12.77 7.64 11.94 4.35 10.43 9.00 15.00 -33.75 33.75
66 0 30 45 120 60.43 68.27 0.68 23.00 8.57 11.81 3.68 13.13 8.00 16.00 -45.00 45.00
67 0 30 45 120 120.25 96.04 2.44 73.03 10.33 9.68 3.00 17.18 -3.00 17.00 -56.25 56.25
68 0 30 45 150 45.17 52.86 0.01 0.63 6.73 12.00 6.38 7.05 12.00 12.00 -11.25 11.25
69 0 30 45 150 60.43 56.17 0.17 8.79 7.40 11.90 5.03 9.75 9.00 14.00 -33.75 33.75
70 0 30 45 150 120.25 67.18 0.97 31.11 9.18 11.72 4.35 13.80 8.00 16.00 -56.25 56.25
71 0 30 45 150 150.16 71.86 1.34 40.70 9.62 11.68 3.68 15.15 1.00 16.00 -56.25 56.25
72 0 30 45 150 180.38 76.12 1.71 53.57 9.92 11.14 3.68 15.83 -1.00 16.00 -56.25 56.25
73 0 30 45 150 210.29 79.87 2.07 63.86 10.14 10.75 3.68 16.50 -1.00 17.00 -56.25 56.25
74 0 30 45 150 240.20 83.21 2.41 73.28 10.25 10.36 3.68 16.50 -2.00 17.00 -56.25 56.25
75 0 30 45 180 120.25 56.59 0.31 14.31 7.99 11.67 5.03 10.43 9.00 14.00 -45.00 45.00
76 0 30 45 180 150.16 58.79 0.52 20.19 8.47 11.74 5.03 11.78 8.00 15.00 -56.25 56.25
77 0 30 45 180 180.38 60.66 0.73 26.44 8.76 11.66 4.35 12.45 8.00 15.00 -56.25 56.25
78 0 30 45 180 210.29 62.25 0.89 30.32 8.99 11.61 4.35 13.13 8.00 15.00 -56.25 56.25
79 0 30 45 180 240.20 63.63 1.03 34.52 9.16 11.64 4.35 13.80 8.00 16.00 -56.25 56.25
80 0 30 45 210 150.16 52.74 0.04 3.94 7.56 11.65 6.38 8.40 11.00 13.00 -33.75 33.75
81 0 30 45 210 180.38 53.85 0.15 9.30 7.70 11.61 5.70 9.08 10.00 13.00 -45.00 45.00
82 0 30 45 210 210.29 54.79 0.26 14.32 7.92 11.74 5.70 9.75 9.00 14.00 -56.25 56.25
83 0 30 45 210 240.20 55.59 0.37 17.82 8.08 11.65 5.70 10.43 9.00 14.00 -56.25 56.25
84 0 30 60 90 30.22 87.54 0.63 19.16 9.18 11.96 3.00 14.48 8.00 16.00 -22.50 22.50
85 0 30 60 210 60.43 53.79 0.09 6.54 6.99 11.96 5.70 8.40 11.00 13.00 -56.25 56.25
86 0 30 60 210 120.25 63.30 1.15 38.22 8.66 11.74 4.35 12.45 8.00 15.00 -78.75 78.75
87 0 30 60 210 150.16 67.39 1.56 48.11 9.10 11.80 3.68 13.80 8.00 16.00 -78.75 78.75
88 0 30 60 210 180.38 71.12 1.92 56.45 9.47 11.78 3.68 14.48 7.00 16.00 -90.00 90.00
89 0 30 60 210 210.29 74.43 2.24 64.71 9.72 11.74 3.68 15.15 7.00 16.00 -90.00 90.00
90 0 30 60 210 240.20 77.37 2.52 70.77 9.94 11.72 3.68 15.15 7.00 17.00 -90.00 90.00
91 0 30 60 210 270.42 80.00 2.74 76.34 10.08 11.76 3.68 15.83 6.00 17.00 -90.00 90.00
92 0 30 60 210 300.33 82.30 2.96 81.83 10.21 11.72 3.00 15.83 6.00 17.00 -90.00 90.00
93 0 30 60 210 360.46 86.35 3.33 91.01 10.47 11.70 3.00 16.50 6.00 17.00 -90.00 90.00
94 0 45 45 90 30.22 63.79 0.45 18.39 7.70 6.00 4.35 11.10 -3.00 15.00 -22.50 22.50
95 0 45 45 90 45.17 76.17 1.20 37.51 9.26 6.00 3.68 14.48 -4.00 16.00 -22.50 22.50
96 0 45 45 90 60.43 89.95 2.05 60.07 10.47 6.00 3.00 17.18 -5.00 17.00 -33.75 33.75
97 0 45 45 120 30.22 54.67 0.08 7.29 6.52 6.00 5.03 7.73 -2.00 14.00 -22.50 22.50
98 0 45 45 120 45.17 61.51 0.69 26.12 7.67 6.00 4.35 10.43 -3.00 15.00 -33.75 33.75
99 0 45 45 120 60.43 68.46 1.42 47.75 8.62 6.00 3.68 13.13 -4.00 16.00 -45.00 45.00












































101 0 45 45 150 45.17 52.91 0.01 1.62 6.68 6.00 6.38 7.05 0.00 12.00 -11.25 11.25
102 0 45 45 150 60.43 56.28 0.38 18.85 7.44 6.00 5.03 9.75 -2.00 14.00 -33.75 33.75
103 0 45 45 150 120.25 67.84 2.21 70.28 9.31 6.01 3.68 13.80 -4.00 16.00 -56.25 56.25
104 0 45 45 150 150.16 72.94 3.08 89.36 9.82 6.00 3.68 15.15 -4.00 16.00 -56.25 56.25
105 0 45 45 150 180.38 77.72 3.76 103.40 10.24 6.00 3.68 15.83 -4.00 16.00 -56.25 56.25
106 0 45 45 150 210.29 82.04 4.32 115.38 10.56 6.02 3.68 16.50 -5.00 17.00 -56.25 56.25
107 0 45 45 150 240.20 85.93 4.74 124.76 10.81 6.02 3.00 17.18 -5.00 17.00 -56.25 56.25
108 0 45 45 150 270.42 89.44 5.15 133.52 11.00 6.02 3.00 17.85 -5.00 17.00 -56.25 56.25
109 0 45 45 150 300.33 92.52 5.45 141.33 11.16 6.02 3.00 17.85 -5.00 17.00 -67.50 67.50
110 0 45 45 150 360.46 97.83 6.05 156.24 11.42 6.02 3.00 18.53 -5.00 17.00 -67.50 67.50
111 0 45 45 180 120.25 56.97 0.76 31.58 8.15 6.02 5.03 11.10 -2.00 14.00 -45.00 45.00
112 0 45 45 180 150.16 59.38 1.27 48.81 8.59 6.00 5.03 11.78 -3.00 15.00 -56.25 56.25
113 0 45 45 180 180.38 61.49 1.71 60.03 8.92 6.01 4.35 13.13 -3.00 15.00 -56.25 56.25
114 0 45 45 180 210.29 63.32 2.13 70.79 9.17 6.01 4.35 13.13 -3.00 16.00 -56.25 56.25
115 0 45 45 180 240.20 64.92 2.50 79.36 9.37 6.01 4.35 13.80 -4.00 16.00 -56.25 56.25
116 0 45 45 210 150.16 53.14 0.16 13.67 7.64 6.00 6.38 9.08 -1.00 13.00 -45.00 45.00
117 0 45 45 210 180.38 54.41 0.47 27.00 7.93 6.08 5.70 9.75 -2.00 14.00 -56.25 56.25
118 0 45 45 210 210.29 55.48 0.77 36.10 8.11 6.00 5.70 10.43 -2.00 14.00 -56.25 56.25
119 0 45 45 210 240.20 56.41 1.02 46.01 8.34 6.02 5.03 11.10 -2.00 14.00 -67.50 67.50
120 0 45 60 90 30.22 87.57 0.87 28.67 8.77 8.77 3.00 14.48 -3.00 16.00 -22.50 22.50
121 0 45 60 120 30.22 66.58 0.46 19.03 7.42 10.79 3.68 11.10 -2.00 15.00 -45.00 45.00
122 0 45 60 120 45.17 83.89 1.43 45.51 8.62 8.87 3.00 13.80 -3.00 16.00 -45.00 45.00
123 0 45 60 150 30.22 55.69 0.10 6.07 6.48 12.00 5.03 7.73 10.00 14.00 -33.75 33.75
124 0 45 60 150 45.17 63.62 0.53 19.54 7.84 11.72 4.35 11.10 0.00 15.00 -45.00 45.00
125 0 45 60 150 60.43 72.23 1.21 41.49 8.50 9.88 3.68 13.13 -2.00 16.00 -56.25 56.25
126 0 45 60 180 45.17 55.41 0.15 8.61 6.91 11.86 5.03 8.40 10.00 14.00 -45.00 45.00
127 0 45 60 180 60.43 59.96 0.47 18.71 7.73 11.87 4.35 10.43 9.00 15.00 -56.25 56.25
128 0 45 60 180 120.25 76.96 2.26 71.60 9.38 9.37 3.68 15.15 -2.00 16.00 -67.50 67.50
129 0 45 60 180 150.16 85.10 3.18 94.86 9.82 8.79 3.00 15.83 -3.00 17.00 -67.50 67.50
130 0 45 60 180 180.38 92.91 3.96 111.16 10.22 8.55 3.00 17.18 -3.00 17.00 -67.50 67.50
131 0 45 60 180 210.29 99.93 4.55 124.63 10.53 8.38 3.00 17.85 -4.00 17.00 -78.75 78.75
132 0 45 60 210 60.43 53.87 0.10 7.45 6.94 11.82 5.70 8.40 10.00 13.00 -56.25 56.25
133 0 45 60 210 120.25 63.69 1.21 39.52 8.71 11.63 4.35 12.45 8.00 15.00 -78.75 78.75
134 0 45 60 210 150.16 67.99 1.85 62.49 9.05 10.67 3.68 13.80 -1.00 16.00 -78.75 78.75
135 0 45 60 210 180.38 71.94 2.51 81.49 9.36 9.90 3.68 14.48 -2.00 16.00 -90.00 90.00
136 0 45 60 210 210.29 75.47 3.11 97.65 9.54 9.41 3.68 15.15 -2.00 16.00 -90.00 90.00
137 0 45 60 210 240.20 78.63 3.62 109.02 9.71 9.13 3.68 15.83 -2.00 17.00 -90.00 90.00
138 0 45 60 210 270.42 81.46 4.05 118.85 9.85 8.95 3.68 15.83 -3.00 17.00 -90.00 90.00
139 0 45 60 210 300.33 83.98 4.41 126.00 9.99 8.85 3.00 16.50 -3.00 17.00 -90.00 90.00
140 0 45 60 210 360.46 88.36 5.10 142.57 10.23 8.61 3.00 16.50 -3.00 17.00 -90.00 90.00
141 0 60 60 90 30.22 87.61 1.30 39.95 9.16 6.00 3.00 14.48 -4.00 16.00 -22.50 22.50
142 0 60 60 120 30.22 66.60 0.85 31.56 7.50 6.00 3.68 11.10 -3.00 15.00 -45.00 45.00
143 0 60 60 120 45.17 84.01 2.19 64.49 8.96 6.00 3.00 13.80 -4.00 16.00 -45.00 45.00
144 0 60 60 150 30.22 55.71 0.21 12.14 6.48 6.00 5.03 7.73 -2.00 14.00 -33.75 33.75
145 0 60 60 150 45.17 63.68 1.08 38.40 7.84 6.00 4.35 11.10 -3.00 15.00 -45.00 45.00
146 0 60 60 150 60.43 72.42 2.09 66.30 8.73 6.00 3.68 13.13 -4.00 16.00 -56.25 56.25
147 0 60 60 180 45.17 55.45 0.29 17.23 6.91 6.00 5.03 8.40 -2.00 14.00 -45.00 45.00
148 0 60 60 180 60.43 60.07 0.98 38.98 7.74 6.00 4.35 10.43 -3.00 15.00 -56.25 56.25
149 0 60 60 180 120.25 77.72 3.86 106.64 9.75 6.00 3.68 15.15 -4.00 16.00 -67.50 67.50












































151 0 60 60 180 180.38 95.02 6.00 155.95 10.86 6.02 3.00 17.18 -5.00 17.00 -67.50 67.50
152 0 60 60 210 60.43 53.95 0.22 16.00 7.00 6.00 5.70 8.40 -1.00 13.00 -56.25 56.25
153 0 60 60 210 120.25 64.16 2.64 87.02 8.78 6.00 4.35 12.45 -3.00 16.00 -78.75 78.75
154 0 60 60 210 150.16 68.79 3.81 113.70 9.31 6.01 3.68 13.80 -4.00 16.00 -78.75 78.75
155 0 60 60 210 180.38 73.18 4.73 133.92 9.66 6.01 3.68 14.48 -4.00 16.00 -90.00 90.00
156 0 60 60 210 210.29 77.16 5.48 147.89 10.01 6.00 3.68 15.15 -4.00 16.00 -90.00 90.00
157 0 60 60 210 240.20 80.76 6.14 162.18 10.25 6.02 3.68 15.83 -5.00 17.00 -90.00 90.00
158 0 60 60 210 270.42 84.03 6.76 176.35 10.47 6.02 3.00 16.50 -5.00 17.00 -90.00 90.00
159 0 60 60 210 300.33 87.01 7.21 186.36 10.63 6.01 3.00 16.50 -5.00 17.00 -90.00 90.00
160 0 60 60 210 360.46 92.12 7.93 202.06 10.90 6.03 3.00 17.18 -5.00 17.00 -90.00 90.00
161 30 30 30 90 45.17 54.80 0.14 8.73 7.43 0.00 5.70 9.08 -14.00 14.00 -11.25 11.25
162 30 30 30 90 60.43 58.27 0.49 21.18 8.48 0.00 5.03 11.78 -15.00 15.00 -11.25 11.25
163 30 30 30 90 120.25 69.92 2.31 73.81 10.36 0.00 4.35 16.50 -16.00 16.00 -22.50 22.50
164 30 30 30 90 150.16 74.95 3.02 87.12 11.01 0.00 3.68 17.85 -16.00 16.00 -22.50 22.50
165 30 30 30 90 180.38 79.57 3.71 104.13 11.48 0.00 3.68 19.20 -16.00 16.00 -33.75 33.75
166 30 30 30 90 210.29 83.67 4.23 117.69 11.72 0.00 3.68 19.88 -17.00 17.00 -33.75 33.75
167 30 30 30 90 240.20 87.32 4.69 127.37 11.90 0.00 3.68 19.88 -17.00 17.00 -33.75 33.75
168 30 30 30 90 270.42 90.56 5.09 135.25 12.07 0.00 3.00 20.55 -17.00 17.00 -33.75 33.75
169 30 30 30 90 300.33 93.41 5.36 140.07 12.20 0.00 3.00 20.55 -17.00 17.00 -33.75 33.75
170 30 30 30 90 360.46 98.25 5.94 155.00 12.50 0.00 3.00 21.23 -17.00 17.00 -33.75 33.75
171 30 30 30 120 120.25 58.63 1.02 44.56 8.55 0.00 5.03 11.78 -15.00 15.00 -33.75 33.75
172 30 30 30 120 150.16 61.31 1.66 61.74 9.00 0.00 4.35 13.13 -15.00 15.00 -33.75 33.75
173 30 30 30 120 180.38 63.66 2.17 74.30 9.45 0.00 4.35 14.48 -15.00 15.00 -33.75 33.75
174 30 30 30 120 210.29 65.71 2.70 90.45 9.71 0.00 4.35 15.15 -16.00 16.00 -45.00 45.00
175 30 30 30 120 240.20 67.52 3.19 102.41 9.84 0.00 4.35 15.15 -16.00 16.00 -45.00 45.00
176 30 30 30 150 150.16 52.17 0.00 0.26 7.73 0.00 7.73 15.15 0.00 16.00 -45.00 45.00
177 30 30 30 150 180.38 53.23 0.05 4.95 8.01 0.00 6.38 9.08 -12.00 12.00 -22.50 22.50
178 30 30 30 150 210.29 54.10 0.20 13.86 8.14 0.00 6.38 10.43 -13.00 13.00 -22.50 22.50
179 30 30 30 150 240.20 54.85 0.38 23.15 8.27 0.00 5.70 11.10 -13.00 13.00 -33.75 33.75
180 30 30 45 90 30.22 63.77 0.22 8.95 7.70 11.93 4.35 11.10 9.00 15.00 -22.50 22.50
181 30 30 45 90 45.17 76.05 0.67 24.21 9.02 9.51 3.68 14.48 -14.00 16.00 -22.50 22.50
182 30 30 45 90 60.43 89.63 1.31 43.43 9.93 7.34 3.00 17.18 -15.00 17.00 -33.75 33.75
183 30 30 45 120 30.22 54.65 0.04 3.64 6.53 11.89 5.03 7.73 10.00 14.00 -22.50 22.50
184 30 30 45 120 45.17 61.43 0.34 12.77 7.64 11.94 4.35 10.43 9.00 15.00 -33.75 33.75
185 30 30 45 120 60.43 68.27 0.68 23.00 8.57 11.81 3.68 13.13 8.00 16.00 -45.00 45.00
186 30 30 45 120 120.25 96.05 2.87 90.33 10.11 6.94 3.00 17.18 -15.00 17.00 -56.25 56.25
187 30 30 45 150 45.17 52.86 0.01 0.63 6.73 12.00 6.38 7.05 12.00 12.00 -11.25 11.25
188 30 30 45 150 60.43 56.17 0.17 8.79 7.40 11.90 5.03 9.75 9.00 14.00 -33.75 33.75
189 30 30 45 150 120.25 67.18 0.97 31.11 9.18 11.72 4.35 13.80 8.00 16.00 -56.25 56.25
190 30 30 45 150 150.16 71.87 1.37 43.91 9.60 11.41 3.68 15.15 -1.00 16.00 -56.25 56.25
191 30 30 45 150 180.38 76.13 1.81 58.25 9.86 10.58 3.68 15.83 -12.00 16.00 -56.25 56.25
192 30 30 45 150 210.29 79.90 2.26 72.83 10.02 9.74 3.68 16.50 -13.00 17.00 -56.25 56.25
193 30 30 45 150 240.20 83.24 2.66 83.81 10.12 9.02 3.68 16.50 -13.00 17.00 -56.25 56.25
194 30 30 45 150 270.42 86.23 3.00 91.75 10.24 8.56 3.00 17.18 -13.00 17.00 -56.25 56.25
195 30 30 45 150 300.33 88.84 3.29 100.59 10.35 8.25 3.00 17.18 -14.00 17.00 -56.25 56.25
196 30 30 45 150 360.46 93.24 3.94 117.38 10.53 7.16 3.00 17.85 -14.00 17.00 -67.50 67.50
197 30 30 45 180 120.25 56.59 0.31 14.31 7.99 11.67 5.03 10.43 9.00 14.00 -45.00 45.00
198 30 30 45 180 150.16 58.79 0.52 20.19 8.47 11.74 5.03 11.78 8.00 15.00 -56.25 56.25
199 30 30 45 180 180.38 60.67 0.73 26.51 8.76 11.64 4.35 12.45 8.00 15.00 -56.25 56.25












































201 30 30 45 180 240.20 63.65 1.03 34.54 9.16 11.62 4.35 13.80 8.00 16.00 -56.25 56.25
202 30 30 45 210 150.16 52.74 0.04 3.94 7.56 11.65 6.38 8.40 11.00 13.00 -33.75 33.75
203 30 30 45 210 180.38 53.86 0.15 9.35 7.72 11.61 5.70 9.75 10.00 13.00 -45.00 45.00
204 30 30 45 210 210.29 54.80 0.26 14.31 7.91 11.74 5.70 9.75 9.00 14.00 -56.25 56.25
205 30 30 45 210 240.20 55.60 0.37 17.92 8.09 11.61 5.70 10.43 9.00 14.00 -56.25 56.25
206 30 30 60 90 30.22 87.54 0.63 19.16 9.18 11.96 3.00 14.48 8.00 16.00 -22.50 22.50
207 30 30 60 120 30.22 66.56 0.42 15.34 7.51 11.89 3.68 11.10 8.00 15.00 -45.00 45.00
208 30 30 60 120 45.17 83.78 1.03 30.67 8.94 11.93 3.00 13.80 7.00 16.00 -45.00 45.00
209 30 30 60 150 30.22 55.68 0.10 6.07 6.48 12.00 5.03 7.73 10.00 14.00 -33.75 33.75
210 30 30 60 150 45.17 63.55 0.50 17.61 7.80 11.95 4.35 11.10 8.00 15.00 -45.00 45.00
211 30 30 60 150 60.43 72.06 0.98 30.73 8.70 11.91 3.68 13.13 8.00 16.00 -56.25 56.25
212 30 30 60 180 45.17 55.36 0.14 8.55 6.90 11.86 5.03 8.40 10.00 14.00 -45.00 45.00
213 30 30 60 180 60.43 59.85 0.46 18.29 7.74 11.94 4.35 10.43 9.00 15.00 -56.25 56.25
214 30 30 60 180 120.25 76.36 1.67 48.52 9.58 11.77 3.68 14.48 7.00 16.00 -67.50 67.50
215 30 30 60 180 150.16 84.13 2.16 60.53 10.11 11.76 3.00 15.83 6.00 17.00 -67.50 67.50
216 30 30 60 180 180.38 91.56 2.64 72.86 10.50 11.70 3.00 16.50 6.00 17.00 -67.50 67.50
217 30 30 60 180 210.29 98.20 3.01 83.26 10.80 11.60 3.00 17.18 4.00 17.00 -67.50 67.50
218 30 30 60 210 60.43 53.79 0.09 6.54 6.99 11.96 5.70 8.40 11.00 13.00 -56.25 56.25
219 30 30 60 210 120.25 63.30 1.15 38.22 8.66 11.74 4.35 12.45 8.00 15.00 -78.75 78.75
220 30 30 60 210 150.16 67.40 1.56 48.07 9.10 11.79 3.68 13.80 8.00 16.00 -78.75 78.75
221 30 30 60 210 180.38 71.13 1.92 56.45 9.47 11.78 3.68 14.48 7.00 16.00 -90.00 90.00
222 30 30 60 210 210.29 74.44 2.24 64.81 9.72 11.73 3.68 15.15 7.00 16.00 -90.00 90.00
223 30 30 60 210 240.20 77.39 2.52 70.77 9.94 11.72 3.68 15.15 7.00 17.00 -90.00 90.00
224 30 30 60 210 270.42 80.03 2.75 76.92 10.07 11.74 3.68 15.83 6.00 17.00 -90.00 90.00
225 30 30 60 210 300.33 82.34 2.97 82.43 10.21 11.70 3.00 15.83 6.00 17.00 -90.00 90.00
226 30 30 60 210 360.46 86.40 3.34 91.18 10.47 11.68 3.00 16.50 6.00 17.00 -90.00 90.00
227 30 45 45 90 30.22 63.84 0.46 18.57 7.72 5.83 4.35 11.10 -3.00 15.00 -22.50 22.50
228 30 45 45 90 45.17 76.38 1.26 41.30 9.25 5.21 3.68 15.15 -14.00 16.00 -22.50 22.50
229 30 45 45 90 60.43 90.52 2.28 69.35 10.36 4.42 3.00 17.18 -15.00 17.00 -33.75 33.75
230 30 45 45 120 30.22 54.70 0.08 7.65 6.53 5.76 5.03 7.73 -2.00 14.00 -22.50 22.50
231 30 45 45 120 45.17 61.66 0.70 26.33 7.68 5.88 4.35 11.10 -3.00 15.00 -33.75 33.75
232 30 45 45 120 60.43 68.84 1.48 48.99 8.66 5.69 3.68 13.13 -4.00 16.00 -45.00 45.00
233 30 45 45 120 120.25 99.64 5.01 139.01 10.75 4.03 3.00 17.85 -15.00 17.00 -56.25 56.25
234 30 45 45 150 45.17 53.00 0.01 1.78 6.66 5.55 6.38 7.05 -1.00 12.00 -11.25 11.25
235 30 45 45 150 60.43 56.51 0.40 19.78 7.48 5.57 5.03 9.75 -3.00 14.00 -33.75 33.75
236 30 45 45 150 120.25 68.91 2.35 73.72 9.38 5.56 3.68 14.48 -4.00 16.00 -56.25 56.25
237 30 45 45 150 150.16 74.50 3.27 94.58 9.89 5.52 3.68 15.15 -11.00 16.00 -56.25 56.25
238 30 45 45 150 180.38 79.69 4.11 116.29 10.27 5.11 3.68 16.50 -13.00 16.00 -56.25 56.25
239 30 45 45 150 210.29 84.37 4.82 133.80 10.57 4.82 3.00 17.18 -13.00 17.00 -56.25 56.25
240 30 45 45 150 240.20 88.57 5.46 149.24 10.77 4.49 3.00 17.85 -14.00 17.00 -56.25 56.25
241 30 45 45 150 270.42 92.34 5.97 160.30 10.97 4.28 3.00 17.85 -14.00 17.00 -56.25 56.25
242 30 45 45 150 300.33 95.67 6.44 171.82 11.12 4.12 3.00 18.53 -14.00 17.00 -67.50 67.50
243 30 45 45 180 120.25 57.65 0.84 34.61 8.22 5.34 5.03 11.10 -3.00 14.00 -45.00 45.00
244 30 45 45 180 150.16 60.29 1.39 52.88 8.68 5.37 4.35 12.45 -4.00 15.00 -56.25 56.25
245 30 45 45 180 180.38 62.60 1.90 65.76 9.03 5.30 4.35 13.13 -4.00 15.00 -56.25 56.25
246 30 45 45 180 210.29 64.60 2.34 76.37 9.27 5.36 4.35 13.80 -4.00 16.00 -56.25 56.25
247 30 45 45 180 240.20 66.36 2.72 84.34 9.51 5.43 4.35 14.48 -4.00 16.00 -56.25 56.25
248 30 45 45 210 150.16 53.80 0.24 17.29 7.71 4.10 5.70 9.08 -2.00 13.00 -45.00 45.00
249 30 45 45 210 180.38 55.19 0.60 31.51 8.01 4.74 5.70 10.43 -2.00 14.00 -56.25 56.25













































251 30 45 45 210 240.20 57.39 1.21 51.65 8.40 4.98 5.03 11.78 -3.00 14.00 -67.50 67.50
252 30 45 60 90 30.22 87.57 0.88 28.87 8.78 8.66 3.00 14.48 -3.00 16.00 -22.50 22.50
253 30 45 60 120 30.22 66.58 0.46 19.36 7.42 10.75 3.68 11.10 -2.00 15.00 -45.00 45.00
254 30 45 60 120 45.17 83.89 1.44 45.66 8.62 8.80 3.00 13.80 -3.00 16.00 -45.00 45.00
255 30 45 60 150 30.22 55.69 0.10 6.07 6.48 12.00 5.03 7.73 10.00 14.00 -33.75 33.75
256 30 45 60 150 45.17 63.62 0.53 20.05 7.83 11.66 4.35 11.10 -1.00 15.00 -45.00 45.00
257 30 45 60 150 60.43 72.23 1.23 42.43 8.50 9.68 3.68 13.13 -3.00 16.00 -56.25 56.25
258 30 45 60 180 45.17 55.41 0.15 8.61 6.91 11.86 5.03 8.40 10.00 14.00 -45.00 45.00
259 30 45 60 180 60.43 59.96 0.47 18.71 7.73 11.87 4.35 10.43 9.00 15.00 -56.25 56.25
260 30 45 60 180 120.25 76.96 2.35 74.75 9.36 8.98 3.68 15.15 -3.00 16.00 -67.50 67.50
261 30 45 60 180 150.16 85.10 3.32 98.44 9.82 8.39 3.00 15.83 -4.00 17.00 -67.50 67.50
262 30 45 60 180 180.38 92.93 4.15 115.92 10.22 8.09 3.00 17.18 -4.00 17.00 -67.50 67.50
263 30 45 60 180 210.29 99.96 4.76 129.61 10.55 7.96 3.00 17.85 -4.00 17.00 -78.75 78.75
264 30 45 60 210 60.43 53.87 0.10 7.45 6.94 11.82 5.70 8.40 10.00 13.00 -56.25 56.25
265 30 45 60 210 120.25 63.69 1.23 41.97 8.69 11.46 4.35 12.45 0.00 15.00 -78.75 78.75
266 30 45 60 210 150.16 67.99 1.95 66.37 9.02 10.17 3.68 13.80 -2.00 16.00 -78.75 78.75
267 30 45 60 210 180.38 71.96 2.64 84.79 9.33 9.44 3.68 14.48 -2.00 16.00 -90.00 90.00
268 30 45 60 210 210.29 75.49 3.30 102.87 9.51 8.88 3.68 15.15 -3.00 16.00 -90.00 90.00
269 30 45 60 210 240.20 78.66 3.81 114.23 9.69 8.64 3.68 15.83 -3.00 17.00 -90.00 90.00
270 30 45 60 210 270.42 81.50 4.25 123.44 9.86 8.50 3.68 15.83 -3.00 17.00 -90.00 90.00
271 30 45 60 210 300.33 84.04 4.65 133.33 9.99 8.36 3.00 16.50 -4.00 17.00 -90.00 90.00
272 30 45 60 210 360.46 88.44 5.36 149.00 10.22 8.14 3.00 16.50 -4.00 17.00 -90.00 90.00
273 30 60 60 90 30.22 87.67 1.30 40.06 9.17 5.95 3.00 14.48 -4.00 16.00 -22.50 22.50
274 30 60 60 120 30.22 66.65 0.87 32.28 7.51 5.83 3.68 11.10 -4.00 15.00 -45.00 45.00
275 30 60 60 120 45.17 84.24 2.21 65.48 8.97 5.92 3.00 13.80 -5.00 16.00 -45.00 45.00
276 30 60 60 150 30.22 55.73 0.21 12.14 6.48 6.00 5.03 7.73 -2.00 14.00 -33.75 33.75
277 30 60 60 150 45.17 63.81 1.09 39.06 7.84 5.92 4.35 11.10 -4.00 15.00 -45.00 45.00
278 30 60 60 150 60.43 72.75 2.12 66.67 8.74 5.88 3.68 13.13 -4.00 16.00 -56.25 56.25
279 30 60 60 180 45.17 55.54 0.30 17.68 6.92 5.68 5.03 8.40 -2.00 14.00 -45.00 45.00
280 30 60 60 180 60.43 60.28 1.00 39.53 7.75 5.86 4.35 10.43 -3.00 15.00 -56.25 56.25
281 30 60 60 180 120.25 78.82 4.03 111.73 9.81 5.63 3.68 15.15 -5.00 16.00 -67.50 67.50
282 30 60 60 180 150.16 88.11 5.29 139.78 10.45 5.65 3.00 16.50 -6.00 17.00 -67.50 67.50
283 30 60 60 180 180.38 97.11 6.27 162.99 10.91 5.63 3.00 17.18 -6.00 17.00 -67.50 67.50
284 30 60 60 210 60.43 54.10 0.24 16.48 7.00 5.65 5.70 8.40 -1.00 13.00 -56.25 56.25
285 30 60 60 210 120.25 64.91 2.79 91.61 8.82 5.59 4.35 13.13 -4.00 16.00 -78.75 78.75
286 30 60 60 210 150.16 69.85 3.97 116.60 9.36 5.70 3.68 13.80 -4.00 16.00 -78.75 78.75
287 30 60 60 210 180.38 74.49 4.97 139.26 9.75 5.66 3.68 15.15 -5.00 16.00 -90.00 90.00
288 30 60 60 210 210.29 78.67 5.78 155.23 10.09 5.60 3.68 15.83 -5.00 16.00 -90.00 90.00
289 30 60 60 210 240.20 82.46 6.46 169.79 10.34 5.65 3.68 16.50 -5.00 17.00 -90.00 90.00
290 30 60 60 210 270.42 85.92 7.10 185.64 10.55 5.62 3.00 16.50 -6.00 17.00 -90.00 90.00
291 30 60 60 210 300.33 89.07 7.59 196.40 10.72 5.61 3.00 17.18 -6.00 17.00 -90.00 90.00
292 30 60 60 210 360.46 94.35 8.36 214.02 10.98 5.60 3.00 17.18 -7.00 17.00 -90.00 90.00
293 45 30 45 90 30.22 63.77 0.45 17.90 7.70 0.00 4.35 11.10 -15.00 15.00 -22.50 22.50
294 45 30 45 90 45.17 76.05 1.21 39.69 9.20 0.00 3.68 14.48 -16.00 16.00 -22.50 22.50
295 45 30 45 90 60.43 89.63 2.13 65.68 10.25 0.00 3.00 17.18 -17.00 17.00 -33.75 33.75
296 45 30 45 120 30.22 54.65 0.08 7.28 6.53 0.00 5.03 7.73 -14.00 14.00 -22.50 22.50
297 45 30 45 120 45.17 61.43 0.68 25.53 7.64 0.00 4.35 10.43 -15.00 15.00 -33.75 33.75
298 45 30 45 120 60.43 68.27 1.36 45.99 8.57 0.00 3.68 13.13 -16.00 16.00 -45.00 45.00
299 45 30 45 120 120.25 96.05 4.70 134.95 10.44 0.00 3.00 17.18 -17.00 17.00 -56.25 56.25












































301 45 30 45 150 60.43 56.17 0.34 17.57 7.40 0.00 5.03 9.75 -14.00 14.00 -33.75 33.75
302 45 30 45 150 120.25 67.18 1.93 62.23 9.18 0.00 4.35 13.80 -16.00 16.00 -56.25 56.25
303 45 30 45 150 150.16 71.87 2.77 87.44 9.60 0.00 3.68 15.15 -16.00 16.00 -56.25 56.25
304 45 30 45 150 180.38 76.14 3.58 110.91 9.89 0.00 3.68 15.83 -16.00 16.00 -56.25 56.25
305 45 30 45 150 210.29 79.91 4.34 130.12 10.12 0.00 3.68 16.50 -17.00 17.00 -56.25 56.25
306 45 30 45 150 240.20 83.27 4.97 144.66 10.30 0.00 3.68 16.50 -17.00 17.00 -56.25 56.25
307 45 30 45 150 270.42 86.27 5.51 157.85 10.45 0.00 3.00 17.18 -17.00 17.00 -56.25 56.25
308 45 30 45 150 300.33 88.89 5.96 166.86 10.57 0.00 3.00 17.18 -17.00 17.00 -56.25 56.25
309 45 30 45 150 360.46 93.32 6.72 183.61 10.83 0.00 3.00 17.85 -17.00 17.00 -67.50 67.50
310 45 30 45 180 120.25 56.59 0.62 28.61 7.99 0.00 5.03 10.43 -14.00 14.00 -45.00 45.00
311 45 30 45 180 150.16 58.79 1.04 40.39 8.47 0.00 5.03 11.78 -15.00 15.00 -56.25 56.25
312 45 30 45 180 180.38 60.67 1.46 53.01 8.76 0.00 4.35 12.45 -15.00 15.00 -56.25 56.25
313 45 30 45 180 210.29 62.27 1.78 60.74 8.99 0.00 4.35 13.13 -15.00 15.00 -56.25 56.25
314 45 30 45 180 240.20 63.66 2.06 69.08 9.16 0.00 4.35 13.80 -16.00 16.00 -56.25 56.25
315 45 30 45 210 150.16 52.74 0.08 7.88 7.56 0.00 6.38 8.40 -13.00 13.00 -33.75 33.75
316 45 30 45 210 180.38 53.86 0.30 18.69 7.72 0.00 5.70 9.75 -13.00 13.00 -45.00 45.00
317 45 30 45 210 210.29 54.80 0.53 28.58 7.91 0.00 5.70 9.75 -14.00 14.00 -56.25 56.25
318 45 30 45 210 240.20 55.61 0.75 35.94 8.09 0.00 5.70 10.43 -14.00 14.00 -56.25 56.25
319 45 30 60 90 30.22 87.54 0.85 28.11 8.79 5.71 3.00 14.48 -15.00 16.00 -22.50 22.50
320 45 30 60 120 30.22 66.56 0.45 18.98 7.43 9.83 3.68 11.10 -14.00 15.00 -45.00 45.00
321 45 30 60 120 45.17 83.78 1.37 43.44 8.62 6.05 3.00 13.80 -15.00 16.00 -45.00 45.00
322 45 30 60 150 30.22 55.68 0.10 6.07 6.48 12.00 5.03 7.73 10.00 14.00 -33.75 33.75
323 45 30 60 150 45.17 63.55 0.51 18.24 7.79 11.70 4.35 11.10 -12.00 15.00 -45.00 45.00
324 45 30 60 150 60.43 72.06 1.15 39.51 8.50 8.38 3.68 13.13 -14.00 16.00 -56.25 56.25
325 45 30 60 180 45.17 55.36 0.14 8.55 6.90 11.86 5.03 8.40 10.00 14.00 -45.00 45.00
326 45 30 60 180 60.43 59.85 0.46 18.29 7.74 11.94 4.35 10.43 9.00 15.00 -56.25 56.25
327 45 30 60 180 120.25 76.36 1.98 62.83 9.33 8.10 3.68 14.48 -14.00 16.00 -67.50 67.50
328 45 30 60 180 150.16 84.13 2.69 81.68 9.79 7.20 3.00 15.83 -15.00 17.00 -67.50 67.50
329 45 30 60 180 180.38 91.56 3.38 99.56 10.13 6.63 3.00 16.50 -15.00 17.00 -67.50 67.50
330 45 30 60 180 210.29 98.21 3.92 113.95 10.39 6.29 3.00 17.18 -15.00 17.00 -67.50 67.50
331 45 30 60 210 60.43 53.79 0.09 6.54 6.99 11.96 5.70 8.40 11.00 13.00 -56.25 56.25
332 45 30 60 210 120.25 63.30 1.15 38.22 8.66 11.74 4.35 12.45 8.00 15.00 -78.75 78.75
333 45 30 60 210 150.16 67.40 1.60 52.01 9.06 11.21 3.68 13.80 -13.00 16.00 -78.75 78.75
334 45 30 60 210 180.38 71.14 2.07 65.80 9.34 10.07 3.68 14.48 -13.00 16.00 -90.00 90.00
335 45 30 60 210 210.29 74.45 2.51 79.09 9.53 9.26 3.68 15.15 -14.00 16.00 -90.00 90.00
336 45 30 60 210 240.20 77.40 2.90 88.83 9.70 8.67 3.68 15.15 -14.00 17.00 -90.00 90.00
337 45 30 60 210 270.42 80.04 3.22 97.81 9.81 8.31 3.68 15.83 -14.00 17.00 -90.00 90.00
338 45 30 60 210 300.33 82.36 3.52 105.48 9.92 8.04 3.00 15.83 -15.00 17.00 -90.00 90.00
339 45 30 60 210 360.46 86.43 4.19 124.03 10.16 6.96 3.00 16.50 -15.00 17.00 -90.00 90.00
340 45 45 45 90 30.22 63.86 0.69 27.95 7.71 0.00 4.35 11.10 -15.00 15.00 -22.50 22.50
341 45 45 45 90 45.17 76.50 1.83 57.62 9.31 0.00 3.68 15.15 -16.00 16.00 -22.50 22.50
342 45 45 45 90 60.43 90.85 3.19 93.52 10.50 0.00 3.00 17.85 -17.00 17.00 -33.75 33.75
343 45 45 45 120 30.22 54.72 0.13 11.30 6.53 0.00 5.03 7.73 -14.00 14.00 -22.50 22.50
344 45 45 45 120 45.17 61.73 1.05 39.75 7.69 0.00 4.35 11.10 -15.00 15.00 -33.75 33.75
345 45 45 45 120 60.43 69.04 2.21 73.63 8.66 0.00 3.68 13.13 -16.00 16.00 -45.00 45.00
346 45 45 45 150 45.17 53.05 0.02 2.65 6.70 0.00 6.38 7.05 -12.00 12.00 -11.25 11.25
347 45 45 45 150 60.43 56.63 0.60 29.61 7.46 0.00 5.03 9.75 -14.00 14.00 -33.75 33.75
348 45 45 45 150 120.25 69.58 3.59 113.07 9.39 0.00 3.68 14.48 -16.00 16.00 -56.25 56.25
349 45 45 45 150 150.16 75.59 5.03 142.84 9.93 0.00 3.68 15.83 -16.00 16.00 -56.25 56.25












































351 45 45 45 150 210.29 86.47 7.07 184.88 10.72 0.00 3.00 17.18 -17.00 17.00 -56.25 56.25
352 45 45 45 150 240.20 91.17 7.79 200.11 10.98 0.00 3.00 17.85 -17.00 17.00 -56.25 56.25
353 45 45 45 150 270.42 95.43 8.44 215.31 11.21 0.00 3.00 18.53 -17.00 17.00 -67.50 67.50
354 45 45 45 150 300.33 99.29 9.01 229.36 11.38 0.00 3.00 18.53 -17.00 17.00 -67.50 67.50
355 45 45 45 180 120.25 58.03 1.26 51.34 8.22 0.00 5.03 11.10 -14.00 14.00 -45.00 45.00
356 45 45 45 180 150.16 60.87 2.14 79.90 8.68 0.00 4.35 12.45 -15.00 15.00 -56.25 56.25
357 45 45 45 180 180.38 63.39 2.91 99.88 9.07 0.00 4.35 13.80 -15.00 15.00 -56.25 56.25
358 45 45 45 180 210.29 65.60 3.65 118.84 9.33 0.00 4.35 14.48 -16.00 16.00 -56.25 56.25
359 45 45 45 180 240.20 67.57 4.23 131.37 9.54 0.00 4.35 14.48 -16.00 16.00 -56.25 56.25
360 45 45 45 210 120.25 52.44 0.01 1.23 7.40 0.00 7.05 7.73 0.00 0.00 -22.50 22.50
361 45 45 45 210 150.16 54.18 0.38 25.80 7.76 0.00 5.70 9.75 -13.00 13.00 -56.25 56.25
362 45 45 45 210 180.38 55.70 0.92 48.28 8.04 0.00 5.70 10.43 -14.00 14.00 -56.25 56.25
363 45 45 45 210 210.29 57.00 1.42 62.08 8.26 0.00 5.03 11.10 -14.00 14.00 -67.50 67.50
364 45 45 45 210 240.20 58.12 1.90 80.08 8.46 0.00 5.03 11.78 -14.00 14.00 -67.50 67.50
365 45 45 60 90 30.22 87.57 1.11 38.24 8.55 4.42 3.00 14.48 -15.00 16.00 -22.50 22.50
366 45 45 60 120 30.22 66.58 0.51 23.01 7.34 8.87 3.68 11.10 -14.00 15.00 -45.00 45.00
367 45 45 60 120 45.17 83.89 1.79 59.15 8.44 4.76 3.00 13.80 -15.00 16.00 -45.00 45.00
368 45 45 60 150 30.22 55.69 0.10 6.07 6.48 12.00 5.03 7.73 10.00 14.00 -33.75 33.75
369 45 45 60 150 45.17 63.62 0.54 20.88 7.82 11.37 4.35 11.10 -12.00 15.00 -45.00 45.00
370 45 45 60 150 60.43 72.23 1.44 52.33 8.35 6.76 3.68 13.13 -14.00 16.00 -56.25 56.25
371 45 45 60 180 45.17 55.41 0.15 8.61 6.91 11.86 5.03 8.40 10.00 14.00 -45.00 45.00
372 45 45 60 180 60.43 59.96 0.47 18.71 7.73 11.87 4.35 10.43 9.00 15.00 -56.25 56.25
373 45 45 60 180 120.25 76.96 2.78 91.57 9.19 5.97 3.68 15.15 -14.00 16.00 -67.50 67.50
374 45 45 60 180 150.16 85.11 4.08 125.90 9.62 4.99 3.00 15.83 -15.00 17.00 -67.50 67.50
375 45 45 60 180 180.38 92.94 5.15 150.03 10.01 4.56 3.00 17.18 -15.00 17.00 -67.50 67.50
376 45 45 60 180 210.29 99.98 6.06 171.22 10.31 4.13 3.00 17.85 -16.00 17.00 -78.75 78.75
377 45 45 60 210 60.43 53.87 0.10 7.45 6.94 11.82 5.70 8.40 10.00 13.00 -56.25 56.25
378 45 45 60 210 120.25 63.69 1.26 43.49 8.68 11.26 4.35 12.45 -1.00 15.00 -78.75 78.75
379 45 45 60 210 150.16 68.00 2.08 74.84 8.94 9.04 3.68 13.80 -13.00 16.00 -78.75 78.75
380 45 45 60 210 180.38 71.96 2.99 104.02 9.20 7.40 3.68 14.48 -14.00 16.00 -90.00 90.00
381 45 45 60 210 210.29 75.50 3.80 124.14 9.36 6.51 3.68 15.15 -14.00 16.00 -90.00 90.00
382 45 45 60 210 240.20 78.68 4.51 142.38 9.54 5.96 3.68 15.83 -14.00 17.00 -90.00 90.00
383 45 45 60 210 270.42 81.53 5.10 156.33 9.68 5.63 3.68 15.83 -15.00 17.00 -90.00 90.00
384 45 45 60 210 300.33 84.07 5.63 168.81 9.80 5.32 3.00 16.50 -15.00 17.00 -90.00 90.00
385 45 45 60 210 360.46 88.49 6.62 191.68 10.04 4.80 3.00 16.50 -15.00 17.00 -90.00 90.00
386 45 60 60 90 30.22 87.71 1.54 49.53 8.94 3.23 3.00 14.48 -15.00 16.00 -22.50 22.50
387 45 60 60 120 30.22 66.67 0.91 35.97 7.47 4.98 3.68 11.10 -14.00 15.00 -45.00 45.00
388 45 60 60 120 45.17 84.35 2.61 80.32 8.79 3.34 3.00 13.80 -15.00 16.00 -45.00 45.00
389 45 60 60 150 30.22 55.75 0.21 12.14 6.48 6.00 5.03 7.73 -2.00 14.00 -33.75 33.75
390 45 60 60 150 45.17 63.87 1.11 40.40 7.84 5.70 4.35 11.10 -12.00 15.00 -45.00 45.00
391 45 60 60 150 60.43 72.92 2.36 77.45 8.64 4.25 3.68 13.13 -14.00 16.00 -56.25 56.25
392 45 60 60 180 45.17 55.58 0.30 17.68 6.92 5.68 5.03 8.40 -2.00 14.00 -45.00 45.00
393 45 60 60 180 60.43 60.39 1.01 39.72 7.76 5.77 4.35 10.43 -3.00 15.00 -56.25 56.25
394 45 60 60 180 120.25 79.42 4.60 133.74 9.66 3.74 3.68 15.15 -14.00 16.00 -67.50 67.50
395 45 60 60 180 150.16 89.09 6.29 173.92 10.24 3.20 3.00 16.50 -15.00 17.00 -67.50 67.50
396 45 60 60 180 180.38 98.47 7.61 201.51 10.71 2.94 3.00 17.85 -15.00 17.00 -67.50 67.50
397 45 60 60 210 60.43 54.18 0.26 18.01 7.04 5.13 5.70 8.40 -2.00 13.00 -56.25 56.25
398 45 60 60 210 120.25 65.30 2.87 92.84 8.87 5.37 4.35 13.13 -4.00 16.00 -78.75 78.75
399 45 60 60 210 150.16 70.46 4.27 132.04 9.35 4.77 3.68 14.48 -13.00 16.00 -90.00 90.00












































401 45 60 60 210 210.29 79.73 6.72 190.77 9.98 3.68 3.68 15.83 -14.00 16.00 -90.00 90.00
402 45 60 60 210 240.20 83.73 7.63 209.76 10.20 3.47 3.00 16.50 -14.00 17.00 -90.00 90.00
403 45 60 60 210 270.42 87.44 8.43 226.45 10.39 3.33 3.00 16.50 -15.00 17.00 -90.00 90.00
404 45 60 60 210 300.33 90.76 9.13 241.84 10.57 3.19 3.00 17.18 -15.00 17.00 -90.00 90.00
405 45 60 60 210 360.46 96.33 10.19 265.38 10.81 2.96 3.00 17.85 -15.00 17.00 -90.00 90.00
406 60 30 60 90 30.22 87.54 1.26 38.33 9.18 0.00 3.00 14.48 -16.00 16.00 -22.50 22.50
407 60 30 60 120 30.22 66.56 0.83 30.68 7.51 0.00 3.68 11.10 -15.00 15.00 -45.00 45.00
408 60 30 60 120 45.17 83.78 2.07 61.34 8.94 0.00 3.00 13.80 -16.00 16.00 -45.00 45.00
409 60 30 60 150 30.22 55.68 0.21 12.14 6.48 0.00 5.03 7.73 -14.00 14.00 -33.75 33.75
410 60 30 60 150 45.17 63.55 1.00 35.22 7.80 0.00 4.35 11.10 -15.00 15.00 -45.00 45.00
411 60 30 60 150 60.43 72.06 1.95 61.45 8.70 0.00 3.68 13.13 -16.00 16.00 -56.25 56.25
412 60 30 60 180 45.17 55.36 0.29 17.10 6.90 0.00 5.03 8.40 -14.00 14.00 -45.00 45.00
413 60 30 60 180 60.43 59.85 0.93 36.57 7.74 0.00 4.35 10.43 -15.00 15.00 -56.25 56.25
414 60 30 60 180 120.25 76.36 3.34 97.05 9.58 0.00 3.68 14.48 -16.00 16.00 -67.50 67.50
415 60 30 60 180 150.16 84.13 4.33 122.03 10.11 0.00 3.00 15.83 -17.00 17.00 -67.50 67.50
416 60 30 60 180 180.38 91.57 5.29 145.91 10.50 0.00 3.00 16.50 -17.00 17.00 -67.50 67.50
417 60 30 60 180 210.29 98.22 6.11 173.23 10.78 0.00 3.00 17.18 -17.00 17.00 -67.50 67.50
418 60 30 60 210 60.43 53.79 0.18 13.08 6.99 0.00 5.70 8.40 -13.00 13.00 -56.25 56.25
419 60 30 60 210 120.25 63.30 2.29 76.45 8.66 0.00 4.35 12.45 -15.00 15.00 -78.75 78.75
420 60 30 60 210 150.16 67.40 3.13 96.14 9.10 0.00 3.68 13.80 -16.00 16.00 -78.75 78.75
421 60 30 60 210 180.38 71.14 3.84 112.95 9.47 0.00 3.68 14.48 -16.00 16.00 -90.00 90.00
422 60 30 60 210 210.29 74.46 4.49 129.58 9.71 0.00 3.68 15.15 -16.00 16.00 -90.00 90.00
423 60 30 60 210 240.20 77.41 5.06 141.99 9.95 0.00 3.68 15.15 -17.00 17.00 -90.00 90.00
424 60 30 60 210 270.42 80.06 5.50 153.86 10.07 0.00 3.68 15.83 -17.00 17.00 -90.00 90.00
425 60 30 60 210 300.33 82.38 5.97 165.29 10.21 0.00 3.00 15.83 -17.00 17.00 -90.00 90.00
426 60 30 60 210 360.46 86.48 6.70 183.00 10.48 0.00 3.00 16.50 -17.00 17.00 -90.00 90.00
427 60 45 60 90 30.22 87.57 1.52 48.54 8.94 0.00 3.00 14.48 -16.00 16.00 -22.50 22.50
428 60 45 60 120 30.22 66.58 0.88 34.72 7.46 0.00 3.68 11.10 -15.00 15.00 -45.00 45.00
429 60 45 60 120 45.17 83.89 2.53 78.40 8.76 0.00 3.00 13.80 -16.00 16.00 -45.00 45.00
430 60 45 60 150 30.22 55.69 0.21 12.14 6.48 0.00 5.03 7.73 -14.00 14.00 -33.75 33.75
431 60 45 60 150 45.17 63.62 1.06 39.09 7.84 0.00 4.35 11.10 -15.00 15.00 -45.00 45.00
432 60 45 60 150 60.43 72.23 2.27 74.99 8.58 0.00 3.68 13.13 -16.00 16.00 -56.25 56.25
433 60 45 60 180 45.17 55.41 0.29 17.23 6.91 0.00 5.03 8.40 -14.00 14.00 -45.00 45.00
434 60 45 60 180 60.43 59.96 0.95 37.41 7.73 0.00 4.35 10.43 -15.00 15.00 -56.25 56.25
435 60 45 60 180 120.25 76.96 4.32 132.99 9.47 0.00 3.68 15.15 -16.00 16.00 -67.50 67.50
436 60 45 60 180 150.16 85.11 5.99 171.26 9.96 0.00 3.00 15.83 -17.00 17.00 -67.50 67.50
437 60 45 60 180 180.38 92.95 7.38 199.55 10.40 0.00 3.00 17.18 -17.00 17.00 -67.50 67.50
438 60 45 60 210 60.43 53.87 0.21 14.90 6.94 0.00 5.70 8.40 -13.00 13.00 -56.25 56.25
439 60 45 60 210 120.25 63.69 2.51 86.01 8.68 0.00 4.35 12.45 -15.00 15.00 -78.75 78.75
440 60 45 60 210 150.16 68.00 3.80 124.29 9.06 0.00 3.68 13.80 -16.00 16.00 -78.75 78.75
441 60 45 60 210 180.38 71.97 5.05 158.06 9.41 0.00 3.68 14.48 -16.00 16.00 -90.00 90.00
442 60 45 60 210 210.29 75.52 6.21 184.77 9.63 0.00 3.68 15.15 -16.00 16.00 -90.00 90.00
443 60 45 60 210 240.20 78.70 7.11 205.02 9.84 0.00 3.68 15.83 -17.00 17.00 -90.00 90.00
444 60 45 60 210 270.42 81.56 7.93 222.36 10.01 0.00 3.68 15.83 -17.00 17.00 -90.00 90.00
445 60 45 60 210 300.33 84.12 8.63 237.07 10.15 0.00 3.00 16.50 -17.00 17.00 -90.00 90.00
446 60 45 60 210 360.46 88.57 9.76 259.48 10.40 0.00 3.00 16.50 -17.00 17.00 -90.00 90.00
447 60 60 60 90 30.22 87.74 1.97 60.81 9.16 0.00 3.00 14.48 -16.00 16.00 -22.50 22.50
448 60 60 60 120 30.22 66.69 1.31 48.50 7.50 0.00 3.68 11.10 -15.00 15.00 -45.00 45.00
449 60 60 60 120 45.17 84.47 3.38 99.38 8.98 0.00 3.00 14.48 -16.00 16.00 -45.00 45.00













































451 60 60 60 150 45.17 63.94 1.66 59.24 7.84 0.00 4.35 11.10 -15.00 15.00 -45.00 45.00
452 60 60 60 150 60.43 73.11 3.24 102.16 8.75 0.00 3.68 13.13 -16.00 16.00 -56.25 56.25
453 60 60 60 180 45.17 55.62 0.45 26.34 6.93 0.00 5.03 8.40 -14.00 14.00 -45.00 45.00
454 60 60 60 180 60.43 60.50 1.53 60.36 7.78 0.00 4.35 11.10 -15.00 15.00 -56.25 56.25
455 60 60 60 180 120.25 80.20 6.23 170.36 9.84 0.00 3.68 15.83 -16.00 16.00 -67.50 67.50
456 60 60 60 180 150.16 90.48 8.16 212.19 10.49 0.00 3.00 17.18 -17.00 17.00 -67.50 67.50
457 60 60 60 210 60.43 54.26 0.38 26.60 7.05 0.00 5.70 8.40 -13.00 13.00 -56.25 56.25
458 60 60 60 210 120.25 65.78 4.32 140.55 8.86 0.00 4.35 13.13 -16.00 16.00 -78.75 78.75
459 60 60 60 210 150.16 71.25 6.25 184.30 9.41 0.00 3.68 14.48 -16.00 16.00 -90.00 90.00
460 60 60 60 210 180.38 76.48 7.84 215.84 9.81 0.00 3.68 15.15 -16.00 16.00 -90.00 90.00
461 60 60 60 210 210.29 81.29 9.08 239.56 10.17 0.00 3.68 15.83 -16.00 16.00 -90.00 90.00
462 60 60 60 210 240.20 85.68 10.22 264.16 10.44 0.00 3.00 16.50 -17.00 17.00 -90.00 90.00
463 60 60 60 210 270.42 89.86 11.14 284.13 10.67 0.00 3.00 17.18 -17.00 17.00 -90.00 90.00
464 60 60 60 210 300.33 93.55 11.87 300.48 10.85 0.00 3.00 17.18 -17.00 17.00 -90.00 90.00




Appendix B: Prostate Largest Tumor Necrosed Results 
 Results of the studies which predicted the largest tumor which could be 
necrosed are displayed in Table 40 – Table 42.   
*1 – tumor centered halfway between r-min and r-centroid. 
  2 – tumor centered at r-centroid. 
  3 – tumor centered halfway between r-centroid and r-max. 
**The largest spherical tumor which can be necrosed at each location. 
***(largest tumor radius)/(equivalent necrosed radius) 





5.45 6.54 7.81 r-Coordinate (mm)
1.00 1.00 1.00 Tumor Radius (mm)**
0.41 0.41 0.41 r-Ratio***
5.95 8.89 12.02 r-Coordinate (mm)
2.00 3.00 2.00 Tumor Radius (mm)**
0.31 0.47 0.31 r-Ratio***
5.95 7.56 9.33 r-Coordinate (mm)
2.00 2.00 1.00 Tumor Radius (mm)**
0.41 0.41 0.20 r-Ratio***
6.42 9.84 13.17 r-Coordinate (mm)
2.00 3.00 3.00 Tumor Radius (mm)**
0.32 0.49 0.49 r-Ratio***
7.08 8.47 10.46 r-Coordinate (mm)
2.00 1.00 1.00 Tumor Radius (mm)**
0.45 0.23 0.23 r-Ratio***
7.15 9.96 13.23 r-Coordinate (mm)
3.00 3.00 2.00 Tumor Radius (mm)**
0.45 0.45 0.30 r-Ratio***
6.85 10.70 14.95 r-Coordinate (mm)
3.00 3.00 3.00 Tumor Radius (mm)**
0.39 0.39 0.39 r-Ratio***
0 30 0 200.76 90
0 30 0 60.77 90
0 30 0 120.46 90
30.39 90
0 45 0 30.39 90
0 45 0 55.35 90






















5.37 7.07 8.75 r-Coordinate (mm)
2.00 2.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.05 9.11 12.80 r-Coordinate (mm)
3.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
5.78 7.88 10.17 r-Coordinate (mm)
2.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.31 9.62 13.40 r-Coordinate (mm)
3.00 4.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.55 8.08 9.59 r-Coordinate (mm)
1.00 1.00 1.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.68 8.34 10.06 r-Coordinate (mm)
1.00 2.00 1.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.76 8.49 10.47 r-Coordinate (mm)
2.00 2.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.56 8.77 10.95 r-Coordinate (mm)
1.00 2.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.50 8.65 11.22 r-Coordinate (mm)
1.00 2.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
5.84 8.00 10.56 r-Coordinate (mm)
2.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.16 9.31 12.91 r-Coordinate (mm)
3.00 4.00 3.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.38 8.42 10.77 r-Coordinate (mm)
2.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.21 8.74 11.61 r-Coordinate (mm)
2.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.42 9.17 12.50 r-Coordinate (mm)
3.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
0 45 0 150.16 150
0 45 0 210.29 150
0 60 0 105.3 150
0 45 0 120.25 150
0 30 0 240.2 120
0 60 0 60.43 150
0 30 0 180.38 120
0 30 0 210.29 120
0 30 0 120.25 120
0 30 0 150.16 120
0 45 0 60.43 120
0 45 0 120.25 120
0 60 0 30.39 120





















5.84 7.33 8.88 r-Coordinate (mm)
1.00 2.00 1.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.19 8.70 11.59 r-Coordinate (mm)
2.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.02 9.04 12.43 r-Coordinate (mm)
3.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.16 9.31 12.91 r-Coordinate (mm)
3.00 4.00 3.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.29 9.59 13.38 r-Coordinate (mm)
3.00 4.00 3.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.32 7.61 9.02 r-Coordinate (mm)
1.00 1.00 1.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.49 7.96 9.53 r-Coordinate (mm)
1.00 2.00 1.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.59 8.16 9.97 r-Coordinate (mm)
1.00 2.00 1.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.34 8.33 10.39 r-Coordinate (mm)
1.00 2.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.35 8.36 10.74 r-Coordinate (mm)
2.00 2.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.38 8.41 10.77 r-Coordinate (mm)
2.00 2.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
6.44 8.53 11.16 r-Coordinate (mm)
2.00 3.00 2.00 Tumor Radius (mm)**
0.00 0.00 0.00 r-Ratio***
0 45 0 300.33 180
0 45 0 240.2 180
0 45 0 270.42 180
0 45 0 180.38 180
0 45 0 210.29 180
0 45 0 120.25 180
0 45 0 150.16 180
0 60 0 180.38 180
0 60 0 210.29 180
0 60 0 120.25 180
















Appendix C: Breast Focal Point Location Simulations Results 
 Results from the simulations of the heat generation produced from HIFU for 
breast cancer are displayed in Table 43 – Table 54. 












































1 flat 41 20 1 1 1 2.59E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
2 flat 41 20 1 2 1 5.55E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
3 flat 41 20 1 3 1 1.60E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
4 flat 41 20 1 3 1 1.60E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
5 flat 41 20 1 1 2 2.37E+08 13.54 0.00 30.09 17.85 0.00 29.52 4.34 1 0 -2
6 flat 41 20 1 2 2 4.54E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
7 flat 41 20 1 3 2 1.06E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
8 flat 41 20 1 1 3 2.09E+08 11.13 0.00 45.15 13.83 0.00 44.39 2.81 0 0 -1
9 flat 41 20 1 2 3 3.38E+08 20.32 0.00 45.14 23.70 0.00 45.16 3.39 1 0 -1
10 flat 41 20 1 3 3 6.11E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
11 flat 41 20 2 1 1 5.90E+08 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 -1
12 flat 41 20 2 2 1 7.64E+08 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
13 flat 41 20 2 3 1 2.01E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
14 flat 41 20 2 1 2 6.32E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
15 flat 41 20 2 1 2 6.32E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
16 flat 41 20 2 2 2 6.60E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
17 flat 41 20 2 2 2 6.60E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
18 flat 41 20 2 3 2 1.01E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
19 flat 41 20 2 1 3 5.87E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
20 flat 41 20 2 1 3 5.87E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
21 flat 41 20 2 2 3 5.93E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
22 flat 41 20 2 3 3 1.16E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
23 flat 41 20 3 1 1 1.11E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 -1
24 flat 41 20 3 2 1 6.63E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
25 flat 41 20 3 3 1 1.53E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
26 flat 41 20 3 1 2 8.25E+08 13.54 0.00 30.09 14.12 -1.06 31.46 1.82 1 1 0
27 flat 41 20 3 2 2 1.07E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
28 flat 41 20 3 3 2 1.06E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
29 flat 41 20 3 1 3 1.20E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
30 flat 41 20 3 1 3 1.20E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
31 flat 41 20 3 2 3 7.16E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
32 flat 41 20 3 3 3 1.41E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
33 flat 41 30 1 1 1 3.88E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
34 flat 41 30 1 2 1 8.36E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
35 flat 41 30 1 2 1 8.36E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
36 flat 41 30 1 3 1 2.39E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
37 flat 41 30 1 1 2 3.56E+08 13.54 0.00 30.09 17.85 0.00 29.52 4.34 1 0 -2
38 flat 41 30 1 2 2 6.80E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
39 flat 41 30 1 2 2 6.80E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
40 flat 41 30 1 3 2 1.59E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
41 flat 41 30 1 1 3 3.11E+08 11.13 0.00 45.15 13.83 0.00 44.39 2.81 0 0 0
42 flat 41 30 1 1 3 3.11E+08 11.13 0.00 45.15 13.83 0.00 44.39 0.00 0 0 0
43 flat 41 30 1 2 3 5.10E+08 20.32 0.00 45.14 23.70 0.00 45.16 3.39 1 0 -1
44 flat 41 30 1 3 3 9.11E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
45 flat 41 30 1 3 3 9.11E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
46 flat 41 30 2 1 1 8.90E+08 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 -1
47 flat 41 30 2 2 1 1.23E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
48 flat 41 30 2 3 1 2.80E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
49 flat 41 30 2 1 2 9.57E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0

















































51 flat 41 30 2 3 2 1.63E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
52 flat 41 30 2 1 3 8.89E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
53 flat 41 30 2 2 3 9.01E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
54 flat 41 30 2 3 3 1.68E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
55 flat 41 30 3 1 1 1.68E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 -1
56 flat 41 30 3 2 1 9.47E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
57 flat 41 30 3 3 1 2.33E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
58 flat 41 30 3 1 2 1.22E+09 13.54 0.00 30.09 14.12 -1.06 31.46 1.82 1 1 0
59 flat 41 30 3 2 2 1.53E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
60 flat 41 30 3 3 2 1.53E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
61 flat 41 30 3 1 3 1.81E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
62 flat 41 30 3 1 3 1.81E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
63 flat 41 30 3 2 3 1.04E+09 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
64 flat 41 30 3 2 3 1.04E+09 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
65 flat 41 30 3 3 3 2.20E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
66 flat 41 40 1 1 1 5.21E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
67 flat 41 40 1 2 1 1.12E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
68 flat 41 40 1 3 1 3.20E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
69 flat 41 40 1 1 2 4.76E+08 13.54 0.00 30.09 16.03 0.00 30.55 2.53 1 0 -1
70 flat 41 40 1 2 2 9.07E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
71 flat 41 40 1 3 2 2.14E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
72 flat 41 40 1 1 3 4.14E+08 11.13 0.00 45.15 13.83 0.00 44.39 2.81 0 0 0
73 flat 41 40 1 1 3 4.14E+08 11.13 0.00 45.15 13.83 0.00 44.39 0.00 0 0 0
74 flat 41 40 1 2 3 6.81E+08 20.32 0.00 45.14 23.70 0.00 45.16 0.00 1 1 0
75 flat 41 40 1 2 3 6.81E+08 20.32 0.00 45.14 23.70 0.00 45.16 0.00 1 1 0
76 flat 41 40 1 3 3 1.23E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
77 flat 41 40 1 3 3 1.23E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
78 flat 41 40 2 1 1 1.18E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 -1
79 flat 41 40 2 2 1 1.69E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
80 flat 41 40 2 3 1 3.60E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
81 flat 41 40 2 1 2 1.25E+09 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
82 flat 41 40 2 2 2 1.23E+09 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
83 flat 41 40 2 3 2 2.24E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
84 flat 41 40 2 1 3 1.19E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
85 flat 41 40 2 2 3 1.21E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 -1 0
86 flat 41 40 2 2 3 1.21E+09 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
87 flat 41 40 2 3 3 2.28E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
88 flat 41 40 3 1 1 2.23E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 0
89 flat 41 40 3 1 1 2.23E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
90 flat 41 40 3 2 1 1.23E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
91 flat 41 40 3 3 1 3.18E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
92 flat 41 40 3 1 2 1.68E+09 13.54 0.00 30.09 14.12 -1.06 31.46 1.82 1 1 0
93 flat 41 40 3 2 2 1.99E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
94 flat 41 40 3 3 2 2.26E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
95 flat 41 40 3 1 3 2.42E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
96 flat 41 40 3 1 3 2.42E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
97 flat 41 40 3 2 3 1.36E+09 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
98 flat 41 40 3 3 3 2.69E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
99 flat 51 20 1 1 1 2.88E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
















































101 flat 51 20 1 3 1 1.67E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
102 flat 51 20 1 1 2 2.61E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
103 flat 51 20 1 2 2 5.10E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
104 flat 51 20 1 3 2 1.14E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
105 flat 51 20 1 1 3 2.30E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
106 flat 51 20 1 2 3 3.73E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
107 flat 51 20 1 3 3 6.77E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
108 flat 51 20 1 3 3 6.77E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
109 flat 51 20 2 1 1 6.14E+08 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
110 flat 51 20 2 1 1 6.14E+08 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
111 flat 51 20 2 2 1 9.29E+08 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
112 flat 51 20 2 3 1 2.42E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
113 flat 51 20 2 1 2 5.79E+08 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 -1 0
114 flat 51 20 2 1 2 5.79E+08 13.54 0.00 30.09 12.93 0.00 28.72 0.00 -1 -1 0
115 flat 51 20 2 2 2 1.01E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
116 flat 51 20 2 2 2 1.01E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
117 flat 51 20 2 3 2 1.14E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
118 flat 51 20 2 1 3 6.90E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
119 flat 51 20 2 1 3 6.90E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
120 flat 51 20 2 2 3 6.65E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
121 flat 51 20 2 3 3 1.24E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
122 flat 51 20 3 1 1 9.94E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
123 flat 51 20 3 2 1 1.43E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
124 flat 51 20 3 3 1 2.70E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
125 flat 51 20 3 1 2 6.92E+08 13.54 0.00 30.09 13.51 -1.01 30.09 1.01 0 1 0
126 flat 51 20 3 2 2 1.51E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
127 flat 51 20 3 2 2 1.51E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
128 flat 51 20 3 3 2 1.24E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
129 flat 51 20 3 1 3 8.52E+08 11.13 0.00 45.15 10.74 0.80 43.69 1.71 -1 1 0
130 flat 51 20 3 2 3 5.39E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
131 flat 51 20 3 2 3 5.39E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
132 flat 51 20 3 3 3 8.90E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
133 flat 51 30 1 1 1 4.32E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
134 flat 51 30 1 2 1 9.31E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
135 flat 51 30 1 3 1 2.51E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
136 flat 51 30 1 1 2 3.91E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
137 flat 51 30 1 2 2 7.65E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
138 flat 51 30 1 3 2 1.71E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
139 flat 51 30 1 1 3 3.46E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
140 flat 51 30 1 2 3 5.61E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
141 flat 51 30 1 2 3 5.61E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
142 flat 51 30 1 3 3 1.01E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
143 flat 51 30 2 1 1 9.05E+08 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 -1
144 flat 51 30 2 2 1 1.45E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
145 flat 51 30 2 3 1 3.51E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
146 flat 51 30 2 1 2 8.87E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
147 flat 51 30 2 2 2 1.46E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
148 flat 51 30 2 2 2 1.46E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
149 flat 51 30 2 3 2 1.80E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
















































151 flat 51 30 2 1 3 1.03E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
152 flat 51 30 2 2 3 9.79E+08 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
153 flat 51 30 2 2 3 9.79E+08 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
154 flat 51 30 2 3 3 1.97E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
155 flat 51 30 3 1 1 1.54E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
156 flat 51 30 3 2 1 2.22E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
157 flat 51 30 3 3 1 3.81E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
158 flat 51 30 3 1 2 1.05E+09 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
159 flat 51 30 3 1 2 1.05E+09 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
160 flat 51 30 3 2 2 2.18E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
161 flat 51 30 3 3 2 1.78E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
162 flat 51 30 3 1 3 1.28E+09 11.13 0.00 45.15 11.46 -0.86 46.61 1.72 1 1 0
163 flat 51 30 3 2 3 7.66E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
164 flat 51 30 3 3 3 1.35E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
165 flat 51 40 1 1 1 5.79E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 1 0
166 flat 51 40 1 1 1 5.79E+08 14.85 0.00 14.85 16.84 0.00 14.92 0.00 1 1 0
167 flat 51 40 1 2 1 1.24E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
168 flat 51 40 1 3 1 3.35E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
169 flat 51 40 1 1 2 5.23E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
170 flat 51 40 1 2 2 1.02E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
171 flat 51 40 1 3 2 2.29E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
172 flat 51 40 1 1 3 4.62E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
173 flat 51 40 1 2 3 7.48E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
174 flat 51 40 1 3 3 1.36E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
175 flat 51 40 1 3 3 1.36E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
176 flat 51 40 2 1 1 1.20E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
177 flat 51 40 2 1 1 1.20E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
178 flat 51 40 2 2 1 1.95E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
179 flat 51 40 2 3 1 4.60E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
180 flat 51 40 2 1 2 1.17E+09 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 0 0
181 flat 51 40 2 2 2 1.90E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
182 flat 51 40 2 3 2 2.35E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
183 flat 51 40 2 1 3 1.37E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
184 flat 51 40 2 1 3 1.37E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
185 flat 51 40 2 2 3 1.29E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
186 flat 51 40 2 3 3 2.36E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
187 flat 51 40 3 1 1 2.09E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
188 flat 51 40 3 1 1 2.09E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
189 flat 51 40 3 2 1 3.00E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
190 flat 51 40 3 3 1 4.93E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
191 flat 51 40 3 1 2 1.44E+09 13.54 0.00 30.09 13.51 -1.01 30.09 1.01 0 1 0
192 flat 51 40 3 2 2 2.86E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
193 flat 51 40 3 3 2 2.70E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
194 flat 51 40 3 1 3 1.72E+09 11.13 0.00 45.15 11.46 -0.86 46.61 1.72 1 1 0
195 flat 51 40 3 2 3 9.95E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
196 flat 51 40 3 3 3 1.73E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
197 flat 61 20 1 1 1 3.07E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
198 flat 61 20 1 2 1 6.58E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
199 flat 61 20 1 3 1 1.69E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0


















































201 flat 61 20 1 2 2 5.48E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
202 flat 61 20 1 3 2 1.18E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
203 flat 61 20 1 3 2 1.18E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
204 flat 61 20 1 1 3 2.55E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
205 flat 61 20 1 2 3 4.06E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
206 flat 61 20 1 3 3 7.18E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
207 flat 61 20 2 1 1 6.77E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
208 flat 61 20 2 1 1 6.77E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
209 flat 61 20 2 2 1 9.19E+08 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
210 flat 61 20 2 3 1 2.51E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
211 flat 61 20 2 1 2 6.48E+08 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 0 0
212 flat 61 20 2 2 2 1.15E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
213 flat 61 20 2 3 2 1.34E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
214 flat 61 20 2 1 3 6.96E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
215 flat 61 20 2 2 3 6.37E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
216 flat 61 20 2 3 3 1.37E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
217 flat 61 20 3 1 1 9.54E+08 14.85 0.00 14.85 14.81 1.11 14.85 1.11 0 1 0
218 flat 61 20 3 2 1 8.55E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
219 flat 61 20 3 3 1 3.60E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
220 flat 61 20 3 1 2 1.27E+09 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 0 0
221 flat 61 20 3 2 2 8.56E+08 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
222 flat 61 20 3 3 2 1.18E+09 38.97 0.00 30.53 37.78 0.00 29.60 1.50 -1 0 0
223 flat 61 20 3 1 3 1.46E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
224 flat 61 20 3 1 3 1.46E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
225 flat 61 20 3 2 3 6.49E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
226 flat 61 20 3 3 3 1.78E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
227 flat 61 30 1 1 1 4.59E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
228 flat 61 30 1 2 1 9.91E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
229 flat 61 30 1 3 1 2.54E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
230 flat 61 30 1 1 2 4.31E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
231 flat 61 30 1 1 2 4.31E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
232 flat 61 30 1 2 2 8.22E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
233 flat 61 30 1 2 2 8.22E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
234 flat 61 30 1 3 2 1.76E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
235 flat 61 30 1 1 3 3.83E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
236 flat 61 30 1 2 3 6.10E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
237 flat 61 30 1 3 3 1.07E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
238 flat 61 30 1 3 3 1.07E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
239 flat 61 30 2 1 1 1.04E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
240 flat 61 30 2 2 1 1.43E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
241 flat 61 30 2 3 1 3.84E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
242 flat 61 30 2 1 2 9.74E+08 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 -1 0
243 flat 61 30 2 1 2 9.74E+08 13.54 0.00 30.09 12.93 0.00 28.72 0.00 -1 -1 0
244 flat 61 30 2 2 2 1.68E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
245 flat 61 30 2 2 2 1.68E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
246 flat 61 30 2 3 2 2.03E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
247 flat 61 30 2 1 3 1.03E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
248 flat 61 30 2 2 3 9.29E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
249 flat 61 30 2 3 3 2.14E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0

















































251 flat 61 30 3 2 1 1.20E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
252 flat 61 30 3 3 1 5.49E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
253 flat 61 30 3 1 2 1.91E+09 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 -1 0
254 flat 61 30 3 1 2 1.91E+09 13.54 0.00 30.09 12.93 0.00 28.72 0.00 -1 -1 0
255 flat 61 30 3 2 2 1.35E+09 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
256 flat 61 30 3 3 2 1.84E+09 38.97 0.00 30.53 37.78 0.00 29.60 1.50 -1 0 0
257 flat 61 30 3 1 3 2.17E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
258 flat 61 30 3 1 3 2.17E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
259 flat 61 30 3 2 3 9.21E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
260 flat 61 30 3 3 3 2.78E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
261 flat 61 40 1 1 1 6.15E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
262 flat 61 40 1 2 1 1.32E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
263 flat 61 40 1 3 1 3.39E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
264 flat 61 40 1 1 2 5.76E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
265 flat 61 40 1 2 2 1.10E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
266 flat 61 40 1 3 2 2.37E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
267 flat 61 40 1 1 3 5.11E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
268 flat 61 40 1 2 3 8.14E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
269 flat 61 40 1 3 3 1.44E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
270 flat 61 40 2 1 1 1.41E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
271 flat 61 40 2 1 1 1.41E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
272 flat 61 40 2 2 1 1.93E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
273 flat 61 40 2 3 1 5.17E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
274 flat 61 40 2 1 2 1.29E+09 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 0 0
275 flat 61 40 2 2 2 2.21E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
276 flat 61 40 2 3 2 2.59E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
277 flat 61 40 2 1 3 1.36E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
278 flat 61 40 2 2 3 1.22E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 -1 0
279 flat 61 40 2 2 3 1.22E+09 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
280 flat 61 40 2 3 3 2.64E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
281 flat 61 40 3 1 1 1.84E+09 14.85 0.00 14.85 14.81 1.11 14.85 1.11 0 1 0
282 flat 61 40 3 2 1 1.56E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
283 flat 61 40 3 3 1 7.37E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
284 flat 61 40 3 1 2 2.54E+09 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 -1 0
285 flat 61 40 3 1 2 2.54E+09 13.54 0.00 30.09 12.93 0.00 28.72 0.00 -1 -1 0
286 flat 61 40 3 2 2 1.85E+09 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
287 flat 61 40 3 3 2 2.32E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
288 flat 61 40 3 1 3 2.88E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
289 flat 61 40 3 1 3 2.88E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
290 flat 61 40 3 2 3 1.19E+09 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
291 flat 61 40 3 3 3 3.43E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
292 curved 41 20 1 1 1 2.56E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
293 curved 41 20 1 2 1 5.51E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
294 curved 41 20 1 3 1 1.57E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
295 curved 41 20 1 3 1 1.57E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
296 curved 41 20 1 1 2 2.32E+08 13.54 0.00 30.09 16.03 0.00 30.55 2.53 1 0 -1
297 curved 41 20 1 2 2 4.51E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
298 curved 41 20 1 3 2 1.05E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
299 curved 41 20 1 3 2 1.05E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0

















































301 curved 41 20 1 2 3 3.26E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
302 curved 41 20 1 3 3 6.06E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
303 curved 41 20 1 3 3 6.06E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
304 curved 41 20 2 1 1 5.84E+08 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
305 curved 41 20 2 1 1 5.84E+08 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
306 curved 41 20 2 2 1 7.92E+08 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
307 curved 41 20 2 3 1 2.16E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
308 curved 41 20 2 1 2 5.99E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
309 curved 41 20 2 2 2 7.44E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
310 curved 41 20 2 3 2 1.03E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
311 curved 41 20 2 1 3 6.02E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
312 curved 41 20 2 2 3 6.07E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 -1 0
313 curved 41 20 2 2 3 6.07E+08 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
314 curved 41 20 2 3 3 1.14E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
315 curved 41 20 3 1 1 9.61E+08 14.85 0.00 14.85 14.81 1.11 14.85 1.11 0 1 0
316 curved 41 20 3 2 1 1.28E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
317 curved 41 20 3 3 1 2.66E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
318 curved 41 20 3 1 2 8.98E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
319 curved 41 20 3 2 2 9.27E+08 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
320 curved 41 20 3 3 2 1.57E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
321 curved 41 20 3 1 3 8.72E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
322 curved 41 20 3 1 3 8.72E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
323 curved 41 20 3 2 3 5.67E+08 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
324 curved 41 20 3 2 3 5.67E+08 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
325 curved 41 20 3 3 3 1.12E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
326 curved 41 30 1 1 1 3.84E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
327 curved 41 30 1 2 1 8.29E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
328 curved 41 30 1 2 1 8.29E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
329 curved 41 30 1 3 1 2.35E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
330 curved 41 30 1 3 1 2.35E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
331 curved 41 30 1 1 2 3.47E+08 13.54 0.00 30.09 16.03 0.00 30.55 0.00 1 1 0
332 curved 41 30 1 1 2 3.47E+08 13.54 0.00 30.09 16.03 0.00 30.55 0.00 1 1 0
333 curved 41 30 1 2 2 6.76E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
334 curved 41 30 1 3 2 1.57E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
335 curved 41 30 1 1 3 3.07E+08 11.13 0.00 45.15 13.83 0.00 44.39 2.81 0 0 0
336 curved 41 30 1 1 3 3.07E+08 11.13 0.00 45.15 13.83 0.00 44.39 0.00 0 0 0
337 curved 41 30 1 2 3 4.90E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
338 curved 41 30 1 2 3 4.90E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
339 curved 41 30 1 3 3 9.04E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
340 curved 41 30 2 1 1 8.73E+08 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 -1
341 curved 41 30 2 2 1 1.26E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
342 curved 41 30 2 3 1 3.07E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
343 curved 41 30 2 1 2 9.13E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
344 curved 41 30 2 2 2 1.04E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
345 curved 41 30 2 3 2 1.65E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
346 curved 41 30 2 1 3 9.08E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
347 curved 41 30 2 2 3 9.13E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
348 curved 41 30 2 3 3 1.70E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
349 curved 41 30 3 1 1 1.43E+09 14.85 0.00 14.85 14.81 1.11 14.85 1.11 0 1 0

















































351 curved 41 30 3 3 1 3.92E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
352 curved 41 30 3 1 2 1.37E+09 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
353 curved 41 30 3 2 2 1.47E+09 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
354 curved 41 30 3 3 2 2.49E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
355 curved 41 30 3 1 3 1.31E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
356 curved 41 30 3 1 3 1.31E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
357 curved 41 30 3 2 3 8.52E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
358 curved 41 30 3 3 3 1.55E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
359 curved 41 40 1 1 1 5.15E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
360 curved 41 40 1 2 1 1.11E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
361 curved 41 40 1 2 1 1.11E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
362 curved 41 40 1 3 1 3.15E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
363 curved 41 40 1 1 2 4.68E+08 13.54 0.00 30.09 16.03 0.00 30.55 2.53 1 0 -1
364 curved 41 40 1 2 2 9.01E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
365 curved 41 40 1 3 2 2.11E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
366 curved 41 40 1 1 3 4.08E+08 11.13 0.00 45.15 13.83 0.00 44.39 2.81 0 0 0
367 curved 41 40 1 1 3 4.08E+08 11.13 0.00 45.15 13.83 0.00 44.39 0.00 0 0 0
368 curved 41 40 1 2 3 6.54E+08 20.32 0.00 45.14 23.70 0.00 45.16 3.39 1 0 -1
369 curved 41 40 1 3 3 1.22E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
370 curved 41 40 1 3 3 1.22E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
371 curved 41 40 2 1 1 1.16E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
372 curved 41 40 2 1 1 1.16E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
373 curved 41 40 2 2 1 1.72E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
374 curved 41 40 2 3 1 3.99E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
375 curved 41 40 2 1 2 1.17E+09 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
376 curved 41 40 2 1 2 1.17E+09 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
377 curved 41 40 2 2 2 1.34E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
378 curved 41 40 2 3 2 2.09E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
379 curved 41 40 2 1 3 1.21E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
380 curved 41 40 2 1 3 1.21E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
381 curved 41 40 2 2 3 1.22E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
382 curved 41 40 2 3 3 2.22E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
383 curved 41 40 3 1 1 1.91E+09 14.85 0.00 14.85 14.81 1.11 14.85 1.11 0 1 0
384 curved 41 40 3 2 1 2.74E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
385 curved 41 40 3 3 1 5.17E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
386 curved 41 40 3 1 2 1.80E+09 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 -1 0
387 curved 41 40 3 1 2 1.80E+09 13.54 0.00 30.09 12.93 0.00 28.72 0.00 -1 -1 0
388 curved 41 40 3 2 2 2.02E+09 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
389 curved 41 40 3 3 2 2.81E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
390 curved 41 40 3 1 3 1.75E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
391 curved 41 40 3 1 3 1.75E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
392 curved 41 40 3 2 3 1.13E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
393 curved 41 40 3 3 3 2.27E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
394 curved 51 20 1 1 1 2.80E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
395 curved 51 20 1 2 1 6.09E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
396 curved 51 20 1 3 1 1.63E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
397 curved 51 20 1 3 1 1.63E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
398 curved 51 20 1 1 2 2.59E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
399 curved 51 20 1 2 2 5.04E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0

















































401 curved 51 20 1 1 3 2.30E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
402 curved 51 20 1 1 3 2.30E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
403 curved 51 20 1 2 3 3.70E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
404 curved 51 20 1 3 3 6.67E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
405 curved 51 20 1 3 3 6.67E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
406 curved 51 20 2 1 1 5.60E+08 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
407 curved 51 20 2 1 1 5.60E+08 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
408 curved 51 20 2 2 1 8.50E+08 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
409 curved 51 20 2 3 1 2.25E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
410 curved 51 20 2 1 2 5.87E+08 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 0 0
411 curved 51 20 2 2 2 1.00E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
412 curved 51 20 2 3 2 1.27E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
413 curved 51 20 2 1 3 6.55E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
414 curved 51 20 2 1 3 6.55E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
415 curved 51 20 2 2 3 6.23E+08 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
416 curved 51 20 2 2 3 6.23E+08 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
417 curved 51 20 2 3 3 1.28E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
418 curved 51 20 3 1 1 9.62E+08 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 0
419 curved 51 20 3 1 1 9.62E+08 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
420 curved 51 20 3 2 1 1.33E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
421 curved 51 20 3 3 1 2.66E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
422 curved 51 20 3 1 2 8.24E+08 13.54 0.00 30.09 14.12 -1.06 31.46 1.82 1 1 0
423 curved 51 20 3 2 2 1.69E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
424 curved 51 20 3 3 2 1.20E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
425 curved 51 20 3 1 3 1.19E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
426 curved 51 20 3 2 3 1.19E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 -1 0
427 curved 51 20 3 2 3 1.19E+09 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
428 curved 51 20 3 3 3 1.26E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
429 curved 51 30 1 1 1 4.19E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 1 0
430 curved 51 30 1 1 1 4.19E+08 14.85 0.00 14.85 16.84 0.00 14.92 0.00 1 1 0
431 curved 51 30 1 2 1 9.18E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
432 curved 51 30 1 2 1 9.18E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
433 curved 51 30 1 3 1 2.44E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
434 curved 51 30 1 1 2 3.89E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
435 curved 51 30 1 1 2 3.89E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
436 curved 51 30 1 2 2 7.56E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
437 curved 51 30 1 3 2 1.67E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
438 curved 51 30 1 1 3 3.45E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
439 curved 51 30 1 1 3 3.45E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
440 curved 51 30 1 2 3 5.56E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
441 curved 51 30 1 3 3 9.96E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
442 curved 51 30 2 1 1 8.59E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
443 curved 51 30 2 1 1 8.59E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
444 curved 51 30 2 2 1 1.33E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
445 curved 51 30 2 3 1 3.50E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
446 curved 51 30 2 1 2 8.78E+08 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 -1 0
447 curved 51 30 2 1 2 8.78E+08 13.54 0.00 30.09 12.93 0.00 28.72 0.00 -1 -1 0
448 curved 51 30 2 2 2 1.45E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
449 curved 51 30 2 2 2 1.45E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0

















































451 curved 51 30 2 1 3 9.71E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
452 curved 51 30 2 1 3 9.71E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
453 curved 51 30 2 2 3 9.12E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
454 curved 51 30 2 3 3 1.95E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
455 curved 51 30 3 1 1 1.42E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 -1
456 curved 51 30 3 2 1 2.06E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
457 curved 51 30 3 3 1 4.19E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
458 curved 51 30 3 1 2 1.25E+09 13.54 0.00 30.09 14.12 -1.06 31.46 1.82 1 1 0
459 curved 51 30 3 2 2 2.48E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
460 curved 51 30 3 2 2 2.48E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
461 curved 51 30 3 3 2 1.67E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
462 curved 51 30 3 1 3 1.77E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
463 curved 51 30 3 1 3 1.77E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
464 curved 51 30 3 2 3 1.76E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
465 curved 51 30 3 3 3 1.88E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
466 curved 51 40 1 1 1 5.61E+08 14.85 0.00 14.85 16.84 0.00 14.92 1.99 1 0 -1
467 curved 51 40 1 2 1 1.23E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
468 curved 51 40 1 3 1 3.26E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
469 curved 51 40 1 1 2 5.20E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
470 curved 51 40 1 1 2 5.20E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
471 curved 51 40 1 2 2 1.01E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
472 curved 51 40 1 3 2 2.24E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
473 curved 51 40 1 3 2 2.24E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
474 curved 51 40 1 1 3 4.60E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
475 curved 51 40 1 2 3 7.42E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
476 curved 51 40 1 3 3 1.34E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
477 curved 51 40 2 1 1 1.17E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
478 curved 51 40 2 2 1 1.81E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
479 curved 51 40 2 3 1 4.75E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
480 curved 51 40 2 1 2 1.18E+09 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 -1 0
481 curved 51 40 2 1 2 1.18E+09 13.54 0.00 30.09 12.93 0.00 28.72 0.00 -1 -1 0
482 curved 51 40 2 2 2 1.90E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
483 curved 51 40 2 3 2 2.49E+09 38.97 0.00 30.53 40.15 0.00 31.45 1.50 1 0 0
484 curved 51 40 2 1 3 1.29E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
485 curved 51 40 2 2 3 1.20E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 -1 0
486 curved 51 40 2 2 3 1.20E+09 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
487 curved 51 40 2 3 3 2.48E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
488 curved 51 40 3 1 1 1.87E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 0
489 curved 51 40 3 1 1 1.87E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
490 curved 51 40 3 2 1 2.78E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
491 curved 51 40 3 3 1 5.72E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
492 curved 51 40 3 1 2 1.62E+09 13.54 0.00 30.09 14.12 -1.06 31.46 1.82 1 1 0
493 curved 51 40 3 2 2 3.25E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
494 curved 51 40 3 3 2 2.70E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
495 curved 51 40 3 1 3 2.35E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
496 curved 51 40 3 1 3 2.35E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
497 curved 51 40 3 2 3 2.32E+09 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
498 curved 51 40 3 2 3 2.32E+09 20.32 0.00 45.14 19.70 0.00 43.77 0.00 -1 -1 0
499 curved 51 40 3 3 3 2.49E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0

















































501 curved 61 20 1 2 1 6.44E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
502 curved 61 20 1 3 1 1.62E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
503 curved 61 20 1 1 2 2.85E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
504 curved 61 20 1 1 2 2.85E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
505 curved 61 20 1 2 2 5.38E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
506 curved 61 20 1 3 2 1.14E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
507 curved 61 20 1 1 3 2.53E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
508 curved 61 20 1 1 3 2.53E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
509 curved 61 20 1 2 3 4.00E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
510 curved 61 20 1 3 3 7.01E+08 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
511 curved 61 20 2 1 1 6.86E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
512 curved 61 20 2 2 1 7.42E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
513 curved 61 20 2 3 1 1.64E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
514 curved 61 20 2 1 2 6.31E+08 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 0 0
515 curved 61 20 2 2 2 9.23E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
516 curved 61 20 2 3 2 1.05E+09 38.97 0.00 30.53 37.78 0.00 29.60 1.50 -1 0 0
517 curved 61 20 2 1 3 6.63E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
518 curved 61 20 2 1 3 6.63E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
519 curved 61 20 2 2 3 6.66E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
520 curved 61 20 2 3 3 1.34E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
521 curved 61 20 3 1 1 1.09E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 0
522 curved 61 20 3 1 1 1.09E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
523 curved 61 20 3 2 1 8.94E+08 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
524 curved 61 20 3 3 1 2.09E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
525 curved 61 20 3 1 2 1.15E+09 13.54 0.00 30.09 13.51 -1.01 30.09 1.01 0 1 0
526 curved 61 20 3 2 2 5.19E+08 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
527 curved 61 20 3 3 2 1.44E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
528 curved 61 20 3 1 3 9.66E+08 11.13 0.00 45.15 11.46 -0.86 46.61 1.72 1 1 0
529 curved 61 20 3 2 3 8.52E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
530 curved 61 20 3 3 3 1.21E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
531 curved 61 30 1 1 1 4.55E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
532 curved 61 30 1 2 1 9.69E+08 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
533 curved 61 30 1 3 1 2.43E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
534 curved 61 30 1 1 2 4.27E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
535 curved 61 30 1 1 2 4.27E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
536 curved 61 30 1 2 2 8.06E+08 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
537 curved 61 30 1 3 2 1.71E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
538 curved 61 30 1 1 3 3.81E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
539 curved 61 30 1 1 3 3.81E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
540 curved 61 30 1 2 3 6.01E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
541 curved 61 30 1 3 3 1.05E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
542 curved 61 30 1 3 3 1.05E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
543 curved 61 30 2 1 1 1.06E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
544 curved 61 30 2 2 1 1.02E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
545 curved 61 30 2 3 1 2.44E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
546 curved 61 30 2 1 2 9.50E+08 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 0 0
547 curved 61 30 2 2 2 1.32E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
548 curved 61 30 2 3 2 1.65E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
549 curved 61 30 2 1 3 9.78E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0


















































551 curved 61 30 2 2 3 9.76E+08 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
552 curved 61 30 2 3 3 1.80E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
553 curved 61 30 3 1 1 1.60E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 0
554 curved 61 30 3 1 1 1.60E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
555 curved 61 30 3 2 1 1.42E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
556 curved 61 30 3 3 1 3.11E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
557 curved 61 30 3 1 2 1.70E+09 13.54 0.00 30.09 13.51 -1.01 30.09 1.01 0 1 0
558 curved 61 30 3 2 2 8.20E+08 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
559 curved 61 30 3 3 2 2.37E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
560 curved 61 30 3 1 3 1.45E+09 11.13 0.00 45.15 11.46 -0.86 46.61 1.72 1 1 0
561 curved 61 30 3 2 3 1.24E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
562 curved 61 30 3 3 3 2.00E+09 30.68 0.00 44.44 31.53 0.00 45.68 1.50 1 0 0
563 curved 61 40 1 1 1 6.09E+08 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
564 curved 61 40 1 2 1 1.29E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
565 curved 61 40 1 2 1 1.29E+09 29.22 0.00 15.34 29.22 0.00 15.34 0.00 0 0 0
566 curved 61 40 1 3 1 3.26E+09 44.39 0.00 13.83 44.39 0.00 13.83 0.00 0 0 0
567 curved 61 40 1 1 2 5.71E+08 13.54 0.00 30.09 13.54 0.00 30.09 0.00 0 0 0
568 curved 61 40 1 2 2 1.07E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
569 curved 61 40 1 3 2 2.29E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
570 curved 61 40 1 3 2 2.29E+09 38.97 0.00 30.53 38.97 0.00 30.53 0.00 0 0 0
571 curved 61 40 1 1 3 5.08E+08 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
572 curved 61 40 1 2 3 8.03E+08 20.32 0.00 45.14 20.32 0.00 45.14 0.00 0 0 0
573 curved 61 40 1 3 3 1.41E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
574 curved 61 40 2 1 1 1.43E+09 14.85 0.00 14.85 14.85 0.00 14.85 0.00 0 0 0
575 curved 61 40 2 2 1 1.31E+09 29.22 0.00 15.34 28.24 0.00 17.07 1.99 0 0 1
576 curved 61 40 2 3 1 3.24E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
577 curved 61 40 2 1 2 1.25E+09 13.54 0.00 30.09 12.93 0.00 28.72 1.50 -1 -1 0
578 curved 61 40 2 1 2 1.25E+09 13.54 0.00 30.09 12.93 0.00 28.72 0.00 -1 -1 0
579 curved 61 40 2 2 2 1.71E+09 25.86 0.00 29.19 25.86 0.00 29.19 0.00 0 0 0
580 curved 61 40 2 3 2 2.21E+09 38.97 0.00 30.53 37.78 0.00 29.60 1.50 -1 0 0
581 curved 61 40 2 1 3 1.29E+09 11.13 0.00 45.15 11.13 0.00 45.15 0.00 0 0 0
582 curved 61 40 2 2 3 1.29E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0
583 curved 61 40 2 3 3 2.76E+09 30.68 0.00 44.44 30.68 0.00 44.44 0.00 0 0 0
584 curved 61 40 3 1 1 2.12E+09 14.85 0.00 14.85 15.72 0.00 13.93 1.27 0 0 0
585 curved 61 40 3 1 1 2.12E+09 14.85 0.00 14.85 15.72 0.00 13.93 0.00 0 0 0
586 curved 61 40 3 2 1 1.94E+09 29.22 0.00 15.34 30.55 0.00 16.03 1.50 1 0 0
587 curved 61 40 3 3 1 4.11E+09 44.39 0.00 13.83 45.83 0.00 14.28 1.50 1 0 0
588 curved 61 40 3 1 2 2.32E+09 13.54 0.00 30.09 13.51 -1.01 30.09 1.01 0 1 0
589 curved 61 40 3 2 2 1.12E+09 25.86 0.00 29.19 26.86 0.00 30.31 1.50 1 0 0
590 curved 61 40 3 3 2 2.70E+09 38.97 0.00 30.53 37.78 0.00 29.60 1.50 -1 0 0
591 curved 61 40 3 1 3 1.93E+09 11.13 0.00 45.15 11.46 -0.86 46.61 1.72 1 1 0
592 curved 61 40 3 2 3 1.62E+09 20.32 0.00 45.14 19.70 0.00 43.77 1.50 -1 0 0




Appendix D: Breast Necrosis Simulations Results 
 Results from the simulations of the US propagation and resulting tissue 
necrosis produced from HIFU for breast cancer are displayed in Table 55 – Table 64. 




# of ele/ 
row





1 flat 41 50 20 1 1 1.38E-06 2.64
2 flat 41 50 20 2 1 2.36E-07 0.87
3 flat 41 50 20 3 1 7.13E-08 0.25
4 flat 41 50 20 1 2 2.01E-06 2.99
5 flat 41 50 20 2 2 2.99E-07 1.10
6 flat 41 50 20 3 2 9.59E-08 0.39
7 flat 41 50 20 1 3 3.00E-06 3.69
8 flat 41 50 20 2 3 6.81E-07 1.69
9 flat 41 50 20 3 3 1.92E-07 0.76
10 flat 41 75 20 1 1 1.11E-06 1.62
11 flat 41 75 20 2 1 2.28E-07 0.56
12 flat 41 75 20 3 1 7.13E-08 0.17
13 flat 41 75 20 1 2 1.59E-06 1.81
14 flat 41 75 20 2 2 2.89E-07 0.71
15 flat 41 75 20 3 2 9.59E-08 0.26
16 flat 41 75 20 1 3 2.57E-06 2.20
17 flat 41 75 20 2 3 5.91E-07 1.06
18 flat 41 75 20 3 3 1.19E-07 0.49
19 flat 41 100 20 1 1 1.05E-06 1.16
20 flat 41 100 20 2 1 2.28E-07 0.41
21 flat 41 100 20 3 1 7.13E-08 0.13
22 flat 41 100 20 1 2 1.34E-06 1.30
23 flat 41 100 20 2 2 2.82E-07 0.52
24 flat 41 100 20 3 2 9.59E-08 0.19
25 flat 41 100 20 1 3 2.28E-06 1.56
26 flat 41 100 20 2 3 5.91E-07 0.77
27 flat 41 100 20 3 3 1.19E-07 0.37
28 flat 41 50 30 1 1 1.16E-06 1.62
29 flat 41 50 30 2 1 2.27E-07 0.56
30 flat 41 50 30 3 1 7.13E-08 0.17
31 flat 41 50 30 1 2 1.52E-06 1.82
32 flat 41 50 30 2 2 2.89E-07 0.71
33 flat 41 50 30 3 2 9.59E-08 0.26
34 flat 41 50 30 1 3 2.44E-06 2.20
35 flat 41 50 30 2 3 5.92E-07 1.05
36 flat 41 50 30 3 3 1.52E-07 0.50
37 flat 41 75 30 1 1 1.03E-06 1.02
38 flat 41 75 30 2 1 2.19E-07 0.36
39 flat 41 75 30 3 1 7.13E-08 0.11
40 flat 41 75 30 1 2 1.26E-06 1.13
41 flat 41 75 30 2 2 2.82E-07 0.46
42 flat 41 75 30 3 2 9.59E-08 0.17
43 flat 41 75 30 1 3 2.06E-06 1.36
44 flat 41 75 30 2 3 5.36E-07 0.67
45 flat 41 75 30 3 3 1.19E-07 0.33
46 flat 41 100 30 1 1 9.55E-07 0.74
47 flat 41 100 30 2 1 1.99E-07 0.27
48 flat 41 100 30 3 1 7.13E-08 0.09
49 flat 41 100 30 1 2 1.19E-06 0.82








# of ele/ 
row





51 flat 41 100 30 3 2 9.59E-08 0.13
52 flat 41 100 30 1 3 1.92E-06 0.98
53 flat 41 100 30 2 3 4.81E-07 0.49
54 flat 41 100 30 3 3 1.19E-07 0.24
55 flat 41 50 40 1 1 1.01E-06 1.15
56 flat 41 50 40 2 1 2.08E-07 0.41
57 flat 41 50 40 3 1 7.13E-08 0.13
58 flat 41 50 40 1 2 1.39E-06 1.31
59 flat 41 50 40 2 2 2.82E-07 0.52
60 flat 41 50 40 3 2 9.59E-08 0.19
61 flat 41 50 40 1 3 2.14E-06 1.56
62 flat 41 50 40 2 3 5.05E-07 0.76
63 flat 41 50 40 3 3 1.19E-07 0.36
64 flat 41 75 40 1 1 9.40E-07 0.73
65 flat 41 75 40 2 1 1.72E-07 0.27
66 flat 41 75 40 3 1 7.13E-08 0.09
67 flat 41 75 40 1 2 1.25E-06 0.83
68 flat 41 75 40 2 2 2.82E-07 0.34
69 flat 41 75 40 3 2 9.59E-08 0.13
70 flat 41 75 40 1 3 1.90E-06 0.98
71 flat 41 75 40 2 3 4.81E-07 0.49
72 flat 41 75 40 3 3 1.19E-07 0.24
73 flat 41 100 40 1 1 8.51E-07 0.53
74 flat 41 100 40 2 1 1.72E-07 0.20
75 flat 41 100 40 3 1 7.13E-08 0.06
76 flat 41 100 40 1 2 1.17E-06 0.60
77 flat 41 100 40 2 2 2.63E-07 0.25
78 flat 41 100 40 3 2 9.59E-08 0.10
79 flat 41 100 40 1 3 1.78E-06 0.71
80 flat 41 100 40 2 3 4.35E-07 0.36
81 flat 41 100 40 3 3 1.10E-07 0.18
82 flat 51 50 20 1 1 1.29E-06 2.63
83 flat 51 50 20 2 1 1.52E-07 0.79
84 flat 51 50 20 3 1 4.27E-08 0.24
85 flat 51 50 20 1 2 1.91E-06 3.11
86 flat 51 50 20 2 2 2.39E-07 1.04
87 flat 51 50 20 3 2 6.84E-08 0.37
88 flat 51 50 20 1 3 3.22E-06 3.94
89 flat 51 50 20 2 3 7.01E-07 1.74
90 flat 51 50 20 3 3 1.91E-07 0.70
91 flat 51 75 20 1 1 1.10E-06 1.58
92 flat 51 75 20 2 1 1.52E-07 0.51
93 flat 51 75 20 3 1 4.27E-08 0.16
94 flat 51 75 20 1 2 1.48E-06 1.84
95 flat 51 75 20 2 2 2.33E-07 0.67
96 flat 51 75 20 3 2 6.84E-08 0.24
97 flat 51 75 20 1 3 2.59E-06 2.26
98 flat 51 75 20 2 3 6.39E-07 1.08
99 flat 51 75 20 3 3 1.64E-07 0.45








# of ele/ 
row





100 flat 51 100 20 1 1 9.44E-07 1.12
101 flat 51 100 20 2 1 1.52E-07 0.38
102 flat 51 100 20 3 1 4.27E-08 0.12
103 flat 51 100 20 1 2 1.28E-06 1.30
104 flat 51 100 20 2 2 2.33E-07 0.49
105 flat 51 100 20 3 2 6.84E-08 0.18
106 flat 51 100 20 1 3 2.42E-06 1.58
107 flat 51 100 20 2 3 5.40E-07 0.78
108 flat 51 100 20 3 3 1.21E-07 0.34
109 flat 51 50 30 1 1 1.11E-06 1.58
110 flat 51 50 30 2 1 1.46E-07 0.51
111 flat 51 50 30 3 1 4.27E-08 0.16
112 flat 51 50 30 1 2 1.44E-06 1.84
113 flat 51 50 30 2 2 2.33E-07 0.67
114 flat 51 50 30 3 2 6.84E-08 0.24
115 flat 51 50 30 1 3 2.56E-06 2.27
116 flat 51 50 30 2 3 6.37E-07 1.07
117 flat 51 50 30 3 3 1.49E-07 0.46
118 flat 51 75 30 1 1 9.44E-07 0.98
119 flat 51 75 30 2 1 1.46E-07 0.33
120 flat 51 75 30 3 1 4.27E-08 0.11
121 flat 51 75 30 1 2 1.20E-06 1.13
122 flat 51 75 30 2 2 2.33E-07 0.43
123 flat 51 75 30 3 2 6.84E-08 0.16
124 flat 51 75 30 1 3 2.19E-06 1.38
125 flat 51 75 30 2 3 5.05E-07 0.68
126 flat 51 75 30 3 3 1.10E-07 0.30
127 flat 51 100 30 1 1 8.39E-07 0.71
128 flat 51 100 30 2 1 1.46E-07 0.24
129 flat 51 100 30 3 1 4.27E-08 0.08
130 flat 51 100 30 1 2 1.07E-06 0.81
131 flat 51 100 30 2 2 2.23E-07 0.31
132 flat 51 100 30 3 2 6.84E-08 0.12
133 flat 51 100 30 1 3 1.94E-06 0.98
134 flat 51 100 30 2 3 4.17E-07 0.49
135 flat 51 100 30 3 3 1.10E-07 0.22
136 flat 51 50 40 1 1 9.78E-07 1.12
137 flat 51 50 40 2 1 1.46E-07 0.37
138 flat 51 50 40 3 1 4.27E-08 0.12
139 flat 51 50 40 1 2 1.25E-06 1.28
140 flat 51 50 40 2 2 2.33E-07 0.49
141 flat 51 50 40 3 2 5.33E-08 0.18
142 flat 51 50 40 1 3 2.23E-06 1.59
143 flat 51 50 40 2 3 5.15E-07 0.77
144 flat 51 50 40 3 3 1.64E-07 0.33
145 flat 51 75 40 1 1 8.17E-07 0.70
146 flat 51 75 40 2 1 1.41E-07 0.24
147 flat 51 75 40 3 1 4.27E-08 0.08
148 flat 51 75 40 1 2 1.08E-06 0.80
149 flat 51 75 40 2 2 2.23E-07 0.31








# of ele/ 
row





151 flat 51 75 40 1 3 1.97E-06 0.99
152 flat 51 75 40 2 3 4.54E-07 0.49
153 flat 51 75 40 3 3 1.21E-07 0.22
154 flat 51 100 40 1 1 7.62E-07 0.51
155 flat 51 100 40 2 1 1.25E-07 0.18
156 flat 51 100 40 3 1 4.27E-08 0.06
157 flat 51 100 40 1 2 1.01E-06 0.58
158 flat 51 100 40 2 2 1.96E-07 0.23
159 flat 51 100 40 3 2 5.33E-08 0.09
160 flat 51 100 40 1 3 1.79E-06 0.71
161 flat 51 100 40 2 3 3.59E-07 0.35
162 flat 51 100 40 3 3 1.10E-07 0.16
163 flat 61 50 20 1 1 1.33E-06 2.67
164 flat 61 50 20 2 1 1.36E-07 0.76
165 flat 61 50 20 3 1 4.27E-08 0.24
166 flat 61 50 20 1 2 1.92E-06 3.23
167 flat 61 50 20 2 2 2.34E-07 1.00
168 flat 61 50 20 3 2 4.10E-08 0.36
169 flat 61 50 20 1 3 3.26E-06 4.14
170 flat 61 50 20 2 3 6.16E-07 1.66
171 flat 61 50 20 3 3 1.62E-07 0.67
172 flat 61 75 20 1 1 1.03E-06 1.58
173 flat 61 75 20 2 1 1.36E-07 0.49
174 flat 61 75 20 3 1 4.27E-08 0.16
175 flat 61 75 20 1 2 1.42E-06 1.87
176 flat 61 75 20 2 2 2.23E-07 0.64
177 flat 61 75 20 3 2 4.10E-08 0.24
178 flat 61 75 20 1 3 2.64E-06 2.33
179 flat 61 75 20 2 3 5.24E-07 1.02
180 flat 61 75 20 3 3 1.34E-07 0.44
181 flat 61 100 20 1 1 9.23E-07 1.11
182 flat 61 100 20 2 1 1.22E-07 0.36
183 flat 61 100 20 3 1 4.27E-08 0.12
184 flat 61 100 20 1 2 1.31E-06 1.31
185 flat 61 100 20 2 2 2.04E-07 0.46
186 flat 61 100 20 3 2 4.10E-08 0.18
187 flat 61 100 20 1 3 2.29E-06 1.62
188 flat 61 100 20 2 3 4.06E-07 0.73
189 flat 61 100 20 3 3 1.34E-07 0.32
190 flat 61 50 30 1 1 1.09E-06 1.58
191 flat 61 50 30 2 1 1.36E-07 0.49
192 flat 61 50 30 3 1 4.27E-08 0.16
193 flat 61 50 30 1 2 1.41E-06 1.87
194 flat 61 50 30 2 2 2.23E-07 0.64
195 flat 61 50 30 3 2 4.10E-08 0.24
196 flat 61 50 30 1 3 2.56E-06 2.34
197 flat 61 50 30 2 3 5.26E-07 1.02
198 flat 61 50 30 3 3 1.34E-07 0.44
199 flat 61 75 30 1 1 9.55E-07 0.97








# of ele/ 
row





201 flat 61 75 30 3 1 4.27E-08 0.11
202 flat 61 75 30 1 2 1.25E-06 1.13
203 flat 61 75 30 2 2 2.04E-07 0.41
204 flat 61 75 30 3 2 4.10E-08 0.16
205 flat 61 75 30 1 3 2.11E-06 1.40
206 flat 61 75 30 2 3 3.56E-07 0.64
207 flat 61 75 30 3 3 1.34E-07 0.28
208 flat 61 100 30 1 1 8.02E-07 0.70
209 flat 61 100 30 2 1 1.22E-07 0.23
210 flat 61 100 30 3 1 4.27E-08 0.08
211 flat 61 100 30 1 2 1.04E-06 0.81
212 flat 61 100 30 2 2 1.63E-07 0.30
213 flat 61 100 30 3 2 4.10E-08 0.12
214 flat 61 100 30 1 3 1.93E-06 0.98
215 flat 61 100 30 2 3 3.33E-07 0.46
216 flat 61 100 30 3 3 1.21E-07 0.21
217 flat 61 50 40 1 1 8.33E-07 1.11
218 flat 61 50 40 2 1 1.27E-07 0.36
219 flat 61 50 40 3 1 4.27E-08 0.12
220 flat 61 50 40 1 2 1.26E-06 1.30
221 flat 61 50 40 2 2 2.04E-07 0.46
222 flat 61 50 40 3 2 4.10E-08 0.18
223 flat 61 50 40 1 3 2.21E-06 1.62
224 flat 61 50 40 2 3 3.85E-07 0.73
225 flat 61 50 40 3 3 1.34E-07 0.32
226 flat 61 75 40 1 1 7.56E-07 0.69
227 flat 61 75 40 2 1 1.22E-07 0.23
228 flat 61 75 40 3 1 4.27E-08 0.08
229 flat 61 75 40 1 2 1.03E-06 0.80
230 flat 61 75 40 2 2 1.63E-07 0.30
231 flat 61 75 40 3 2 4.10E-08 0.12
232 flat 61 75 40 1 3 1.79E-06 0.98
233 flat 61 75 40 2 3 3.56E-07 0.46
234 flat 61 75 40 3 3 1.34E-07 0.21
235 flat 61 100 40 1 1 6.54E-07 0.50
236 flat 61 100 40 2 1 1.22E-07 0.17
237 flat 61 100 40 3 1 4.27E-08 0.06
238 flat 61 100 40 1 2 9.31E-07 0.57
239 flat 61 100 40 2 2 1.63E-07 0.22
240 flat 61 100 40 3 2 4.10E-08 0.09
241 flat 61 100 40 1 3 1.54E-06 0.70
242 flat 61 100 40 2 3 2.89E-07 0.33
243 flat 61 100 40 3 3 1.21E-07 0.15
244 curved 41 50 20 1 1 1.42E-06 2.79
245 curved 41 50 20 2 1 2.14E-07 0.87
246 curved 41 50 20 3 1 7.13E-08 0.25
247 curved 41 50 20 1 2 2.07E-06 3.18
248 curved 41 50 20 2 2 2.89E-07 1.15
249 curved 41 50 20 3 2 9.59E-08 0.39








# of ele/ 
row





251 curved 41 50 20 2 3 6.83E-07 1.77
252 curved 41 50 20 3 3 1.21E-07 0.77
253 curved 41 75 20 1 1 1.11E-06 1.70
254 curved 41 75 20 2 1 1.95E-07 0.57
255 curved 41 75 20 3 1 7.13E-08 0.17
256 curved 41 75 20 1 2 1.62E-06 1.92
257 curved 41 75 20 2 2 2.89E-07 0.74
258 curved 41 75 20 3 2 9.59E-08 0.26
259 curved 41 75 20 1 3 2.61E-06 2.40
260 curved 41 75 20 2 3 5.78E-07 1.11
261 curved 41 75 20 3 3 1.10E-07 0.50
262 curved 41 100 20 1 1 9.88E-07 1.22
263 curved 41 100 20 2 1 1.49E-07 0.42
264 curved 41 100 20 3 1 7.13E-08 0.13
265 curved 41 100 20 1 2 1.49E-06 1.37
266 curved 41 100 20 2 2 2.71E-07 0.54
267 curved 41 100 20 3 2 9.59E-08 0.19
268 curved 41 100 20 1 3 2.34E-06 1.70
269 curved 41 100 20 2 3 5.40E-07 0.81
270 curved 41 100 20 3 3 1.10E-07 0.37
271 curved 41 50 30 1 1 1.22E-06 1.70
272 curved 41 50 30 2 1 1.73E-07 0.56
273 curved 41 50 30 3 1 5.88E-08 0.17
274 curved 41 50 30 1 2 1.57E-06 1.92
275 curved 41 50 30 2 2 2.89E-07 0.74
276 curved 41 50 30 3 2 9.59E-08 0.26
277 curved 41 50 30 1 3 2.54E-06 2.39
278 curved 41 50 30 2 3 5.44E-07 1.10
279 curved 41 50 30 3 3 1.10E-07 0.50
280 curved 41 75 30 1 1 1.05E-06 1.06
281 curved 41 75 30 2 1 1.73E-07 0.37
282 curved 41 75 30 3 1 5.88E-08 0.12
283 curved 41 75 30 1 2 1.35E-06 1.19
284 curved 41 75 30 2 2 2.47E-07 0.48
285 curved 41 75 30 3 2 9.59E-08 0.17
286 curved 41 75 30 1 3 2.20E-06 1.48
287 curved 41 75 30 2 3 5.39E-07 0.70
288 curved 41 75 30 3 3 1.10E-07 0.33
289 curved 41 100 30 1 1 9.45E-07 0.77
290 curved 41 100 30 2 1 1.43E-07 0.27
291 curved 41 100 30 3 1 5.88E-08 0.09
292 curved 41 100 30 1 2 1.22E-06 0.86
293 curved 41 100 30 2 2 2.25E-07 0.35
294 curved 41 100 30 3 2 9.59E-08 0.13
295 curved 41 100 30 1 3 2.11E-06 1.06
296 curved 41 100 30 2 3 4.78E-07 0.51
297 curved 41 100 30 3 3 1.10E-07 0.24
298 curved 41 50 40 1 1 9.75E-07 1.21
299 curved 41 50 40 2 1 1.68E-07 0.41








# of ele/ 
row





301 curved 41 50 40 1 2 1.48E-06 1.38
302 curved 41 50 40 2 2 2.71E-07 0.54
303 curved 41 50 40 3 2 9.59E-08 0.19
304 curved 41 50 40 1 3 2.28E-06 1.69
305 curved 41 50 40 2 3 5.44E-07 0.80
306 curved 41 50 40 3 3 1.10E-07 0.37
307 curved 41 75 40 1 1 8.63E-07 0.77
308 curved 41 75 40 2 1 1.48E-07 0.27
309 curved 41 75 40 3 1 7.13E-08 0.09
310 curved 41 75 40 1 2 1.17E-06 0.87
311 curved 41 75 40 2 2 2.25E-07 0.35
312 curved 41 75 40 3 2 9.59E-08 0.13
313 curved 41 75 40 1 3 2.06E-06 1.06
314 curved 41 75 40 2 3 5.04E-07 0.51
315 curved 41 75 40 3 3 1.10E-07 0.24
316 curved 41 100 40 1 1 8.02E-07 0.56
317 curved 41 100 40 2 1 1.39E-07 0.20
318 curved 41 100 40 3 1 7.13E-08 0.07
319 curved 41 100 40 1 2 9.91E-07 0.63
320 curved 41 100 40 2 2 2.25E-07 0.26
321 curved 41 100 40 3 2 9.59E-08 0.10
322 curved 41 100 40 1 3 1.94E-06 0.77
323 curved 41 100 40 2 3 4.39E-07 0.38
324 curved 41 100 40 3 3 1.10E-07 0.18
325 curved 51 50 20 1 1 1.21E-06 2.78
326 curved 51 50 20 2 1 1.41E-07 0.81
327 curved 51 50 20 3 1 4.27E-08 0.25
328 curved 51 50 20 1 2 1.87E-06 3.34
329 curved 51 50 20 2 2 1.98E-07 1.06
330 curved 51 50 20 3 2 5.33E-08 0.37
331 curved 51 50 20 1 3 3.02E-06 4.27
332 curved 51 50 20 2 3 6.37E-07 1.78
333 curved 51 50 20 3 3 1.34E-07 0.71
334 curved 51 75 20 1 1 9.86E-07 1.66
335 curved 51 75 20 2 1 1.41E-07 0.52
336 curved 51 75 20 3 1 4.27E-08 0.17
337 curved 51 75 20 1 2 1.39E-06 1.95
338 curved 51 75 20 2 2 1.82E-07 0.68
339 curved 51 75 20 3 2 5.33E-08 0.25
340 curved 51 75 20 1 3 2.40E-06 2.42
341 curved 51 75 20 2 3 5.10E-07 1.09
342 curved 51 75 20 3 3 1.21E-07 0.46
343 curved 51 100 20 1 1 8.96E-07 1.17
344 curved 51 100 20 2 1 1.41E-07 0.38
345 curved 51 100 20 3 1 4.27E-08 0.13
346 curved 51 100 20 1 2 1.19E-06 1.38
347 curved 51 100 20 2 2 1.82E-07 0.49
348 curved 51 100 20 3 2 5.33E-08 0.19
349 curved 51 100 20 1 3 2.21E-06 1.68








# of ele/ 
row





351 curved 51 100 20 3 3 1.10E-07 0.34
352 curved 51 50 30 1 1 1.04E-06 1.66
353 curved 51 50 30 2 1 1.41E-07 0.52
354 curved 51 50 30 3 1 4.27E-08 0.17
355 curved 51 50 30 1 2 1.39E-06 1.96
356 curved 51 50 30 2 2 1.82E-07 0.68
357 curved 51 50 30 3 2 5.33E-08 0.25
358 curved 51 50 30 1 3 2.46E-06 2.43
359 curved 51 50 30 2 3 4.40E-07 1.09
360 curved 51 50 30 3 3 1.21E-07 0.47
361 curved 51 75 30 1 1 8.57E-07 1.02
362 curved 51 75 30 2 1 1.19E-07 0.34
363 curved 51 75 30 3 1 4.27E-08 0.11
364 curved 51 75 30 1 2 1.12E-06 1.20
365 curved 51 75 30 2 2 1.63E-07 0.44
366 curved 51 75 30 3 2 5.33E-08 0.17
367 curved 51 75 30 1 3 1.98E-06 1.46
368 curved 51 75 30 2 3 3.71E-07 0.69
369 curved 51 75 30 3 3 1.10E-07 0.30
370 curved 51 100 30 1 1 7.93E-07 0.73
371 curved 51 100 30 2 1 1.19E-07 0.25
372 curved 51 100 30 3 1 4.27E-08 0.09
373 curved 51 100 30 1 2 9.94E-07 0.86
374 curved 51 100 30 2 2 1.63E-07 0.32
375 curved 51 100 30 3 2 4.10E-08 0.12
376 curved 51 100 30 1 3 1.78E-06 1.04
377 curved 51 100 30 2 3 3.26E-07 0.50
378 curved 51 100 30 3 3 1.10E-07 0.22
379 curved 51 50 40 1 1 8.41E-07 1.17
380 curved 51 50 40 2 1 1.36E-07 0.38
381 curved 51 50 40 3 1 4.27E-08 0.13
382 curved 51 50 40 1 2 1.19E-06 1.36
383 curved 51 50 40 2 2 1.82E-07 0.50
384 curved 51 50 40 3 2 4.10E-08 0.18
385 curved 51 50 40 1 3 2.11E-06 1.69
386 curved 51 50 40 2 3 4.03E-07 0.78
387 curved 51 50 40 3 3 1.21E-07 0.34
388 curved 51 75 40 1 1 7.48E-07 0.73
389 curved 51 75 40 2 1 1.19E-07 0.25
390 curved 51 75 40 3 1 4.27E-08 0.08
391 curved 51 75 40 1 2 1.01E-06 0.85
392 curved 51 75 40 2 2 1.63E-07 0.32
393 curved 51 75 40 3 2 4.10E-08 0.12
394 curved 51 75 40 1 3 1.74E-06 1.04
395 curved 51 75 40 2 3 3.26E-07 0.50
396 curved 51 75 40 3 3 1.10E-07 0.22
397 curved 51 100 40 1 1 6.68E-07 0.53
398 curved 51 100 40 2 1 1.19E-07 0.18
399 curved 51 100 40 3 1 4.27E-08 0.06
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row





401 curved 51 100 40 2 2 1.63E-07 0.23
402 curved 51 100 40 3 2 4.10E-08 0.09
403 curved 51 100 40 1 3 1.56E-06 0.75
404 curved 51 100 40 2 3 2.85E-07 0.36
405 curved 51 100 40 3 3 1.10E-07 0.17
406 curved 61 50 20 1 1 1.13E-06 2.97
407 curved 61 50 20 2 1 1.15E-07 0.79
408 curved 61 50 20 3 1 4.27E-08 0.25
409 curved 61 50 20 1 2 1.60E-06 3.44
410 curved 61 50 20 2 2 1.91E-07 1.03
411 curved 61 50 20 3 2 4.10E-08 0.37
412 curved 61 50 20 1 3 3.34E-06 4.73
413 curved 61 50 20 2 3 4.72E-07 1.72
414 curved 61 50 20 3 3 1.31E-07 0.70
415 curved 61 75 20 1 1 8.40E-07 1.72
416 curved 61 75 20 2 1 9.86E-08 0.50
417 curved 61 75 20 3 1 4.27E-08 0.17
418 curved 61 75 20 1 2 1.15E-06 1.94
419 curved 61 75 20 2 2 1.40E-07 0.65
420 curved 61 75 20 3 2 4.10E-08 0.25
421 curved 61 75 20 1 3 2.21E-06 2.47
422 curved 61 75 20 2 3 3.76E-07 1.05
423 curved 61 75 20 3 3 1.10E-07 0.45
424 curved 61 100 20 1 1 7.15E-07 1.20
425 curved 61 100 20 2 1 8.78E-08 0.37
426 curved 61 100 20 3 1 4.27E-08 0.13
427 curved 61 100 20 1 2 9.71E-07 1.35
428 curved 61 100 20 2 2 1.40E-07 0.48
429 curved 61 100 20 3 2 4.10E-08 0.18
430 curved 61 100 20 1 3 1.78E-06 1.68
431 curved 61 100 20 2 3 3.14E-07 0.75
432 curved 61 100 20 3 3 1.10E-07 0.33
433 curved 61 50 30 1 1 8.83E-07 1.72
434 curved 61 50 30 2 1 9.86E-08 0.50
435 curved 61 50 30 3 1 4.27E-08 0.17
436 curved 61 50 30 1 2 1.15E-06 1.94
437 curved 61 50 30 2 2 1.40E-07 0.65
438 curved 61 50 30 3 2 4.10E-08 0.25
439 curved 61 50 30 1 3 2.10E-06 2.47
440 curved 61 50 30 2 3 3.56E-07 1.04
441 curved 61 50 30 3 3 1.10E-07 0.45
442 curved 61 75 30 1 1 7.36E-07 1.04
443 curved 61 75 30 2 1 8.78E-08 0.32
444 curved 61 75 30 3 1 4.27E-08 0.11
445 curved 61 75 30 1 2 9.03E-07 1.17
446 curved 61 75 30 2 2 1.30E-07 0.42
447 curved 61 75 30 3 2 4.10E-08 0.16
448 curved 61 75 30 1 3 1.56E-06 1.44
449 curved 61 75 30 2 3 2.72E-07 0.65
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451 curved 61 100 30 1 1 6.61E-07 0.74
452 curved 61 100 30 2 1 8.78E-08 0.24
453 curved 61 100 30 3 1 4.27E-08 0.08
454 curved 61 100 30 1 2 7.82E-07 0.83
455 curved 61 100 30 2 2 1.30E-07 0.30
456 curved 61 100 30 3 2 4.10E-08 0.12
457 curved 61 100 30 1 3 1.24E-06 1.01
458 curved 61 100 30 2 3 2.61E-07 0.47
459 curved 61 100 30 3 3 8.54E-08 0.22
460 curved 61 50 40 1 1 7.19E-07 1.20
461 curved 61 50 40 2 1 8.78E-08 0.37
462 curved 61 50 40 3 1 4.27E-08 0.13
463 curved 61 50 40 1 2 1.00E-06 1.34
464 curved 61 50 40 2 2 1.40E-07 0.48
465 curved 61 50 40 3 2 4.10E-08 0.18
466 curved 61 50 40 1 3 1.61E-06 1.67
467 curved 61 50 40 2 3 2.85E-07 0.75
468 curved 61 50 40 3 3 1.10E-07 0.33
469 curved 61 75 40 1 1 6.31E-07 0.74
470 curved 61 75 40 2 1 8.78E-08 0.24
471 curved 61 75 40 3 1 4.27E-08 0.08
472 curved 61 75 40 1 2 7.52E-07 0.82
473 curved 61 75 40 2 2 1.30E-07 0.30
474 curved 61 75 40 3 2 4.10E-08 0.12
475 curved 61 75 40 1 3 1.19E-06 1.01
476 curved 61 75 40 2 3 2.61E-07 0.47
477 curved 61 75 40 3 3 8.54E-08 0.21
478 curved 61 100 40 1 1 5.61E-07 0.53
479 curved 61 100 40 2 1 8.78E-08 0.18
480 curved 61 100 40 3 1 4.27E-08 0.06
481 curved 61 100 40 1 2 6.50E-07 0.59
482 curved 61 100 40 2 2 1.30E-07 0.22
483 curved 61 100 40 3 2 4.10E-08 0.09
484 curved 61 100 40 1 3 1.07E-06 0.71
485 curved 61 100 40 2 3 2.47E-07 0.34




Appendix E: Heating Time v. Power for Breast US Simulations 
 Graphs of the heating time versus the transducer power for different 
transducer parameters and focus locations are displayed in Figure 128 and Figure 
129.  
 
Figure 128 Heating time versus transducer power for flat transducers focused at (a) zn=1, (b) zn=2, (c) zn=3 for 





Figure 129 Heating time versus transducer power for curved transducers focused at (a) zn=1, (b) zn=2, (c) zn=3 






Appendix F: Heater Assembly Technical Drawings 
 Technical drawings of the heater assembly components not purchased are 
shown in Figure 130 – Figure 135. 
 
 





Figure 131 Technical drawing of aluminum top piece. 
 













Figure 134 Technical drawing of plastic slide holder. 
 





Appendix G: Cell Viabilities from Cell Experiments 
 The graphs of the temperatures measured by the thermocouples in the DAQ 
are shown in Table 65 – Table 104. 
MCF-7 Viability Data 
Table 65 Raw data from MCF-7 test at 49oC for 14min. 
 
Table 66 Raw data from MCF-7 test at 49oC for 16min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 69 4 94.52055 52 5 91.22807
2 156 13 92.30769 40 6 86.95652
3 76 4 95 151 11 93.20988
1 59 13 81.94444 120 10 92.30769
2 83 8 91.20879 65 17 79.26829
3 61 16 79.22078 88 5 94.62366
1 98 16 85.96491 88 11 88.88889
2 96 9 91.42857 48 17 73.84615
3 118 7 94.4 75 20 78.94737
1 110 9 92.43697 59 23 71.95122
2 100 19 84.03361 78 16 82.97872
3 105 6 94.59459 58 5 92.06349
1 112 14 88.88889 61 24 71.76471
2 138 13 91.39073 114 18 86.36364







Slide Picture # Live Dead % Viable Live Dead % Viable
1 41 5 89.13043 35 8 81.39535
2 38 8 82.6087 96 15 86.48649
3 29 5 85.29412 57 16 78.08219
1 37 8 82.22222 31 11 73.80952
2 33 9 78.57143 37 12 75.5102
3 21 4 84 55 15 78.57143
1 82 10 89.13043 52 8 86.66667
2 51 14 78.46154 40 22 64.51613
3 72 11 86.74699 19 61 23.75
1 63 7 90 38 13 74.5098
2 54 10 84.375 44 15 74.57627
3 53 8 86.88525 32 47 40.50633
1 100 12 89.28571 45 36 55.55556
2 67 4 94.3662 51 48 51.51515











Table 67 Raw data from MCF-7 test at 49oC for 18min. 
 
Table 68 Raw data from MCF-7 test at 49oC for 20min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 86 10 89.58333 90 12 88.23529
2 99 9 91.66667 120 12 90.90909
3 82 5 94.25287 61 14 81.33333
1 126 11 91.9708 143 25 85.11905
2 63 11 85.13514 98 13 88.28829
3 103 19 84.42623 83 7 92.22222
1 117 17 87.31343 73 19 79.34783
2 90 16 84.90566 60 20 75
3 86 11 88.65979 84 38 68.85246
1 83 10 89.24731 64 17 79.01235
2 113 10 91.86992 140 18 88.60759
3 77 11 87.5 38 59 39.17526
1 68 11 86.07595 57 40 58.76289
2 70 10 87.5 97 28 77.6







Slide Picture # Live Dead % Viable Live Dead % Viable
1 81 12 87.09677 95 19 83.33333
2 100 11 90.09009 106 11 90.59829
3 108 9 92.30769 128 9 93.43066
1 72 8 90 53 14 79.10448
2 96 10 90.56604 59 22 72.83951
3 53 14 79.10448 53 8 86.88525
1 80 10 88.88889 11 24 31.42857
2 66 3 95.65217 24 97 19.83471
3 109 11 90.83333 62 46 57.40741
1 92 15 85.98131 49 19 72.05882
2 80 21 79.20792 58 61 48.7395
3 120 17 87.59124 100 46 68.49315
1 81 16 83.50515 37 94 28.24427
2 123 22 84.82759 21 67 23.86364











Table 69 Raw data from MCF-7 test at 49oC for 22min. 
 
Table 70 Raw data from MCF-7 test at 53oC for 8min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 60 16 78.94737 63 18 77.77778
2 77 5 93.90244 47 5 90.38462
3 91 11 89.21569 82 14 85.41667
1 45 11 80.35714 37 7 84.09091
2 68 10 87.17949 77 12 86.51685
3 56 11 83.58209 52 13 80
1 45 8 84.90566 87 86 50.28902
2 183 25 87.98077 3 87 3.333333
3 115 24 82.73381 66 77 46.15385
1 15 14 51.72414 46 45 50.54945
2 27 9 75 0 23 0
3 54 14 79.41176 0 72 0
1 78 15 83.87097 102 36 73.91304
2 75 6 92.59259 29 77 27.35849







Slide Picture # Live Dead % Viable Live Dead % Viable
1 78 11 87.64045 56 17 76.71233
2 44 4 91.66667 111 12 90.2439
3 148 4 97.36842 51 10 83.60656
1 75 10 88.23529 50 16 75.75758
2 120 24 83.33333 33 19 63.46154
3 95 15 86.36364 86 22 79.62963
1 115 19 85.8209 41 70 36.93694
2 162 21 88.52459 36 67 34.95146
3 119 18 86.86131 44 83 34.64567
1 41 8 83.67347 73 77 48.66667
2 170 16 91.39785 39 72 35.13514
3 156 34 82.10526 50 57 46.72897
1 176 28 86.27451 65 64 50.3876
2 175 16 91.62304 56 66 45.90164










Table 71 Raw data from MCF-7 test at 53oC for 11min. 
 
Table 72 Raw data from MCF-7 test at 53oC for 14min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 131 16 89.11565 107 25 81.06061
2 77 14 84.61538 105 18 85.36585
3 143 18 88.81988 80 13 86.02151
1 113 9 92.62295 33 14 70.21277
2 125 4 96.89922 42 15 73.68421
3 48 20 70.58824 165 19 89.67391
1 118 29 80.27211 64 80 44.44444
2 112 17 86.82171 24 59 28.91566
3 130 12 91.5493 39 79 33.05085
1 145 19 88.41463 31 90 25.61983
2 134 25 84.27673 35 91 27.77778
3 112 18 86.15385 48 84 36.36364
1 117 18 86.66667 61 57 51.69492
2 119 13 90.15152 35 59 37.23404







Slide Picture # Live Dead % Viable Live Dead % Viable
1 45 6 88.23529 39 0 100
2 29 2 93.54839 28 7 80
3 53 2 96.36364 40 18 68.96552
1 43 1 97.72727 49 2 96.07843
2 35 0 100 61 2 96.8254
3 36 2 94.73684 38 1 97.4359
1 40 5 88.88889 52 21 71.23288
2 43 2 95.55556 42 14 75
3 40 2 95.2381 17 11 60.71429
1 35 3 92.10526 20 11 64.51613
2 56 5 91.80328 35 13 72.91667
3 60 1 98.36066 45 16 73.77049
1 41 7 85.41667 32 34 48.48485
2 55 2 96.49123 25 40 38.46154










Table 73 Raw data from MCF-7 test at 53oC for 16.5min. 
 
Table 74 Raw data from MCF-7 test at 53oC for 18min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 46 4 92 12 5 70.58824
2 45 5 90 46 7 86.79245
3 41 4 91.11111 48 5 90.56604
1 31 16 65.95745 39 0 100
2 41 3 93.18182 26 1 96.2963
3 31 3 91.17647 40 1 97.56098
1 35 5 87.5 31 32 49.20635
2 26 1 96.2963 49 30 62.02532
3 23 0 100 18 20 47.36842
1 14 2 87.5 0 19 0
2 19 9 67.85714 1 34 2.857143
3 35 0 100 0 22 0
1 32 1 96.9697 18 31 36.73469
2 54 3 94.73684 13 26 33.33333







Slide Picture # Live Dead % Viable Live Dead % Viable
1 21 2 91.30435 23 3 88.46154
2 35 0 100 22 1 95.65217
3 42 0 100 33 2 94.28571
1 28 0 100 32 1 96.9697
2 13 0 100 30 0 100
3 27 0 100 16 0 100
1 36 0 100 0 9 0
2 15 0 100 0 8 0
3 9 0 100 1 9 10
1 34 31 52.30769 5 27 15.625
2 31 7 81.57895 4 26 13.33333
3 31 8 79.48718 12 41 22.64151
1 23 1 95.83333 0 23 0
2 7 8 46.66667 2 46 4.166667










Table 75 Raw data from MCF-7 test at 55oC for 2min. 
 
Table 76 Raw data from MCF-7 test at 55oC for 4min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 105 15 87.5 139 24 85.27607
2 168 24 87.5 116 19 85.92593
3 126 14 90 108 16 87.09677
1 124 11 91.85185 108 13 89.2562
2 144 19 88.34356 131 9 93.57143
3 108 22 83.07692 63 20 75.90361
1 175 14 92.59259 98 16 85.96491
2 140 13 91.50327 140 39 78.21229
3 193 29 86.93694 79 33 70.53571
1 128 25 83.66013 52 35 59.77011
2 120 11 91.60305 49 24 67.12329
3 129 15 89.58333 85 50 62.96296
1 64 10 86.48649 10 24 29.41176
2 41 2 95.34884 17 11 60.71429







Slide Picture # Live Dead % Viable Live Dead % Viable
1 72 9 88.88889 35 1 97.22222
2 65 11 85.52632 62 2 96.875
3 59 6 90.76923 69 9 88.46154
1 141 5 96.57534 102 6 94.44444
2 121 6 95.27559 132 12 91.66667
3 101 2 98.05825 97 5 95.09804
1 58 6 90.625 98 53 64.90066
2 77 4 95.06173 62 21 74.6988
3 131 6 95.62044 66 21 75.86207
1 70 2 97.22222 58 39 59.79381
2 71 0 100 55 48 53.39806
3 112 2 98.24561 36 49 42.35294
1 88 7 92.63158 35 18 66.03774
2 77 8 90.58824 58 31 65.16854










Table 77 Raw data from MCF-7 test at 55oC for 5min. 
 
Table 78 Raw data from MCF-7 test at 55oC for 6min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 64 11 85.33333 85 5 94.44444
2 48 8 85.71429 39 23 62.90323
3 50 23 68.49315 20 15 57.14286
1 62 9 87.32394 87 4 95.6044
2 74 7 91.35802 94 6 94
3 70 14 83.33333 56 19 74.66667
1 71 6 92.20779 41 36 53.24675
2 83 11 88.29787 32 27 54.23729
3 71 12 85.54217 61 42 59.2233
1 38 11 77.55102 8 69 10.38961
2 97 15 86.60714 49 64 43.36283
3 48 8 85.71429 50 29 63.29114
1 91 5 94.79167 71 29 71
2 88 0 100 49 46 51.57895







Slide Picture # Live Dead % Viable Live Dead % Viable
1 106 9 92.17391 76 3 96.20253
2 72 6 92.30769 124 4 96.875
3 52 11 82.53968 68 8 89.47368
1 32 7 82.05128 70 3 95.89041
2 107 11 90.67797 116 3 97.47899
3 82 4 95.34884 90 19 82.56881
1 88 3 96.7033 19 85 18.26923
2 113 3 97.41379 23 85 21.2963
3 59 3 95.16129 19 81 19
1 63 6 91.30435 8 69 10.38961
2 82 7 92.13483 14 41 25.45455
3 41 10 80.39216 20 78 20.40816
1 67 3 95.71429 39 48 44.82759
2 66 3 95.65217 46 31 59.74026










Table 79 Raw data from MCF-7 test at 55oC for 7min. 
 
Table 80 Raw data from MCF-7 test at 57oC for 0.5min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 79 11 87.77778 117 35 76.97368
2 87 9 90.625 64 14 82.05128
3 174 25 87.43719 48 10 82.75862
1 126 9 93.33333 55 15 78.57143
2 107 16 86.99187 73 12 85.88235
3 5 16 23.80952 84 13 86.59794
1 123 16 88.48921 67 26 72.04301
2 102 11 90.26549 20 51 28.16901
3 82 10 89.13043 40 50 44.44444
1 107 12 89.91597 28 125 18.30065
2 132 12 91.66667 12 104 10.34483
3 87 14 86.13861 6 94 6
1 75 8 90.36145 1 45 2.173913
2 123 21 85.41667 7 77 8.333333







Slide Picture # Live Dead % Viable Live Dead % Viable
1 51 0 100 46 13 77.9661
2 129 5 96.26866 60 12 83.33333
3 69 5 93.24324 36 6 85.71429
1 201 21 90.54054 108 10 91.52542
2 158 24 86.81319 96 13 88.07339
3 145 7 95.39474 143 14 91.0828
1 97 6 94.17476 60 13 82.19178
2 116 18 86.56716 44 14 75.86207
3 85 6 93.40659 38 20 65.51724
1 60 13 82.19178 29 6 82.85714
2 99 10 90.82569 70 21 76.92308
3 107 12 89.91597 71 22 76.34409
1 77 11 87.5 98 29 77.16535
2 76 13 85.39326 65 22 74.71264










Table 81 Raw data from MCF-7 test at 57oC for 1min.  The rows with dashes have data that was lost before it 
was able to be counted. 
 
Table 82 Raw data from MCF-7 test at 57oC for 2min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 35 16 68.62745 96 17 84.95575
2 157 30 83.95722 69 11 86.25
3 116 13 89.92248 93 11 89.42308
1 19 5 79.16667 40 4 90.90909
2 75 8 90.36145 71 12 85.54217
3 43 7 86 44 14 75.86207
1 85 8 91.39785 73 30 70.87379
2 -- -- 170 62 73.27586
3 -- -- 37 16 69.81132
1 41 8 83.67347 115 35 76.66667
2 123 7 94.61538 77 30 71.96262
3 175 18 90.67358 68 34 66.66667
1 144 11 92.90323 108 36 75
2 161 14 92 80 25 76.19048







Slide Picture # Live Dead % Viable Live Dead % Viable
1 126 10 92.64706 137 16 89.54248
2 196 27 87.89238 110 18 85.9375
3 123 9 93.18182 97 18 84.34783
1 93 14 86.91589 36 4 90
2 50 7 87.7193 114 24 82.6087
3 137 17 88.96104 39 1 97.5
1 88 3 96.7033 57 43 57
2 79 2 97.53086 64 31 67.36842
3 99 8 92.52336 79 50 61.24031
1 86 9 90.52632 72 43 62.6087
2 112 12 90.32258 70 37 65.42056
3 101 15 87.06897 55 45 55
1 103 9 91.96429 41 46 47.12644
2 130 20 86.66667 47 24 66.19718










Table 83 Raw data from MCF-7 test at 57oC for 3min. 
 
Table 84 Raw data from MCF-7 test at 57oC for 5min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 83 6 93.25843 99 10 90.82569
2 129 5 96.26866 107 5 95.53571
3 93 7 93 157 17 90.22989
1 137 13 91.33333 41 12 77.35849
2 176 8 95.65217 118 8 93.65079
3 122 4 96.8254 45 7 86.53846
1 113 11 91.12903 43 30 58.90411
2 108 9 92.30769 74 40 64.91228
3 103 4 96.26168 101 68 59.76331
1 39 4 90.69767 28 27 50.90909
2 163 11 93.67816 42 94 30.88235
3 63 1 98.4375 16 28 36.36364
1 138 6 95.83333 58 70 45.3125
2 142 10 93.42105 73 82 47.09677







Slide Picture # Live Dead % Viable Live Dead % Viable
1 176 4 97.77778 77 12 86.51685
2 98 26 79.03226 107 6 94.69027
3 75 16 82.41758 40 3 93.02326
1 91 4 95.78947 32 4 88.88889
2 118 4 96.72131 32 8 80
3 73 3 96.05263 88 12 88
1 124 13 90.51095 35 79 30.70175
2 93 6 93.93939 21 117 15.21739
3 135 13 91.21622 11 50 18.03279
1 83 11 88.29787 59 123 32.41758
2 122 6 95.3125 63 90 41.17647
3 134 4 97.10145 45 78 36.58537
1 125 14 89.92806 57 102 35.84906
2 153 16 90.53254 20 92 17.85714











T-47D Viability Data 
Table 85 Raw data from T-47D test at 49oC for 20min. 
 
Table 86 Raw data from T-47D test at 49oC for 24min. 
 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 88 6 93.61702 113 14 88.97638
2 127 10 92.70073 104 9 92.0354
3 99 3 97.05882 95 6 94.05941
1 117 7 94.35484 128 5 96.2406
2 146 6 96.05263 118 8 93.65079
3 66 4 94.28571 142 8 94.66667
1 110 6 94.82759 145 7 95.39474
2 123 5 96.09375 102 5 95.3271
3 73 3 96.05263 110 9 92.43697
1 70 5 93.33333 95 7 93.13725
2 75 1 98.68421 52 5 91.22807
3 105 5 95.45455 98 6 94.23077
1 94 4 95.91837 84 35 70.58824
2 72 10 87.80488 101 19 84.16667







Slide Picture # Live Dead % Viable Live Dead % Viable
1 48 2 96 31 1 96.875
2 67 2 97.10145 111 10 91.73554
3 117 7 94.35484 54 3 94.73684
1 169 11 93.88889 62 5 92.53731
2 58 0 100 158 11 93.49112
3 41 1 97.61905 136 10 93.15068
1 98 23 80.99174 29 37 43.93939
2 79 5 94.04762 48 12 80
3 65 4 94.2029 45 6 88.23529
1 70 12 85.36585 96 7 93.20388
2 107 5 95.53571 76 15 83.51648
3 115 6 95.04132 36 15 70.58824
1 66 3 95.65217 98 11 89.90826
2 115 8 93.49593 16 18 47.05882










Table 87 Raw data from T-47D test at 49oC for 28min. 
 
Table 88 Raw data from T-47D test at 49oC for 32min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 129 15 89.58333 145 6 96.02649
2 161 11 93.60465 131 9 93.57143
3 200 15 93.02326 104 11 90.43478
1 114 11 91.2 123 7 94.61538
2 159 15 91.37931 154 20 88.50575
3 125 9 93.28358 219 14 93.99142
1 114 4 96.61017 84 20 80.76923
2 139 7 95.20548 96 96 50
3 122 11 91.72932 110 84 56.70103
1 148 11 93.08176 76 76 50
2 147 17 89.63415 101 59 63.125
3 165 5 97.05882 127 68 65.12821
1 54 5 91.52542 57 38 60
2 34 0 100 62 68 47.69231







Slide Picture # Live Dead % Viable Live Dead % Viable
1 87 11 88.77551 49 4 92.45283
2 83 5 94.31818 209 15 93.30357
3 83 6 93.25843 15 2 88.23529
1 129 10 92.80576 107 6 94.69027
2 153 6 96.22642 129 9 93.47826
3 147 27 84.48276 71 5 93.42105
1 114 7 94.21488 5 96 4.950495
2 85 13 86.73469 0 133 0
3 167 6 96.53179 73 25 74.4898
1 148 15 90.79755 120 67 64.17112
2 142 2 98.61111 113 47 70.625
3 120 18 86.95652 125 43 74.40476
1 132 7 94.96403 3 92 3.157895
2 132 8 94.28571 24 129 15.68627










Table 89 Raw data from T-47D test at 49oC for 34min. 
 
Table 90 Raw data from T-47D test at 52oC for 12min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 49 2 96.07843 238 8 96.74797
2 197 5 97.52475 242 12 95.27559
3 348 12 96.66667 301 7 97.72727
1 219 15 93.58974 301 7 97.72727
2 219 2 99.09502 315 32 90.7781
3 354 5 98.60724 250 22 91.91176
1 193 5 97.47475 46 83 35.65891
2 184 3 98.39572 4 93 4.123711
3 90 11 89.10891 230 60 79.31034
1 150 5 96.77419 21 9 70
2 112 4 96.55172 18 51 26.08696
3 184 7 96.33508 98 27 78.4
1 114 7 94.21488 94 89 51.36612
2 160 10 94.11765 135 25 84.375







Slide Picture # Live Dead % Viable Live Dead % Viable
1 522 8 98.49057 256 25 91.1032
2 377 8 97.92208 274 12 95.8042
3 126 5 96.18321 203 29 87.5
1 213 12 94.66667 196 19 91.16279
2 256 16 94.11765 234 11 95.5102
3 264 11 96 396 17 95.88378
1 250 12 95.41985 226 33 87.25869
2 335 23 93.57542 171 45 79.16667
3 400 24 94.33962 288 39 88.07339
1 332 10 97.07602 303 35 89.64497
2 304 18 94.40994 283 28 90.99678
3 385 29 92.99517 245 52 82.49158
1 377 8 97.92208 214 37 85.25896
2 316 10 96.93252 346 48 87.81726










Table 91 Raw data from T-47D test at 52oC for 14min. 
 
Table 92 Raw data from T-47D test at 52oC for 16min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 361 12 96.78284 211 10 95.47511
2 342 9 97.4359 179 14 92.74611
3 236 12 95.16129 219 7 96.90265
1 187 7 96.39175 181 7 96.2766
2 203 11 94.85981 213 15 93.42105
3 157 8 95.15152 191 28 87.21461
1 257 9 96.61654 168 17 90.81081
2 299 9 97.07792 237 44 84.34164
3 184 3 98.39572 314 24 92.89941
1 156 9 94.54545 196 31 86.34361
2 220 5 97.77778 178 26 87.2549
3 267 2 99.25651 187 31 85.77982
1 152 11 93.25153 155 25 86.11111
2 225 5 97.82609 230 37 86.14232







Slide Picture # Live Dead % Viable Live Dead % Viable
1 225 10 95.74468 189 16 92.19512
2 361 16 95.75597 218 17 92.76596
3 361 22 94.25587 255 20 92.72727
1 214 20 91.45299 285 9 96.93878
2 324 17 95.01466 244 12 95.3125
3 330 15 95.65217 209 10 95.43379
1 375 13 96.64948 208 29 87.76371
2 307 14 95.63863 320 44 87.91209
3 281 17 94.2953 263 33 88.85135
1 165 18 90.16393 282 36 88.67925
2 553 24 95.84055 244 66 78.70968
3 331 22 93.76771 278 73 79.20228
1 299 3 99.00662 172 56 75.4386
2 161 15 91.47727 339 69 83.08824










Table 93 Raw data from T-47D test at 52oC for 18min. 
 
Table 94 Raw data from T-47D test at 52oC for 20min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 134 11 92.41379 141 12 92.15686
2 186 17 91.62562 156 23 87.15084
3 172 10 94.50549 146 12 92.40506
1 256 14 94.81481 243 17 93.46154
2 204 10 95.3271 240 11 95.61753
3 278 19 93.60269 192 6 96.9697
1 167 11 93.82022 71 100 41.52047
2 172 20 89.58333 150 33 81.96721
3 225 18 92.59259 254 45 84.94983
1 199 17 92.12963 90 132 40.54054
2 183 14 92.8934 104 117 47.05882
3 182 14 92.85714 59 124 32.24044
1 181 10 94.7644 31 93 25
2 167 24 87.43455 0 181 0







Slide Picture # Live Dead % Viable Live Dead % Viable
1 158 9 94.61078 197 5 97.52475
2 199 5 97.54902 304 10 96.81529
3 186 9 95.38462 195 8 96.05911
1 209 30 87.4477 185 16 92.0398
2 187 18 91.21951 316 27 92.12828
3 162 20 89.01099 200 58 77.51938
1 184 13 93.40102 363 145 71.45669
2 143 5 96.62162 406 66 86.01695
3 262 17 93.90681 240 109 68.76791
1 176 6 96.7033 0 173 0
2 140 7 95.2381 12 232 4.918033
3 195 5 97.5 0 156 0
1 161 7 95.83333 5 209 2.336449
2 314 32 90.75145 0 167 0










Table 95 Raw data from T-47D test at 54oC for 4min. 
 
Table 96 Raw data from T-47D test at 54oC for 6min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 90 28 76.27119 105 16 86.77686
2 70 9 88.60759 76 13 85.39326
3 21 3 87.5 90 16 84.90566
1 103 16 86.55462 87 17 83.65385
2 86 14 86 104 14 88.13559
3 85 18 82.52427 156 29 84.32432
1 84 12 87.5 168 24 87.5
2 72 16 81.81818 115 14 89.14729
3 112 22 83.58209 51 11 82.25806
1 165 27 85.9375 83 9 90.21739
2 133 17 88.66667 128 10 92.75362
3 69 11 86.25 132 16 89.18919
1 87 11 88.77551 122 13 90.37037
2 95 10 90.47619 81 8 91.01124







Slide Picture # Live Dead % Viable Live Dead % Viable
1 39 1 97.5 58 7 89.23077
2 80 4 95.2381 61 10 85.91549
3 40 2 95.2381 30 9 76.92308
1 77 6 92.77108 53 3 94.64286
2 63 4 94.02985 113 11 91.12903
3 55 6 90.16393 53 4 92.98246
1 78 12 86.66667 56 17 76.71233
2 76 4 95 40 20 66.66667
3 116 2 98.30508 57 22 72.1519
1 110 18 85.9375 45 28 61.64384
2 91 23 79.82456 32 14 69.56522
3 60 10 85.71429 73 37 66.36364
1 79 14 84.94624 101 37 73.18841
2 95 20 82.6087 47 11 81.03448










Table 97 Raw data from T-47D test at 54oC for 8min. 
 
Table 98 Raw data from T-47D test at 54oC for 10min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 62 7 89.85507 107 9 92.24138
2 166 21 88.77005 149 14 91.41104
3 138 9 93.87755 57 7 89.0625
1 61 5 92.42424 60 4 93.75
2 121 2 98.37398 144 6 96
3 58 3 95.08197 89 7 92.70833
1 70 6 92.10526 55 40 57.89474
2 63 2 96.92308 19 17 52.77778
3 78 5 93.9759 71 40 63.96396
1 38 3 92.68293 47 31 60.25641
2 41 3 93.18182 138 39 77.9661
3 48 2 96 40 36 52.63158
1 97 5 95.09804 77 35 68.75
2 73 5 93.58974 28 22 56







Slide Picture # Live Dead % Viable Live Dead % Viable
1 79 13 85.86957 48 6 88.88889
2 52 18 74.28571 66 4 94.28571
3 98 14 87.5 63 5 92.64706
1 68 23 74.72527 33 4 89.18919
2 60 13 82.19178 41 12 77.35849
3 57 9 86.36364 82 11 88.17204
1 54 22 71.05263 6 38 13.63636
2 90 26 77.58621 79 121 39.5
3 81 21 79.41176 6 51 10.52632
1 43 14 75.4386 15 17 46.875
2 80 12 86.95652 48 35 57.83133
3 60 7 89.55224 0 58 0
1 63 13 82.89474 8 58 12.12121
2 43 7 86 2 42 4.545455










Table 99 Raw data from T-47D test at 54oC for 12min. 
 
Table 100 Raw data from T-47D test at 57oC for 2min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 87 12 87.87879 86 8 91.48936
2 99 6 94.28571 67 5 93.05556
3 99 14 87.61062 134 7 95.03546
1 79 3 96.34146 106 11 90.59829
2 105 21 83.33333 108 6 94.73684
3 92 7 92.92929 55 8 87.30159
1 88 7 92.63158 52 112 31.70732
2 143 9 94.07895 41 86 32.28346
3 114 17 87.0229 21 90 18.91892
1 50 5 90.90909 5 51 8.928571
2 41 0 100 0 30 0
3 25 7 78.125 21 101 17.21311
1 42 4 91.30435 117 122 48.95397
2 43 6 87.7551 3 54 5.263158







Slide Picture # Live Dead % Viable Live Dead % Viable
1 277 42 86.83386 182 28 86.66667
2 192 15 92.75362 193 46 80.75314
3 276 16 94.52055 213 14 93.8326
1 224 5 97.81659 272 12 95.77465
2 232 14 94.30894 264 22 92.30769
3 174 66 72.5 383 52 88.04598
1 403 50 88.96247 309 61 83.51351
2 335 21 94.10112 237 33 87.77778
3 173 8 95.58011 284 25 91.90939
1 260 20 92.85714 332 64 83.83838
2 356 18 95.18717 424 51 89.26316
3 371 35 91.37931 242 47 83.73702
1 415 66 86.27859 288 24 92.30769
2 294 32 90.18405 263 39 87.08609










Table 101 Raw data from T-47D test at 57oC for 3min. 
 
Table 102 Raw data from T-47D test at 57oC for 4.5min. 
 
Slide Picture # Live Dead % Viable Live Dead % Viable
1 328 12 96.47059 309 21 93.63636
2 362 16 95.7672 601 27 95.70064
3 367 8 97.86667 350 13 96.41873
1 310 14 95.67901 316 27 92.12828
2 173 30 85.22167 315 13 96.03659
3 365 22 94.31525 245 12 95.33074
1 716 23 96.88769 409 270 60.23564
2 625 24 96.302 474 178 72.69939
3 658 26 96.19883 431 182 70.30995
1 595 22 96.43436 604 54 91.79331
2 516 18 96.62921 449 45 90.89069
3 616 31 95.20866 406 99 80.39604
1 711 25 96.60326 436 76 85.15625
2 512 10 98.08429 454 98 82.24638







Slide Picture # Live Dead % Viable Live Dead % Viable
1 147 9 94.23077 140 18 88.60759
2 280 15 94.91525 143 18 88.81988
3 148 5 96.73203 196 11 94.68599
1 227 25 90.07937 200 7 96.61836
2 162 19 89.50276 139 12 92.05298
3 187 18 91.21951 103 10 91.15044
1 314 14 95.73171 61 248 19.7411
2 380 15 96.20253 39 267 12.7451
3 376 26 93.53234 80 242 24.84472
1 547 19 96.64311 135 218 38.24363
2 481 13 97.36842 296 197 60.04057
3 376 14 96.41026 352 67 84.00955
1 327 14 95.89443 254 50 83.55263
2 282 11 96.24573 208 134 60.81871










Table 103 Raw data from T-47D test at 57oC for 6min. 
 





Slide Picture # Live Dead % Viable Live Dead % Viable
1 155 11 93.37349 190 15 92.68293
2 127 1 99.21875 151 17 89.88095
3 190 7 96.4467 188 21 89.95215
1 194 12 94.17476 198 10 95.19231
2 190 13 93.59606 180 9 95.2381
3 180 9 95.2381 199 10 95.21531
1 139 6 95.86207 140 18 88.60759
2 162 10 94.18605 152 27 84.9162
3 220 17 92.827 229 26 89.80392
1 139 4 97.2028 0 175 0
2 95 3 96.93878 0 108 0
3 102 17 85.71429 0 84 0
1 174 18 90.625 0 108 0
2 102 8 92.72727 0 117 0







Slide Picture # Live Dead % Viable Live Dead % Viable
1 412 23 94.71264 370 28 92.96482
2 355 27 92.93194 241 19 92.69231
3 257 22 92.1147 461 23 95.24793
1 60 3 95.2381 94 6 94
2 221 14 94.04255 117 8 93.6
3 237 23 91.15385 152 15 91.01796
1 354 16 95.67568 0 399 0
2 306 18 94.44444 15 295 4.83871
3 408 19 95.55035 1 231 0.431034
1 337 51 86.85567 2 234 0.847458
2 371 20 94.88491 0 278 0
3 314 18 94.57831 0 249 0
1 288 18 94.11765 0 159 0
2 265 10 96.36364 0 168 0










Appendix H: Data in Cell Survival Curves 
 Table 105 displays the means and confidence intervals of the viability 
percentages at each time and temperature trial for the treatment cells and when they 
are normalized to C-37 and C-Var. 













14 89.1 83.6 94.5 92.2 86.8 97.6 94.1 89.1 99.1
16 74.6 63.6 85.7 82.1 69.9 94.3 79.0 67.3 90.7
18 84.5 76.2 92.7 88.8 80.8 96.8 90.3 82.4 98.2
20 48.3 29.8 66.8 52.4 32.3 72.4 55.2 34.1 76.4
22 39.6 13.9 65.4 42.9 15.0 70.8 44.7 15.6 73.7
20 96.4 93.7 99.2 98.5 96.2 100.8 97.8 95.3 100.3
24 90.5 82.7 98.3 92.9 85.1 100.8 94.1 86.4 101.7
28 59.5 52.3 66.6 62.0 54.5 69.4 62.6 55.1 70.1
32 46.6 16.9 76.2 49.6 18.0 81.2 49.6 18.0 81.2
34 55.0 32.8 77.3 55.7 33.2 78.3 57.8 34.4 81.1
8 46.4 40.1 52.7 51.3 44.3 58.2 54.7 47.3 62.2
11 40.6 33.4 47.9 42.3 34.8 49.8 47.7 39.2 56.2
14 63.3 47.0 79.6 67.9 50.4 85.4 63.7 47.3 80.2
16.5 34.3 13.5 55.0 35.2 13.8 56.5 34.7 13.6 55.7
18 13.8 -5.2 32.9 14.7 -5.6 34.9 14.1 -5.3 33.4
12 90.7 87.7 93.7 96.4 93.5 99.2 94.6 91.6 97.7
14 90.1 88.0 92.2 92.5 90.4 94.7 94.6 92.5 96.8
16 88.8 84.6 93.0 91.4 87.1 95.7 92.6 88.2 96.9
18 35.1 19.1 51.2 36.0 19.6 52.5 36.2 19.7 52.7
20 5.6 -5.1 16.3 5.8 -5.3 16.9 6.2 -5.7 18.1
2 75.8 64.1 87.6 77.8 65.7 89.9 83.6 71.8 95.4
4 66.4 57.1 75.7 70.5 60.7 80.4 68.5 58.9 78.0
5 65.9 56.7 75.1 69.8 60.0 79.5 69.5 59.8 79.2
6 35.2 17.6 52.8 37.4 18.7 56.0 37.0 18.5 55.4
7 15.4 5.6 25.2 17.0 6.2 27.7 16.6 6.1 27.2
4 91.9 88.8 94.9 100.0 100.0 100.0 95.7 93.6 97.9
6 82.1 76.1 88.1 93.8 86.9 100.7 86.0 79.7 92.3
8 66.9 59.4 74.4 71.3 63.3 79.3 68.9 61.1 76.6
10 9.4 2.2 16.6 10.2 2.4 18.0 10.3 2.4 18.2
12 19.4 8.4 30.4 20.8 9.0 32.7 20.0 8.6 31.4
0.5 85.3 80.5 90.1 97.4 93.5 101.4 91.4 86.4 96.4
1 80.9 77.4 84.4 84.7 81.1 88.4 88.6 84.7 92.4
2 65.4 59.9 70.8 68.9 63.1 74.6 69.7 63.9 75.5
3 50.8 40.7 60.8 52.9 42.5 63.4 56.0 44.9 67.0
5 30.3 22.5 38.1 33.1 24.6 41.6 34.0 25.3 42.7
2 93.2 90.2 96.2 97.3 96.1 98.6 95.8 94.0 97.7
3 85.9 78.8 93.0 87.2 80.0 94.4 89.4 82.0 96.7
4.5 53.2 30.9 75.5 55.9 32.5 79.3 57.0 33.2 80.9
6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
8 0.7 -0.6 2.0 0.7 -0.6 2.0 0.8 -0.6 2.1
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